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Abstract 
 
Every year 2 million people are diagnosed with leishmaniasis and 350 million 
are at risk of becoming infected. Spread throughout 88 countries in the 
world, leishmaniasis is a group of diseases comprising visceral, 
mucocutaneous and cutaneous leishmaniasis as the main forms. Visceral 
leishmanisis is the most severe form of the disease and is caused by 
Leishmania donovani.  The parasite, Leishmania, is transmitted to humans by 
a sandfly vector. The absence of vector-control procedures and effective 
vaccines for humans makes chemotherapy the only weapon against 
leishmaniasis. Great efforts have been made to develop new drugs against 
these diseases, however toxic side effect and the constant cases of resistance 
call for new drug targets and drugs to be discovered and developed. 
 
Cysteine is a key building block of trypanothione, an antioxidant unique to 
trypanosomatids that plays a pivotal role for the survival of the parasites. 
Leishmania can obtain cysteine in two ways, using the sulphydrylation and 
trans-sulphuration pathways. Humans lack the sulphydrylation pathway, thus 
this, and especially cysteine synthase (CS), of Leishmania could be a 
potential drug target. In order to determine the relative importance of these 
pathways, the levels of thiols at different stages of promastigote growth of 
wild-type, mutants lacking CS (cs), and CS episomal re-expressor parasite 
lines were determined. It was found that during logarithmic phase the 
mutant parasites have significantly reduced levels of thiols, which is reversed 
in the CS re-expressing parasite line. The mRNA and protein levels of 
cystathionine β-synthase (CBS) were increased in cs L. donovani, while this 
decrease was reversed in the CS re-expessing line. These data suggest that 
the reverse trans-sulphuration pathway compensates for the loss of CS to 
some extent but that this is not sufficient to maintain thiol levels during 
logarithmic growth. It was further found that ornithine decarboxylase mRNA 
is up-regulated while the protein levels appear to be reduced in the cs 
parasite line. The latter was supported by the finding that the cs mutant 
iii 
 
 
parasites have low sensitivity to -difluoromethylornithine, an inhibitor of 
ornithine decarboxylase.  
 
The studies on the recombinant L. major cysteine synthase (CS) have shown 
that it can be inhibited by small peptides based on the C-terminal of L. major 
serine acetyltransferase. The CPM assay showed promising results to be used 
in high-throughput screening of CS inhibitors. 
 
The data overall suggests that the levels of thiols are dependent on an 
adequate supply of cysteine through the sulphydrylation pathway. How this 
affects polyamine biosynthesis is yet to be investigated.   
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Chapter 1 – Introduction                                                                                       2 
 
 
1 Introduction 
1.1 Leishmania parasites 
Leishmania parasites are the causative agent of Leishmaniasis, a spectrum of 
diseases that affect people in 88 countries across four continents. About 2 
million people are diagnosed every year with the disease while 350 million 
people are at risk of being infected with this parasite (WHO). Leishmania is a 
protozoan parasite of the order Kinetoplastida and family Trypanosomatidae 
(Myler, 2008). This family also comprises other known parasites, the 
Trypanosoma brucei, the causative agent of the African trypanosomiasis or 
sleeping sickness in humans and Nagana in cattle, and Trypanosoma cruzi, 
the causative agent of the human American trypanosomiasis or Chagas 
disease.  
 
Leishmaniasis can exhibit at least three clinical forms: cutaneous, 
mucocutaneous, and visceral. Each condition depends on the host genetic 
variability and thus their immune response, the transmitting sandfly vector, 
environmental factors and on the species of parasite (Harhay et al., 2011; 
McCall et al., 2013; Peacock et al., 2007).  
 
Cutaneous leishmaniasis (CL), caused by L. mexicana, L. major, L. tropica, L. 
amazonensis, and L. braziliensis, mainly occurs in Afghanistan, Brazil, India, 
Nepal and Sudan. Mucocutaneous leishmaniasis (ML) is caused by L. 
braziliensis, L. panamensis, L. guyanensis, and L. amazonensis. It occurs in 
countries like Bolivia, Brazil and Peru. Cutaneous and mucocutaneous 
leishmaniasis generates slow-healing, localised ulcerations in the skin and 
mucosal surfaces. Visceral leishmanisis (VL) is the most severe form of the 
disease being lethal if left untreated. L. donovani and L. infantum are the 
main causative species of this disease. The countries affected are 
Bangladesh, Brazil, India, Nepal and Sudan. In this case the parasite 
disseminates through internal organs such as the liver, spleen, and bone 
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marrow, causing approximately 70,000 deaths per year (Harhay et al., 2011; 
McCall et al., 2013; Peacock et al., 2007; WHO). 
 
Leishmaniasis is a vector-borne disease, transmitted by 30 species of 
sandflies – Phlebotomus or Lutzomyia (Mishra et al., 2009; Myler, 2008). 
 
The Leishmania parasites are 5-14 m long and occur as two distinctive 
morphologic forms: promastigote and amastigotes (Figure 1.1). The process 
of infection of the host starts when the phlebotomine sandfly takes its blood 
meal (Figure 1.2,1). In the blood stream, metacyclic promastigotes are 
readily captured in the dermis by cells of the host‟s immune system (Figure 
1.2,2). Multiple cell types are involved, such as macrophages, neutrophils 
and/or dermal dendritic cells. Metacyclic promastigotes are the infective 
form with a small cell body and long flagellum that provides the parasites 
with the ability to swim rapidily. Inside the immune cells, the parasites 
undergo differentiation into aflaggelar amastigotes (Figure 1.2,3). These are 
located in the phagolysosome where the pH is low. Amastigotes are capable 
of replicating rapidly (Figure 1.2,4). This rapid replication will result in 
increased number of amastigotes inside the immune cell, which will lead to 
its death, and the release of parasites in to the blood stream (Figure 1.2,4). 
Here they are able to further infect more cells and to proliferate and develop 
the disease (Basu and Ray, 2005; Kaye and Scott, 2011; McConville et al., 
2007; Naderer and McConville, 2008; Sakthianandeswaren et al., 2009).   
 
When the sandfly takes a blood meal from an infected host, the proboscis of 
the insect captures the amastigotes (Figure 1.2,5,6). Inside the insect the 
parasites undergo differentiation as they migrate inside the insect gut (Figure 
1.3). Amastigotes first differentiate into flagellated procyclic promastigotes 
(Figure 1.2,7). They are particularly resistant to the insect‟s digestive 
enzymes allowing them to multiply and proceed with their differentiation 
into the infective stage (metacyclic, Figure 1.2,8). Procyclic promastigotes 
are separated from the midgut of the insect by a type I perithrophic matrix, 
thus their differentiation into the next form, nectomonads (large and slender 
form), allows them to escape it. In the midgut, the nectomonads 
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differentiate into leptomonads (shorter form) and undergo a second 
multiplication. It is still not known if the haptomonads originate from 
nectomonads or from leptomonads, but they do precede the differentiation 
into non-dividing metacyclics parasites. Haptomonads are non-motile leaf-
like parasites with short flagella and are found in the stomodeal valve (Figure 
1.3). Metacyclics are found behind the stomodeal valve where they 
accumulate, waiting for the sandfly to take another blood meal and to re-
Final Thesis 28 novstart of their life cycle (Kamhawi, 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 – The two forms of the Leishmania parasite cell. 
Schematic diagram of a promastigote (a) and a amastigote (b) cell. The 
anterior side of the parasite is demarked by the flagellar pocket (Besteiro 
et al., 2007). 
Printed with permission from Elsevier. 
A 
B 
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Figure 1.2 – Leishmania life cycle. 
Schematic diagram showing each step of Leishmania parasite life cycle. 
(1) a metacyclic form-containing sandfly takes a blood meal infecting the 
host; (2) in the host’s blood, macrophages phagocytise the promastigote 
parasites; (3) in the macrophage the promastigotes differentiate into 
amastigotes; (4) the amastigotes replicate leading to the death of the 
immune system cell and the spread of the amastigotes in the blood 
stream; (5,6) a sandfly gets infected by taking a blood meal from an 
infected host; (7) in the sandfly the amastigotes differentiate into 
promastigotes; (8) the promastigotes undergo differentiation into 
metacyclics, the infective stage (CDC).   
Printed with permission from the Center for Disease Control. 
 
 
 
 
 
 
 
 
 
Figure 1.3 – Anatomy of a sandfly. 
This schematic diagram shows the names of the compartments of a sandfly 
body (Kamhawi, 2006). 
Printed with permission from Elsevier. 
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1.1.1 Interactions between Leishmania and macrophages 
Promastigote cells are coated by a glycocalyx, which consists of 
glycosylphosphatidylinositol (GPI)-anchored proteins, GPI-anchored 
phosphoglycan, lipophosphoglycan (LPG) and a family of free GPI glycolipids 
termed glycoinositolphospholipids (GIPLs) (Naderer and McConville, 2008). 
Mutant analysis showed that LPG protects the cells from a transient rise in 
the reactive oxygen species (ROS) generated during phagocytosis (Naderer 
and McConville, 2008). Studies on L. major concluded that LPG is essential 
for their infectivity (Naderer and McConville, 2008).  
 
On the contrary, L. mexicana promastigotes do not require LPG for their 
virulence. In fact, LPG is downregulated during the infective stage of the 
parasite. In terms of resistance to ROS and RNS (reactive nitrogen species), L. 
mexicana proved to be more resistant than L. major or L. donovani (Naderer 
and McConville, 2008).  
 
The uptake of L. major promastigotes is promoted by the presence of dead 
parasites in the inoculums due to the high levels of surface exposed 
phosphatidylserine that promote the uptake of dead and live promastigotes 
by neutrophil receptors (Naderer and McConville, 2008).   
 
Conversly, amastigotes have low expression levels of LPG and a less complex 
glycocalyx (Naderer and McConville, 2008). This coat prevents the release of 
parasitic peptides that could be presented to the host immune system 
(Naderer and McConville, 2008). Amastigotes produce inositol 
phosphoceramide (IPC) using sphingolipid bases taken by the host, which may 
complement GIPLs in their function (Naderer and McConville, 2008).  
 
The amastigote plasma membrane is rich in phosphatidylserine which may 
proportionate the entrance to the cell without activating the microbicidal 
processes or inflammatory responses (Naderer and McConville, 2008).  
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1.2 Treatment 
Because of the absence of vector-control measures and effective vaccines, 
humans rely solely on chemotherapy to treat leishmaniasis. For more than 60 
years pentavalent antimonials (e.g. sodium stibogluconate and meglumine 
antimoniate) have been used as the primary treatment of leishmaniasis. 
Other drugs also available for treatment of leishmaniasis are amphotericin B 
and its lipid formulations, pentamidine, paramomycin, miltefosine, 
sitamaquine as well as imidazoles and triazoles (Croft and Coombs, 2003; 
Croft et al., 2006). The mechanism of action of these drugs is not completely 
understood. The build up of resistance to antimonial drugs in the city of Bihar 
in India, the severe side effects of the other available drugs, and the 
differences in affectivity between species, and parasite stages, emphasises 
the need to discover new effective drugs against leishmaniasis (Coombs et 
al., 1983; Singh et al., 2012; Sundar, 2001; Sundar et al., 2010; Thakur et 
al., 2001).  
Sodium stibogluconate (SbV) is a pro-drug believed to be activated (converted 
into trivalent form, SbIII) either within macrophages or amastigotes, but not 
in the promastigotes. Both the trivalent and the pentavalent form have anti-
Leishmania activity by DNA fragmentation (Cunningham and Fairlamb, 1995; 
Singh et al., 2012). However, the pentavalent form is ineffective in the 
promastigote form.  It has been demonstrated that the antimony drug inhibits 
the trypanothione reductase enzyme and affects the thiol balance in the cell 
by promoting the extrusion of thiols, which reduces the thiol buffering 
capacity and leaves the cell more susceptible to oxidative stress (Cunningham 
et al., 1994; Mandal et al., 2007; Wyllie et al., 2004; Wyllie et al., 2008). 
Thiol levels have been shown to be elevated in resistant forms of Leishmania 
parasites. Antimonials have been used in the treatment of cases of VL and 
CL. Although very efficient, this drug is expensive, its administration is 
intravenous, and there are severe cases of resistance reported in Bihar, India 
(Singh et al., 2012; Stauch et al., 2012; Sundar, 2001; Sundar et al., 2010; 
Thakur et al., 2001). Resistance to these drugs seems to be associated with 
efflux pumps (P-glycoprotein and multi-drug resistance protein A) that 
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extrude the drug outside the cell. It has also been reported that 
pentamonials inhibit the trypanothione reductase (Ashutosh et al., 2007; 
Cunningham and Fairlamb, 1995; Mittal et al., 2007; Mukhopadhyay et al., 
1996).   
Amphotericin B has been used to treat cases of VL, CL, and ML, and as second 
choice drug to treat cases of VL resistance in Bihar, India. This drug has a 
high affinity for ergosterol present in Leishmania and fungi but absent in 
mammalian cells. However, it is still an expensive and difficult to administer 
drug (via 4 hour parenteral infusion) that has been shown to have toxic side 
effects (Bray et al., 2003; Croft and Coombs, 2003; Croft and Olliaro, 2011; 
Singh et al., 2012). Lipid formulations of this drug have been engineered to 
circumvent the side effects with success, however there are still associated 
with high costs (Pham et al., 2013; Singh et al., 2012). 
 
Pentamidine has been used as an alternative for antimonials. It is thought to 
enter the Leishmania cell by the polyamine and arginine transporter and to 
accumulate in the mitochondria. Currently, due to low efficacy and toxic side 
effects, this drug has been withdrawn from use in India. Its side effects 
include nephrotoxicity, hypoglycaemia and hypotension (Basselin et al., 2000; 
Basselin et al., 1996; Bray et al., 2003; Coelho et al., 2007; Jha, 1983; 
Kandpal and Tekwani, 1997; Singh et al., 2012).  
 
Paramomycin cures both VL and CL. In bacteria its mechanism of action is 
inhibition of protein synthesis by binding to the 30S subunit of ribosomes. In 
Leishmania it is also known to affect the mitochondrion (Singh et al., 2012; 
Thakur et al., 2000). There are no cases of resistance, possibly due to its 
limited used. Nonetheless, one must not underestimate its antibiotic nature 
(Singh et al., 2012). 
 
Miltefosine is the first oral drug available for leishmanisis. It has been used in 
Bihar, India to tackle the VL resistance cases. Its oral availability makes it 
easy to administer as no specialised skills are required which is a necessety in 
poor areas of the globe. Unfortunately, there is variability of efficacy 
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between species. There are still no reported cases of resistance to this drug. 
Being an oral drug allows its miss-use in the endemic areas and therefore new 
drugs should be available. Its mode of action is unclear. Miltefosine is 
associated with teratogenicity and abortifacient side effects, thus cannot be 
used in pregnant women (Croft and Engel, 2006; Escobar et al., 2002; Perez-
Victoria et al., 2006; Seifert et al., 2003; Sundar et al., 2006). 
 
Sitamaquine is an oral drug developed for the treatment of VL. It inserts 
within biological membranes accumulating itself in Leishmania„s acidic 
compartments (Jha et al., 2005; Lopez-Martin et al., 2008; Sundar and 
Chatterjee, 2006). 
 
Azols have been shown to have differential activity in CL and VL cases. 
Differences have been observed between species. The similarities between 
fungi and Leishmania regarding ergosterol content makes it possible for these 
drugs to be used against leishmaniasis. However, side effects affect the 
biosynthesis of adrenal and testicular steroids and thus limit their use. (Croft 
and Coombs, 2003). 
 
The treatment of leishmaniasis depends on sensitivity variation between 
species, emergence of drug resistance (e.g. the city of Bihar in India), and 
variation of drug activity within the immune response of the patient (Croft 
and Coombs, 2003; Croft et al., 2002; Mandal et al., 2007; Seifert et al., 
2010; Stauch et al., 2012; Sundar, 2001). 
 
The use of combination therapy can help to decrease the length of treatment 
necessary and lower the drug dose needed thus avoiding drug resistance. 
Examples of drug combinantions that have been studied as alternatives to 
anti-leishmanisis therapies are the combination of miltefosine and ambisome 
(effective but still presenting side effects) (Singh et al., 2012); the synergy of 
paramomycin with gentamicine has shown to be effective in CL cases (Ben 
Salah et al., 2009); sitamaquine and miltefosine have been proposed as a 
possible combination as both are oral drugs, however more studies need to be 
done (Sangraula et al., 2003); and lovastatin and miconazole, both 
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cholesterol lowering agents, showed some evidence of inhibition of sterol 
biosynthesis (Haughan et al., 1992).  
 
There are many ways to research new drugs. Drugs that are already available 
can be further investigated to determine their toxicity for parasites (e.g. 
azols, fexinidazole, tricyclics compounds). Or new drug targets can be 
investigated. However, new therapeutics must be low in cost; available in 
oral formulations; require a short therapeutical course; and have the ability 
to be used in drug combinations in order to avoid drug resistance and to 
address cases of double infection with VL and HIV virus (Chibale et al., 2000; 
Renslo and McKerrow, 2006; Wyllie et al., 2012). 
 
The main mode of defence against antimonial drugs seams to be due to 
extrusion of thiols (trypanothione and glutathione) and thus imbalance of 
redox homeostasis. Cysteine is the active amino acid in the structure of low-
molecular weight thiols and therefore its synthesis could possibly provide a 
good base of study for new drug targets. Drugs that target this biosynthetic 
pathway could be used in combination therapy with antimonials, possibly 
improving its efficacy or they can be used on their own to allow macrophages 
to win the redox battle against leishmania. 
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1.3 Cysteine biosynthesis 
The cysteine biosynthetic pathway in Leishmania has just recently begun to 
be characterised. Thus this research must rely on knowledge provided by 
well-characterised species such as Trymanosoma cruzi, Arabidopsis thaliana, 
Escherichia coli, Saccharomyces cerevisiae, Salmonella typhimurium and 
Mycobacterium turberculosis (Becker et al., 1969; Duszenko et al., 1992; 
Gorman and Shapiro, 2004; Kredich et al., 1969; Muller et al., 2003; Nozaki 
et al., 2001; Salsi et al., 2010; Thomas and Surdin-Kerjan, 1997; Wirtz and 
Droux, 2005; Zhao et al., 2006). 
 
1.3.1 The sulphydrylation pathway and the reverse trans-
sulphuration pathway 
Williams et al. (2009), have characterised the cysteine biosynthetic pathway 
in Leishmania major. There are two cysteine biosynthetic pathways available 
in this parasite, the sulphydrylation pathway (SP) or de novo biosynthesis 
pathway and the reverse trans-sulphuration pathway (RTS). The essentiality 
of cysteine has not yet been demonstrated in Leishmania parasites. In 
members of the same family, it is an essential growth factor for Trypanosoma 
brucei, and Trypanosoma cruzi is able to synthesise it via the RTS pathway. 
L. major also has forward transsulphuration and thus can synthesise 
methionine, an essential amino acid in humans (Duszenko et al., 1992; Nozaki 
et al., 2001; Williams et al., 2009).  
 
Figure 1.4 shows a schematic diagram of the two biosynthetic pathways. 
Briefly, serine acetyltransferase (SAT) generates O-acetylserine (OAS) by 
transferring acetate from acetyl-CoA to serine. This reaction is followed by 
that of cysteine synthase (CS), a pyridoxal 5‟-phosphate (PLP)-dependent 
protein that catalyses the formation of cysteine from OAS using sulphide 
donors (Bonner et al., 2005). RTS forms homocysteine from methionine, 
homocysteine is converted into cysteine in two steps and is catalysed by 
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cystathionine β-synthase (CBS) and cystathionine γ-lyase (CGL) (Francois et 
al., 2006; Schnell et al., 2007; Williams et al., 2009). 
 
 
 
Figure 1.4 – Cysteine biosynthetic pathway. 
In Leishmania parasites cysteine can be synthesised from serine by the 
sulphydrylation pathway (SP) or from methionine the reverse trans-
sulphuration pathway (RTS). Apart from this parasite, Trychomonas, T. 
cruzi, plants and bacteria are able to use serine to synthesise cysteine. 
RTS is a ubiquitous pathway. For humans cysteine is an essential amino 
acid that is used in the synthesis of methionine. Cysteine is the building 
block of glutathione and trypanothione. Trypanothione is the major low-
molecular weight thiol in Leishmania and is exclusive to trypanosomatids. 
The main thiols are highlighted: cysteine (blue), homocysteine (yellow), 
glutathione (green), and trypanothione (red). 
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1.3.1.2 Cysteine synthase 
The sulphydrylation pathway is absent in humans, thus potentially making is a 
good platform from which to begin a targeted novel drug search. One 
important enzyme of this pathway is cysteine synthase. According to the 
findings of Williams et al. (2009), LmjCS belong structurally to the type A 
class of CS(s). This characteristic is shared by bacteria and A. thaliana CS(s) 
who, like LmjCS, are able to form a complex with SAT and accepts O-acetyl 
serine as a substrate (Kumaran and Jez, 2007). This is possible due to the 
presence of a conserved substrate-binding 8-9 loop present in LmjCS 
(predicted structure) and other type A CS(s). SAT binds to this motif to form 
a complex with CS. When bound, SAT C-terminal residues cover CS‟s active 
site, inhibiting its activity. OAS can disrupt this complex (Kumaran and Jez, 
2007). As said before, type A CS(s) can accept O-acetyl serine, which is a 
relatively small substrate when compared with O-phosphoserine that is 
accepted by Aeropyrum pernix and Trichomonas vaginalis CS(s) (Mino and 
Ishikawa, 2003; Westrop et al., 2006). This characteristic is also conferred by 
the substrate-binding 8-9 loop. This loop restricts the access to the active 
side pocket, allowing only small positively charged substrate to bind to CS. 
Type B CS(s) lack this loop which allows them to accept larger and negatively 
charged substrates. However, they are also unable to form complex with SAT 
(Kumaran and Jez, 2007; Mino and Ishikawa, 2003; Schnell et al., 2007; 
Westrop et al., 2006; Williams et al., 2009; Zocher et al., 2007).  
 
The enzymatic reaction of CS with OAS has been well described in both plant 
and bacterial enzymes. The pyridoxal 5‟-phosphate (PLP) co-factor is bound 
to a lysine in the CS‟s active site forming an internal Schiff base (Figure 1.5, 
step 1). In the first half of the reaction, OAS binds to PLP forming an external 
Schiff base (Figure 1.5, step 2). Its rearrangement generates the release of 
one molecule of acetate and the formation of an α-amino acrylate 
intermediate (Figure 1.5, step 3). In the second half-reaction sulphide 
attacks the nucleophile β-carbon of the aminoacrylate intermediate, and the 
α-carbon is re-protonated resulting in the binding of the cysteine as an 
external Schiff base (Figure 1.5, step 4). The final product is released via 
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regeneration of the external aldimine (Figure 1.5, step 1) (Bonner et al., 
2005; Huang et al., 2005; Schnell et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 – The cysteine synthase reaction. 
The reaction catalysed by cysteine synthase (red) where O-acetyl serine 
(black) is converted into cysteine (pink), in the presence of the co-factor 
pyridoxal 5’-phosphate (blue), in a two-step reaction that involves the 
formation of an -amino acrylate intermediate.  
Printed with permission from the American Society for Biochemistry and 
Molecular Biology.  
 
In Mycobacterium tuberculosis and Salmonella typhimurium CS this last step 
is accompanied by a large conformational change that leads to the closure of 
the active site (Schnell et al., 2007). However, in A. thaliana the 
correspondent structure remains open and the later product is assumed to 
mimic the external aldimine (Schnell et al., 2007). 
 
1.3.1.2.1 Cysteine synthase in plants 
Plants have three types of CS: type A located in the cytosol; type B located in 
the chloroplast; and type C in the mitochondria. The cysteine biochemical 
pathway comprises three stages: the fixing of sulphate and its conversion into 
sulphide by assimilatory reduction; the synthesis of OAS from serine, 
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catalysed by serine acetyl-transferase; and the reaction of sulphide with OAS, 
catalysed by CS, with the formation of cysteine (Bonner et al., 2005; Heeg et 
al., 2008; Hell et al., 2002; Warrilow and Hawkesford, 2002; Wirtz et al., 
2004).  
 
The exclusive location of assimilatory sulphate reduction in plastids suggests 
that sulphide is able to reach cysteine synthesis in cytosol and mitochondria, 
possibly by diffusion of H2S through membranes (Heeg et al., 2008).  
Cysteine synthesis is the terminal step in sulphur assimilation and is an 
important entry reaction of reduced sulphur into metabolism (Croft et al., 
2006). 
 
The cysteine synthesis in A. thaliana cells shows that CS isoforms A 
(cytoplasm) and B (plastids) are more abundant and active than the isoform C 
(mitochondria). Cysteine and sulphide must be exchanged between the 
organelles and cytosol, the compartments can compensate for cysteine 
deficiency to some extent among themselves, and mitochondrial CSC is 
essential for normal growth (Heeg et al., 2008).  
 
In A. thaliana the levels of CS and SAT are not the same in the three 
compartments. However the quantity of cysteine and GSH is maintained in 
the cell with synthesis possibly being compensated by uptake (Heeg et al., 
2008). 
 
1.3.1.2.2 Cysteine synthase in bacteria 
S. typhimurium has one CS enzyme, whereas M. tuberculosis and E. coli have 
two CS enzymes, CysK and CysM. CysK uses sulphide from the sulphate 
reduction pathway as a source of sulphide, whereas CysM is able to use 
thiosulphate or larger sulphide donors. Additionally, CysK uses OAS as 
substrate and CysM uses O-phophoserine, which is important when the 
microorganism is in an anaerobic environment. CysM from M. tuberculosis can 
present as an open or closed conformations, of which there are two types, 
depending on the presence of substrate or a sulphur carrier. As seen in 
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plants, CysM has PLP bound to the lysine of the active site. In the closed 
conformation the surface loops are rearranged and the last five amino acids 
of the C-terminal of CysM are inserted in the active site. In the open 
conformation the active site pocket is big enough to accommodate large 
substrates like OPS. In the closed conformation, the C-terminal stabilises the 
-amino acrylate intermediate and works as a selector for the sulphur donor 
and leaves space for the release of acetate. The CysM is of particular interest 
for the synthesis of pharmaceuticals and agrochemicals since it can 
accommodate larger compounds (Agren et al., 2008; Agren et al., 2009; 
Kredich et al., 1969; Zhao et al., 2006; Zocher et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.1 – Cysteine biosynthetic pathways.   
The table summarises the presence/absence of cysteine biosynthetic pathways, sulphur sources, CS structural 
characteristics, and substrate in different species (please see table for references). Humans and yeast use cysteine 
acquired from the exterior of the cells to synthesise methionine. (SP) sulphydrylation pathway; (TS) trans-sulfuration 
pathway; (CS) cysteine synthase; (SAT) serine acetyl-transferase; (OAS) O-acetyl transferase; (OPS) O-phosphoserine; 
(MSP) mercaptopyruvate sulfurtransferase; (3-MP) 3-mercaptopyruvate. 
 
Cysteine Biosynthetic 
pathways  
Cysteine synthase 
 
 
SP RTS Sulphide source CS Substrate 
Presence of 
8-9 loop 
Complex with 
SAT 
Reference 
Parasites 
       
Leishmania major Yes Yes MSP/3-MP (?) OAS Yes Yes Williams et al. (2009) 
Trypanosoma brucei No Yes         Duszenko et al. (1992) 
Trymanosima cruzi No No 
    
Miles et al. (2009)            
Nozaki et al. (2001) 
Trychomonas vaginalis 
  
Thiosulphate OPS No No Westrop et al. (2006) 
Entamoeba histolitica Yes No 
 
OAS No No 
Kumar et al. (2011)  
Chinthalapudi et al. 
(2008) 
Bacteria 
       
Escherishia coli Yes No 
Hydrogen sulphide (CysK)           
Thiosulphate (CysM) 
OAS (CysK)     
OPS (CysM)   
Claus et al. (2005)               
Zhao et al. (2006)        
  Zocher et al. (2007) 
Mycobacterium 
turberculosis 
Yes No 
Hydrogen sulphide (CysK)           
Thiosulphate (CysM) 
OAS (CysK)     
OPS (CysM)   
Agren et al. (2008) 
Salmonella typhimurium Yes No Sulphur assimilatory pathway OAS 
  
Rabeh et al. (2004)       
Becker et al. (1969) 
Yeast 
       
Saccharomyces cerevisiae No Yes 
    
Thomas et al. (1997) 
Plants 
       
Aeropyrum pernix Yes No Thiosulphate OPS No No Mino et al. (2003) 
Arabidopsis thaliana Yes No Sulphur assimilatory pathway OAS Yes Yes 
Warrilow et al. (2002)  
Heeg et al. (2008)      
Bonner et al. (2005) 
Humans 
       
Homo sapiens No Yes 
    
Banerjee et al. (2005) 
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1.3.1.2.3 The cysteine synthase complex 
SAT and CS are known to form a complex, the cysteine synthase complex 
(CSC) in plants and bacteria. This complex is made of one SAT and two CSs. 
The CSC was first described in S. typhymurium as a bifunctional enzyme 
complex by Kredich et al., (1969).  
 
In plants and bacteria the source of sulphide comes from the inorganic 
sulphur assimilation pathway (Figure 1.6 and 1.7). In bacteria it is important 
that cysteine biosynthesis is regulated because it is interlinked with nitrogen 
and carbon assimilation as well as sulphur assimilation (Figure 1.7). In plants 
cysteine biosynthesis regulates the level of sulphur in the cell (Birke et al., 
2012; Salsi et al., 2010). In plants, cysteine is the sulphide donor for the 
synthesis of methionine, glutathione, phytochelatins, iron-sulphur clusters, 
vitamin cofactors, and multiple secondary metabolites (Bonner et al., 2005; 
Warrilow and Hawkesford, 2002; Wirtz et al., 2004). 
 
CSC is thought to regulate sulphur assimilation and to modulate cysteine 
biosynthesis. When bound in the complex, the SAT activity increases and the 
CS activity decreases. CS activity has been reported to be much higher than 
SAT activity therefore cysteine biosynthesis is likely to be limited by SAT 
activity. SAT in the absence of CS is less active, thus the association with CS 
promotes the activity of SAT. Interaction between SAT and CS and cysteine 
synthesis depends on the sulphur status: if sulphur becomes scarce sulphide is 
missing to stabilize the CSC, and the OAS accumulated from SAT activity, 
dissociates from the complex. This results in a decrease in SAT activity, 
reduced acetyl-CoA consumption, and OAS formation until the cell is 
resupplied with sulphide (Berkowitz et al., 2002; Bogdanova et al., 1997; 
Bonner et al., 2005; Droux et al., 1998; Francois et al., 2006; Heeg et al., 
2008; Kumaran et al., 2007b;. Wirtz et al., 2006).  
 
At high concentrations, OAS isomerizes to N-acetylserine in an irreversible 
chemical process that acts as an inducer of the gene expression for sulphate 
permease. These genes are consequently expressed to enhance sulphate 
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uptake and sulphate reduction, thus providing sulphide for cysteine synthesis. 
Like in plants and bacteria, Entamoeba acquires inorganic sulphur via the 
sulphide reduction pathway (Berkowitz et al., 2002; Bogdanova et al., 1997; 
Bonner et al., 2005; Droux et al., 1998; Francois et al., 2006; Heeg et al., 
2008; Kumaran et al., 2007b;. Wirtz et al., 2006). In T. vaginalis, Westrop et 
al. 2006 postulated that sulphide provision might be via homocysteine 
desulphurase (or methionine γ-lyase) because these parasites lack the de 
novo pathway to generate sulphide.  
 
Excess of Cys inhibits SAT activity in a negative feedback loop. In plants each 
of the cytosolic, chloroplast and mitochondrial SAT proteins have a distinct 
sensitivity towards cysteine which is dependent on the cysteine available in 
each compartment. This feedback is critical and thought to regulate SAT 
activities in A. thaliana (Wirtz et al., 2012).  
 
In the presence of sufficient sulphur, the CS and SAT enzymes form the CSC, 
possibly as a mechanism for sulphur detoxification. When the intracellular 
levels of sulphur are low, OAS accumulates because free CS is unable to 
generate cysteine due to the lack of sulphide. An increase in OAS levels 
(concentrations of 0.1 and 1.0 mM OAS) lead to complex dissociation, which 
down-regulates SAT. Nonetheless, this increase activates expression of genes 
encoding sulphate transporters, ATP sulphurylase, CS, and SAT, leading to an 
increase in sulphur uptake and reduction. With sulphur levels elevated, free 
CS catalyses cysteine formation which reduces OAS levels. This allows 
association of SAT and CS, activation of SAT, and resumption of cysteine 
biosynthesis. Biochemical experiments show that in A. thaliana CSC has the 
same function in cytosol, mitochondria, and plastids (Birke et al., 2012; 
Bonner et al., 2005; Francois et al., 2006; Heeg et al., 2008; Kredich et al., 
1969; Kredich and Tomkins, 1966; Olsen et al., 2004). 
 
The active site pocket of CS-type A of S. typhimurium closes when the 
substrate binds. Only a small channel is left open so acetate can leave and 
hydrogen sulphide can enter and start the second part of the reaction. E. coli 
CS-typeB has highly conserved residues that are also present in S. 
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typhimurium. The same conformational changes are reported for this enzyme 
site pocket. However, there are some differences on the flexible loop located 
on the opposite site of the PLP binding site, which reflects the capacity of 
type B E. coli CS to use thiosulphate instead of hydrogen sulphide. The 
overall differences between type A and type B bacterial CS reside in a loop 
located between β8 and β9 for S. typhimurium CS type A, E. coli CS type B 
and A. thaliana CS, and located between β13 and β14 for A. pernix CS. These 
differences comprise the ability of type B enzymes to use thiosulphate as an 
alternative substrate. The type B proteins do not form complexes with SAT 
while the type A CS forms a regulatory complex with SAT. Type B CS contains 
a conserved positively charged residue (arginine), which affects substrate 
specificity (Kredich et al., 1969; Oda et al., 2005; Westrop et al., 2006; Wirtz 
and Hell, 2006; Zhao et al., 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 – The sulphur assimilation pathway in Plants. 
The assimilation of sulphur in plants can be divided in four stages: (1) the 
uptake of sulphate; (2) the activation of sulphate; (3) the reduction of 
sulphate; and (4) the synthasis of cysteine. (PPi) pyrophosphate; (APS) 
adenosine 5’ phosphosulphate; (DNPases) 3’(2’),5’–diphosphonucleosidase 
3’(2’)–phosphorylase; (PAPS) adenosine 3’-phospho 5’-phosphosulphate; 
(AcoA) Acetyl Co-A; (e-) elctron.  
Printed with permission from Springer. 
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Figure 1.7 – General overview of sulphur assimilation in bacteria. 
The assimilation mechanism of sulphur in bacteria. Enzymes appear in 
bold, except SAT and OASS (or CS, red); (ATPS) ATP sulphurylase; (APSK) 
5-phosphosulphate kinase; (PAPS ST) 3-phosphoadenosine 5-
phosphosulphate sulfotransferase; (NADPH-SR) NADPH-dependent sulphite 
reductase; (PGDH) D-3-phosphoglycerate dehydrogenase; (PSAT) 3-
phosphoserine aminotransferase; (PSP) 3-phosphoserine phosphatase; 
(GluDH) glutamate dehydrogenase (Salsi et al., 2010) 
 
Printed with permission from the American Society for Biochemistry and 
Molecular Biology. 
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1.3.1.2.3.1 CSC in Leishmania 
Williams et al. (2009) has shown that LmjSAT activity was only detected 
when LmjSAT was co-expressed with LmjCS. Additionally, LmjCS activity was 
undetectable when co-expressed with LmjSAT but highly active when 
expressed alone (Westrop et al., 2006; Williams et al., 2009). In Leishmania, 
the source of sulphide is yet to be discovered but Williams et al. (2009) 
suggested possible involvement of mercaptopyruvate as a source for sulphide. 
 
In Leishmania, sulphide is thought to be provided by mercaptopyruvate 
sulphurtransferase (MST) from 3-mercapto pyruvate (3-MP). Contrary to what 
is seen in plants, cysteine biosynthesis may possibly not be aimed to regulate 
intracellular sulphide levels but instead to generate sufficient cysteine 
necessary for the biosynthesis of glutathione and trypanothione, the main 
antioxidants found in these parasites. Williams et al. (2009) showed that 
supplementing medium with exogenous methionine resulted in elevated 
cysteine, glutathione and trypanothione levels, and promoted the growth of 
L. major promastigotes. Thus, cysteine might also be a source of methionine 
when the parasite is in a low-methionine environment (Alphey et al., 2003; 
Williams et al., 2009; Williams et al., 2003). This could be accommodated by 
the forward reverse-transsulphuration pathway in L. major (Williams et al., 
2009). 
 
L. major and L. mexicana contain single copy genes of MST. The structure of 
LmjMST has been solved and it has a C-terminal extension of 80 amino acids 
(compared with other sulphurtransferases) that was shown to be essential for 
protein folding. Both, LmjCS and LmjCBS can use sulphide generated by MST 
for cysteine synthesis (Alphey et al., 2003; Williams et al., 2009; Williams et 
al., 2003). 
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1.3.1.3 Serine acetyl-transferase 
Studies made in plants and bacteria have shown that the formation of the 
complex is not meant to channel the substrate between the two available CS 
active sites (Francois et al., 2006; Huang et al., 2005; Kredich et al., 1969; 
Wirtz et al., 2001; Wirtz and Hell, 2006; Zhao et al., 2006). The conserved C-
terminal isoleucine (Ile) residue is the only amino acid that is conserved 
(Table 1.2) in the C-terminal amino acids. It interacts with the protein side 
chain of CS through specific hydrogen bonds and hydrophobic interactions 
(Francois et al., 2006; Raj et al., 2012; Zhao et al., 2006). 
 
LdSAT MFLEGDGSGI 
AtSAT YLTEWSDYVI 
GmSAT FISEWSDYII 
EcSAT NHTFEYGDGI 
HiSAT GIDDGMNLNI 
 
Table 1.2 – The amino acid sequence of SAT C-terminal. 
The sequences of the last 10 amino acids of SAT(s) from L. donovani 
(LdSAT), A. thaliana (AtSAT), Glycine max (soybean) (GmSAT), E. coli 
(EcSAT), and H. influenza (HiSAT). Adapted from Francois et al. (2006) 
and Raj et al. (2012). 
 
The three-dimensional structure of Haemophilus influenzae CS complexed 
with a peptide that corresponds to the last 10 amino acids located in the C-
terminus of HiSAT, showed that the peptide binds to the active site of CS. 
However, with less affinity than the full length HiSAT (Bonner et al., 2005; 
Mino et al., 2000b). The same phenomenon has been observed in E. coli 
where the affinity determined for the 10 amino acid peptide was much lower 
than of the wild-type SAT (Mino et al., 2000a; Mino et al., 2000b). Studies 
have shown that the affinity for CS complex formation varies with species. 
The affinity for A. thaliana CSC is 10-80 times higher than for E. coli CSC 
(Berkowitz et al., 2002; Zhao et al., 2006). 
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The inhibition of CS triggered by the C-terminal of SAT prompted several 
studies on potential small peptide inhibitors. Salsi et al. (2009) carried out a 
thorough docking study with in silico generated peptides in order to identify 
key amino acids that may play a major role in the binding to H. influenza CS. 
This study confirmed the importance of the C-terminal amino acid Ile of SAT, 
accounting for 50% of the binding energy. Schnell et al. 2007 tested the 
peptide DFSI, correspondent to the last four amino acids of M. tuberculosis 
SAT, against MtCS. This peptide was able to form a complex and to inhibit 
MtCS‟s activity (Poyraz et al., 2013; Schnell et al., 2007). 
 
Salmonella CS undergoes a large-scale conformational changes between the 
open and closed binding conformations, which plays an important role in the 
recognition of the SAT C-terminal (Francois et al., 2006). Wang and Leyd 
(2012) have proposed that the formation of E. coli CSC goes through three 
conformational stages. First the EcSAT binds to one CS active site leaving the 
other monomer unoccupied. However, EcSAT triggers a conformational 
change in the empty monomer that prevents a 10 amino acids peptide (last 
10 amino acids of EcSAT) from binding to it. Additionally, the peptide alone 
was not able to trigger the conformational change seen with the full length 
EcSAT. Thus, the peptide does not contain all the necessary amino acids for 
the interaction between EcSAT and EcCS (Wang and Leyh, 2012). 
 
 
1.3.1.4 Cystathionine -synthase 
L. major CBS is a PLP-dependant enzyme of the RTS pathway (Williams et al., 
2009). L. major CBS differs from human CBS because it does not have an 
haem-binding N-terminal and a C-terminal regulatory domain in the active 
site pocket. In mammals the haem-binding N-terminal works as a redox 
sensor while the C-terminal regulatory domain controls the tetrameric state 
of CBS and thus CBS‟s activity (Banerjee and Zou, 2005; Frank et al., 2008; 
Meier et al., 2001; Miles and Kraus, 2004). These groups block the entry of 
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the large acetyl groups of OAS (Frank et al., 2008). This difference might 
constitute to a good base of study for new anti-Leishmania drugs.  
 
CBS catalyses the production of cystathionine from serine but is also able to 
form cystathionine from sulphide, homocysteine and cysteine by a β-
replacement reaction (Williams et al., 2009). The CBS from T. cruzi (lacks 
the C-terminal) and S. cerevisiae (lacks the N-terminal) can accommodate 
these large groups once it lacks one of them (Nozaki et al., 2001; Williams et 
al., 2009) However, the activity reported by Williams et al. 2009 from LmjCS 
suggests that it lacks both terminals (Williams et al., 2009). 
 
CBS is closely related structurally to CS. In L. major, Williams et al. (2009) 
showed that LmjCBS can also form cysteine from OAS and sulphide, however 
with a higher Km than LmjCS (Figure 1.8). The different sensitivity to OAS and 
sulphide might be relevant for adaption to different environments when 
differentiating between the two life-cycle stages (Williams et al., 2009). This 
feature is also shared by T. cruzi CBS. In T. cruzi CBS only three out of eight 
genes have an N-terminal extension suggesting that the other five have more 
similarities with the biochemical proprieties of LmjCS (Nozaki et al., 2001) In 
humans, CBS lacks CS activity but with a low catalytic efficiency (Braunstein 
et al., 1971; Nozaki et al., 2001; Williams et al., 2009).  
 
(a) Homocysteine  + Cysteine   Cystathionine 
(b) Cysteine + Homocysteine   Cystathionine 
(c) OAS + Sulphide   Cysteine 
(d) Serine + Sulphide   Cysteine 
(e) Cysteine + 2-mercaptoethanol   S-hydroxyethylcysteine + hydrogen 
sulphide 
 
Figure 1.8 – Reactions catalysed by LmjCBS. 
LmjCBS is able to catalyse different reactions. The activities reported by 
Williams et al. (2009) are: (a) CBS activity; (b) homocysteine 
sulphydrylase; (c) CS activity; (d) serine sulphydrylase; and (e) cysteine 
desulphurase. 
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1.4 Trypanohione biosynthesis 
1.5.1 Glutathione biosynthetic pathway 
In humans and the majority of eukaryotes and many microorganisms, 
glutathione is used in the defence against xenobiotics and the detoxification 
of peroxides (Husain et al., 2011; Krauth-Siegel and Leroux, 2012; Muller et 
al., 2003; Pompella et al., 2003; Smirnova and Oktyabrsky, 2005). In 
Leishmania and other trypanosomatids, glutathione is used for the synthesis 
of trypanothione, which has been proven to carry out glutathione functions in 
these parasites. The cysteine generated by either of the cysteine biosynthetic 
pathways of Leishmania, is converted into glutathione by two ATP-dependant 
steps: firstly, cysteine and glutamate form -glutamylcysteine in the presence 
of -glutamylcysteine synthase; and secondly, -glutamylcysteine is converted 
into glutathione by glutathione synthase (Figure 1.9) (Carter et al. 2003). 
Entamoeba, Giardia and Trichomonas lack the glutathione biosynthesis 
pathway and it has been suggested that cysteine is responsible for redox 
buffering (Coombs et al., 2004; Husain et al., 2011; Krauth-Siegel and 
Comini, 2008; Nozaki et al., 1998; Nozaki et al., 1999).  
 
1.5.2 Polyamine biosynthetic pathway 
Figure 1.10 shows a schematic diagram of the polyamine biosynthetic 
pathway in Leishmania parasites. Ornithine and urea originate from the 
enzymatic hydrolysis of arginine by the arginase enzyme. Ornithine is then 
converted into putrescine by ornithine decarboxylase, a PLP-dependent 
enzyme. The decarboxylase S-adenosylmethionine donates an aminopropryl 
group to putrescine to form spermidine. This reaction is catalysed by 
spermidine synthase. Decarboxylase S-adenosylmethionine is formed from S-
adenosylmethinine by S-adenosylmethionine decarboxylase (Birkholtz et al., 
2011). T. brucei is able to synthesise putrescine from ornithine, whereas T. 
cruzi has to acquire polyamines from the exterior of the cell (Fairlamb et al., 
1987; Hunter et al., 1994).  
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The polyamine biosynthetic pathway is essential in Leishmania as shown by 
extensive gene deletion studies (Jiang et al., 1999; Reguera et al., 2009; 
Roberts et al., 2001). Polyamines are important for the stimulation of DNA 
and RNA synthesis. Their concentration is increased during maximal growth in 
prokaryotic and eukaryotic cells (Bachrach et al., 1973). Bachrach et al. 
(1979) have shown that in Leishmania promastigotes polyamines vary with the 
growth stage and that blocking polyamine biosynthesis impairs growth. Thus, 
the polyamine biosynthetic pathway is essential for promastigotes viability 
and growth. Additionally Gilroy et al. (2011) have demonstrated that 
spermidine synthase is essential for a robust infection of L. donovani in mice, 
supporting the notion that polyamines are essential for parasite virulence. 
However, Leishmania parasites are able to scavenge polyamines from the 
exterior, which makes their biosynthesis a less attractive as drug target. A 
good example is that of α-difluoromethylornithine (DFMO), a suicide inhibitor 
of the ODC enzyme, which selectively inhibits the Leishmania enzyme but 
does not kill the parasites in the presence of exogenous polyamines (Kandpal 
and Tekwani, 1997) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9 – Thiol biosynthetic pathways in Leishmania. 
The cysteine (blue), glutathione (green), polyamine (yellow) and trypanothione (red) biosynthetic pathways are highlighted 
in the diagram. The thiols analysed in this study were: cysteine (blue), homocysteine (yellow), glutathione (green), and 
trypanothione (red). Other thiols present in these pathways are: -glutamylcysteine and glutathionyl-spermidine. The 
enzymes are in bold blue. The substrates and bi-products are in black. The arrows indicate the direction of the reaction.  
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Figure 1.10 – Polyamine biosynthesis in trypanosomatids and humans. 
Shematic diagram showing the major differences between 
trypanosomatids and human polyamine biosynthetic pathways. The major 
difference resides in the use of spermidine. In trypanosomatids it is used 
to synthesise trypanothione, their major thiol. In humans it is used to 
synthesise spermine. The decarboxylated adenosilmethionine supplies 
aminopropryl groups to the synthesis of spermidine and spermine in 
humans, whereas in trypanosomatids it only supplies aminopropryl 
groups to the synthesis of spermidine. Additionally this figure highlights 
the fact that polyamines can be acquired axenically in trypanosomatids 
and humans (cylinders). The cylinders are sized according to their 
efficiency. (AdoMet) adenosyl methionine; (AdoMetDC) adenosyl 
methionine decarboxylase; (dcAdoMet) decarboxylated adenosyl 
methionine; (Cad) cadaverine; (homoT(SH)2) homotrypanothione; (MTA) 
5’-methylthioadenosine; (ODC) ornithine decarboxylase; (Orn) ornithine; 
(Put) putrescine; (ROS) reactive oxygen species; (Spd) spermidine; (SpdS) 
spermidine synthase; (Spm) spermine; (TryR) trypanothione reductase; 
(TryS) trypanothione synthase; (TS2) trypanothione disulphide; (T(SH)2) 
dihydrotrypanothione  (Birkholtz et al., 2011) 
 
Printed with permission from Biochemical Journal. 
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1.5.3 Trypanothione as anti-oxidant defence 
Trypanothione is the major low-molecular weight thiol in trypanosomatids 
was discovered in 1985 by Professor Alan Fairlamb, contributing to a major 
advance in the development of effective therapies against trypanosomatids. 
This thiol plays an important role in the thiol redox balance, in the synthesis 
of deoxyribonucleotides, drug resistance and in the defence against 
chemical and oxidative stress. Its absence in humans makes its biosynthesis 
a good base of study for potential drug targets (Fairlamb et al., 1985; 
Fairlamb and Cerami, 1985, 1992; Oza et al., 2005) 
 
Trypanosomatids lack genes for both glutathione reductase and thioredoxin 
reductase. In these organisms, trypanothione is kept in a reduced state by 
trypanothione reductase (structurally similar to glutathione reductase), 
which has been shown to be essential for this parasite (Figure 1.11) (Tovar 
et al., 1998a; Tovar et al., 1998b). Trypanothione is synthesised by 
trypanothione synthethase in two ATP-dependent steps that involve two 
molecules of glutathione and one molecule of spermidine (Ariyanayagam et 
al., 2005; Legare et al., 2001). During cell growth, trypanothione levels in L. 
donovani promastigotes decrease when the cells reach the stationary phase 
(Krauth-Siegel and Comini, 2008). Since trypanothione depends on the 
availability of spermidine, DFMO causes spermidine levels to decrease and 
thus trypanothione levels to be depleted (Fairlamb et al., 1987). Another 
way to reduce trypanothione levels is to deplete trypanothione synthethase 
mRNA or by the down-regulation of tryparedoxin (experiments carried out in 
T. brucei) (Comini et al., 2007; Dumas et al., 1997). Trypanothione levels 
also depend on the level of glutathione, thus the inhibition of 
glutathionylspermidine and glutathione by buthionine sulfoximine (BSO) also 
lowers trypanothione levels (Faundez et al., 2005). In fact, BSO is able to 
potentiate the toxicity of nifurtimox in T. brucei. However, in L. donovani 
the growth defect was not so pronounced (Weldrick et al., 1999). Metal-
containing drugs (i.e. antimonials and arsenites) induce trypanothione and 
glutathione efflux through Gp-glycoprotein-like protein A, a member of the 
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ABC (ATP-binding cassette) class of transporters (Wyllie et al., 2004). In 
contrast, higher levels of thiols have been found in antimonial resistant L. 
donovani (Mittal et al., 2007). 
 
The trypanothione/tryparedoxin system acts as a reducing agent of enzymes 
(i.e. ribonucleotide reductase), and detoxification of hydroperoxides by 
transferring reducing equivalents from NADPH to peroxidases (Krauth-Siegel 
and Leroux, 2012). Wyllie et al., (2010) have shown that antimonial-
resistant parasites overexpress tryparedoxin and tryparedoxin peroxidase 
(both kept reduced by trypanothione), which resulted in a higher ability to 
detoxify hydropexides. Trypanosomatids have a single mitochondrion that 
contains the unique kinetoplastid DNA (kDNA) arranged in minicircles and 
maxicircles. For the replication, the parasites need a ribonucleotide 
reductase to reduce the deoxyribonucleotide precursors. This enzyme is 
kept in reduced state by trypanothione in T. brucei. Additionally, for the 
minicircle replication process to initiate, the universal minicircle sequence-
binding protein (UMSBP) needs to bind the minicircles origin sequence. The 
trypanothione and tryparodoxin system can activate UMSBP in C. fasciculata 
(Milman et al., 2007; Onn et al., 2004). 
 
 
Figure 1.11 – Reduction of trypanothione. 
Dithiol trypanothione (TS2) is reduced to trypanothione (T(SH)2) by 
trypanothione reductase with the consumption of NADPH (Muller et al., 
2003). 
Printed with permission from Elsevier. 
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Aims of this study 
Leishmaniasis are neglected tropical diseases that affect people worldwide. 
Its multiple cases of drug resistance (India and Nepal) and the absence of a 
vaccine for humans leaves us in desperate need to develop new drugs and to 
find new drug targets. Thiols are the major protectors of cells against 
oxidative or xenobiotic stress and have also been involved in the resistance 
against antimonal drugs (main treatment of visceral leishmaniasis). 
Leishmania presents two life cycle states that involve two very different 
hosts. Thus, adaption to different environments and oxidative challenges are 
crucial for the virulence and survival of these parasites. A lot of research 
has been done in order to find drug targets in the polyamine and 
trypanothione biosynthetic pathways. This work proposes to start this search 
at a much earlier stage, cysteine. Cysteine is the building block of 
glutathione and trypanothione and therefore possibly a very important piece 
of the puzzle.  Therefore this study intends to:    
 
 Assess the essentiality of the cysteine synthase of the sulphydrylation 
pathway in L. donovani. 
 Study of the inhibition of cysteine synthase by small peptides. 
 Analyse the relative contribution of the two cysteine synthase 
biosynthetic pathways in L. donovani. 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
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2 Materials and Methods 
2.1 Consumables, Biological and chemical reagents 
Alpha laboratories 1.2 mL Cryovial  
Ambion RETROscript reverse transcription for real time 
PCR kit, Turbo DNA-free, RNaseZap 
Applied Biosystems Power Sybr® Green PCR Master Mix, Micro AmpTM 
Optical 96-well reaction plate  
BD Plastic 50 mL syringe 
Bio-Rad  Bradford protein assay reagent, Precision Plus 
Dual-Color ProteinTM Standard 
Eurogentec    Oligonucleotides, antisera generation programmes 
Fisher Scientific  10 x Phosphate buffered saline (PBS), Reddy mix 
PCR mastermix, imidazole (low absorbance), 
restore western stripping buffer, 0.2 µm syringe 
filters, sodium hydrogen carbonate 
Fluka Dimethyl sulphoxide 
Gibco HOMEM medium 
Greiner Aspiration pipettes, 50 mL pipettes, 96 well 
plates 
GE Healthcare  Gene images AlkPhos direct labelling and 
detection system, gene images CDP-Star, 
detection module, hypercassettes (18 x 24 cm), 
Hyperfilm ECL, Hybond N+ membrane 
Invitrogen Glycogen (20µg/µL), UltraPureTM agarose, 
UltraPureTM low melting point agarose  
Kodak Autoradiography film 
Life Technologies Accuprime Pfx SuperMix, gel cassettes, glycogen, 
gentamycin, SYBR Safe 
Lonza Human T Nucleofector solution 
Melford  Leupeptin, E64, proteinase K, ampicillin, 
kanamycin, isopropyl-O-dithiogalacopyranoside  
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Millipore ImmobilonTM western chemiluminescent HRP 
substrate, nylon membrane 0.20 m of pore size 
New England Biolabs  1 kb DNA ladder, 100 kb DNA ladder, T4 DNA 
ligase, T4 ligase buffer, 6 x DNA loading dye, 
restriction endonucleases and respective buffers 
Novagen  Chemically competent E. coli BL21(DE3), pET15b 
vector 
PAA Fetal bovine serum gold, heat inactivated 
Promega  anti-rabbit IgG (HRP conjugated), anti-mouse IgG 
(HRP conjugated), pGEM-T Easy vector system II  
Qiagen  RNeasy Mini, QIAquick gel extraction kit, QIAamp 
DNA mini kit, QIAprep spin Miniprep kit, QIAquick 
PCR purification kit, Ni-NTA agorose 
Roche  Bovine serum albumin (BSA) 
Santa Cruz Biotech Donkey anti-sheep antibody 
Sartorius  Ministart syringe filter hydrophobic 
Sigma  All chemicals unless otherwise stated 
Stratagene  XL10-Gold® Ultracompetent Cells, StrataClone 
Blunt PCR cloning kit 
Thermo Scientific GelCodeTM Blue Safe Protein Stain, Restore Plus 
western blot stripping buffer, ZebaTM desalting 
column 
Whatman Protran® Nictrocelulose Transfer Membrane 
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2.2 Equipment 
Applied Systems Micro AmpTM Optical 96-well reaction plate, 7500 
real-time PCR system, 7500 real-time PCR 
software, primer express 3.0 for real-time PCR 
software 
Beckman   GS-15R centrifuge, coulter AllegraTM X-12R 
centrifuge (rotor SX4750), Coulter Avanti J-26 XP 
(rotors JA25.50 and F10BCL)  
Bio-Rad  TransBlot SD Semi-dry transfer cell, Gel tanks, 
Gene Pulser Xcell electroporator, Power Pac 300, 
Power Pac Basic, PowerPac HC, Transblot semi-
dry transfer cell, GelDoc 2000 (Mitsubishi P91 
printer) CHEF-DR-III system, Biologic DuoFlow 
purification system, BioFrac collector, 583 Gel 
dryer (KNF vacuum pump) 
BMG labtech FLUOstar OPTIMA 
Constant Systems  Cell disrupter 
Denver instrument Ultra basic US-10 pH meter 
Dionex Ultimate 3000 HPLC, ultimate 3000 autosampler, 
ultimate 3000 variable wavelength detector, RF 
2000 fluorescence detector, ChromeleonTM version 
6.8 SP2 built 2284  
Eppendorf  Microcentrifuge 5415D (rotor F45-24-11) 
Fisher  Microcentrifuge Accuspin MicroR (rotor 13-100-
515), water bath, vaccum pump FB70155, gel 
tanks 
GE Healthcare  VaccuGene XL apparatus 
G Storm  GS4 4 block PCR machine 
Grant  Heat block QBT2, water bath 
GraphPad GraphPad Prism software 
Hawksley BS.748 Neubauer chamber 
Heidolph  Rotamax 120 shaker 
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Hybaid  Mini 10 incubator 
Kühner  Shaker ISF-1-W 
Konica  Konica Minolta SRX-101A tabletop processor 
Life Technologies 250 EX power pack, Vector NTI software 
Lonza Nucleofector® Device 
Millipore Quantum ddH2O system 
Molecular Devices Versamax microplate reader 
Phonomenex Gemini 5 m C-18 110Å silica column, security 
guard guard cartridge kit KJ0-4282 
Schnakenbery HermLe 2400k (rotor H208698033) 
Sigma  1-15 microfuge (rotor 12124), 6K15 centrifuge 
(rotor 11150) 
Sonics Vibracell ultrasonic processor 
Stuart SB2 rotator, roller mixer SRT6 
Techne TC-412 thermocycler 
Thermo Scientific  Sorvall ST-16R centrifuge (rotor TX-400), 
NanoDrop 1000 spectrophotometer, Holten Safe 
2010 hood 
UVP  HB-1000 hybridization oven, UV cross linker, 
2UVTM transiluminator 
VWR Genosmart transiluminator 
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2.3 Buffers, solutions and media 
2.3.1 DNA analysis 
 
6x DNA loading dye 0.25% (w/v) orange-G, 0.25% (w/v) bromophenol 
blue, 0.25% orange-G, 40% (w/v) sucrose 
1x TAE 40 mM Tris-acetate, 1 mM EDTA, pH 8.0 
Southern blot: 
Depurination solution 0.25 M HCl 
Denaturation solution 1.5 M NaCl, 0.5 M NaOH 
Neutralisation solution  3 M NaCl, 0.5 M Tris HCl (pH 7) 
20x SSC 300 mM trisodium citrate, 3 M NaCl 
Primary wash buffer 2 M urea, 0.1% (w/v) SDS, 50 mM sodium 
phosphate pH 7.0, 150 mM NaCl, 1 mM MgCl2, 0.2% 
(w/v) blocking reagent 
Secondary wash buffer 50 mM Tris base, 100 mM NaCl, 2 mM MgCl2 
 
2.3.2 Protein analysis 
Lysis buffer 0.25 M sucrose, 0.25% Triton X-100, 10 mM EDTA, 
20 M E-64, 4 M 1,10-phenanthroline, 8 M 
Pepstain A, 2 mM Phenylmethylsulfonylfluoride  
Coomassie stain GelCodeTM Blue Safe Protein Stain (Thermo 
Scientific), or Coomassie blue stain (40% (v/v) 
methanol, 10% (v/v) acetic acid, 0.1% (w/v) 
Coomassie brilliant blue R-250) 
Destaining solution 20% (v/v) methanol and 10% (v/v) acetic acid 
Protein loading buffer 62.3 mM Tris-HCl pH 6.8, 2% (w/v) SDS, 10% (v/v) 
glycerol. 0.001% (w/v) bromophenol blue, 5% (v/v) 
2-mercaptoethanol 
Resolving gel buffer 1.5 M Tris base pH 8.9, 0.4% SDS 
Stacking gel buffer 0.5 M Tris base pH 6.7, 0.4% SDS 
Chapter 2 – Materials and methods                                                                      39 
 
 
1x PRB electrode buffer 2.5 mM Tris, 192 M glycine, 0.1% (w/v) SDS 
Towbin buffer 25 mM Tris base, 1.92 mM glycine, 1.3 mM SDS and 
20% methanol 
Purification of rLmjCS: 
Lysis buffer 50 mM phosphate buffer pH8, 300 mM NaCl and 10 
mM imidazole 
Wash buffer 50 mM phosphate buffer pH8, 300 mM NaCl and 20 
mM imidazole 
Elution buffer 50 mM phosphate buffer pH8, 300 mM NaCl and 
250 mM imidazole 
HPLC buffer 40 mM N-[2-hydroxyethyl]-piperazine-N‟[3-
propanesulphonic acid] (EPPS), 4 mM of 
diethylenetriamine pentaacetic acid (DTPA), and 
pH 8 adjusted with 1 M lithium hydroxide 
 
2.3.3 Parasites culture 
PSGEMKA 0.02 M phosphate buffer, 180 mM NaCl, 55 mM 
glucose, 650 M EDTA, 10 mM MgCl2.6H2O, 10 mM 
KCl, 0.2 g/L albumin 
Freezing solution HOMEM with 20% (V/V) heat inactivated foetal calf 
serum, 1% penicillin/streptomycin, 5% dimethyl 
sulfoxide 
Medium HOMEM, 10% (V/V) heat inactivated foetal calf 
serum, 1% penicillin/streptomycin 
 
2.3.4 Bacteria culture 
Ampicillin 100 µg/mL final concentration 
Kanamycin 50 µg/mL concentration 
Luria broth (LB) medium 10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl 
LB agar 10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl, 
1.5% (w/v) agar 
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TFBI 100 mM RbCl, 50 mM MnCl2-4H2O, 30 mM 
NaH2AsO4, 10 mM CaCl2-2H2O and 15% glycerol 
TFBII 0.2 M MOPS, 10 mM RbCl, 75 mM CaCl2-2H2O and 
15% glycerol 
 
2.3.5 Bacterial strains 
BL21 (DE3) (Novagen): 
F- ompT hsdSB(rB- mB-) gal dcm (DE3)  
 
SoloPack® (Stratagene): 
Tetr Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 
relA1 lac The [F´ proAB lacIqZΔM15 Tn10 (Tetr) Amy Camr] 
 
XL10-Gold® Ultracompetent Cells (Stratagene):  
TetrD(mcrA)183 D(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 
relA1 lac Hte [F´ proAB lacIqZDM15 Tn10 (Tetr) Amy Camr] 
 
2.3.6 Leishmania strains 
 
L. donovani – BPK 206 clone 10  
L. donovani – BPK206 clone 10 lacking cysteine synthase alleles 
L. major – MHOM/IL/80/Friedlin 
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2.3.7 Oligonucleotide primers 
2.3.7.1 Transfection in Leishmania donovani 
The restriction sites are highlighted in bold and the start and termination 
codon are underlined: 
 
CS forward 5‟ GATATCATGGCGGCAGCGTCCGAC 3‟ (EcoRV) 
CS reverse  5‟ GGATCCTCAGTCCTGCAGCTCCGAGG 3‟ (BamHI) 
 
 
2.3.7.2 Recombinant protein expression 
The restriction sites are highlighted in bold and the start and termination 
codon are underlined: 
 
Lmj1  5‟ GCCATATGGCAGCACCGTTCGACAAGTC 3‟ (NdeI) 
Lmj2  5‟ CGGATCCTCAGTCCTGCAGCTCCGAGGCATC 3‟ (BamHI) 
 
2.3.7.3 Quantitative real-time polymerase chain reaction 
analysis 
GPI8 forward        5‟ CAACAACTGGGCTGTCATTCTC 3‟ 
GPI8 reverse         5‟ TGGCAGTGTGACGGTAGTTGA 3‟ 
ODC forward         5‟ ACCTACGTGACGGTGGACAAC 3‟ 
ODC reverse         5‟ GCATCAGGCGACTGA 3‟ 
CS forward            5‟ TTTGCGTGGCAGGTGATG 3‟ 
CS reverse            5‟ GCTGCGCGTGAGCTTCA 3‟ 
CBS forward         5‟ TGGCGGCAGCGTCAA 3‟ 
CBS reverse    5‟ TTTTCGGCGTGGAGTATCATC 3‟ 
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2.3.8 Antibodies 
Antibody Animal Source Dilution 
Primary 
anti-L. mexicana 
cysteine synthase 
Rabbit SAPU 1:5,000 
anti-L. major 
cysteine β-synthase 
Rabbit SAPU 1:10,000 
anti-L. donovani 
ornithine 
decarboxylase 
Rabbit 
Buddy Ullman 
(Boitz et al., 
2009) 
1:5,000 
anti-Histidine Mouse Clonetech 1:10,000 
anti-L. major 
oligopeptidase B 
(OPB)  
Rabbit  1:20,000 
anti-mouse EF-1α 
clone CBP KK1 
Mouse Millipore 1:10,000 
Secondary 
Donkey anti-Sheep 
 
Santa Cruz 
Biotechnology 
1:10,000 
anti-Rabbit IgG (HRP 
conjugated) 
 Promega 1:10,000 
anti-Mouse IgG (HRP 
conjugated) 
 Promega 1:10,000 
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2.4 Molecular methods 
2.4.1 Determination of DNA and RNA concentration 
DNA and RNA concentrations were determined using a Nanodrop 1000 
spectrophotometer (Thermo Scientific). Optical density 260 mm (OD260mm) of 
1 corresponds to a double-stranded (dsDNA) concentration of 50 µg/mL. To 
assess the purity of each sample, the ratio of the DNA absorbance at 260 nm 
and at 280nm (A260/280) was determined. For high purity DNA the expected 
ratio A260/280 should be ~ 1.8, and for pure RNA, the ratio should be in the 
range of A260/280 of ~ 2.  
 
2.4.2 Ethanol precipitation  
DNA was precipitated by adding three volumes of ice cold absolute ethanol 
absolute and 0.1 volumes of 3 M sodium acetate pH 5.4 and 2 µg of glycogen 
was added to the DNA before incubating it at -20 ºC overnight. The pellet 
was collected at 4°C, 13,000 rpm for 30 minutes. The DNA was washed with 
ice cold 70% ethanol, air dried and then resuspended in 50 µL of double 
distilled water (ddH2O). 
 
2.4.3 Restriction endonuclease digests 
In order to verify the size of plasmid inserts, restriction endonuclease 
digests were carried as per manufacturer‟s instructions. Routinely 1 µL of 
plasmid DNA was digested with 1 µL of restriction enzyme and respective 
supplied buffer (New England Biolabs). With exception of SmaI (25°C), all 
the restriction endonuclease digests were incubated for a minimum of 2 h at 
37°C. DNA fragments were analysed by gel electrophoresis (see section 
2.2.4). 
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2.4.4 Agarose gel electrophoresis 
The quality and quantity of DNA were assessed by gel electrophoresis. 
Agarose or low-melting point agarose was dissolved in 1 x TAE buffer at the 
appropriate percentage in a microwave. SYBR safe was added to 0.5 µg/mL 
prior to casting the gels. 6 x DNA loading dye was added to the DNA samples 
before these were loaded into the wells of the gel. The separation was 
performed in a gel tank containing 1 x TAE at 5 – 10 V/cm2. The size of the 
DNA fragments was determined by comparison with a 1 kb or 100 bp ladder 
that was loaded and separated alongside the DNA samples. A 
transilluminator (2UVTM transiluminator, UVP) was used to visualize (365 nm) 
and aid band excision for further DNA purification.  
 
2.4.5 DNA sequencing 
DNA sequencing was performed by Source Bioscience Life Sciences. The 
samples requirements per sequencing reaction were 1 ng/µL per 100 bp of 
PCR product or 100 ng/µL of plasmid and 3.2 pmol/µL of sequencing 
primers. 
 
2.4.6 Southern blot analysis 
To verify the genotype of the genetically-manipulated L. donovani lines, 2 
µg of gDNA were digested with XhoI restriction endonuclease overnight at 
37°C with the respective provided buffer. The digests analyzed by gel 
electrophoresis in a SYBR-safe free 0.7% agarose gel at 20V for ~22 hours.  
The DNA was depurinated with 0.25 M HCl, denaturated with 1.5 M NaCl, 0.5 
M NaOH, and neutralised with 0.5 M Tris containing 3 M NaCl pH 7. DNA was 
then transferred to a Hybond-N+ membrane (GE healthcare) with a 20 X SSC 
solution (300 mM trisodium citrate and 3 M NaCl pH 7) using a VacuGene XL 
apparatus (GE Healthcare) for 1.5 h. DNA was then crosslinked to the 
membrane using a UV crosslinker at 700 x 100 µJ/cm2 (UVP laboratory 
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products). The membranes were pre-hybridized with hybridization buffer 
(0.5 M NaCl and 4% (w/v) of blocking reagent) at 60 °C. The probes were 
generated using DNA fragments excised from plasmids that were restriction 
endonuclease digested. The cysteine synthase (cs) gene was excised from 
the pGL102cs plasmid using SmaI and BamHI restriction endonucleases, 
hygromicin phosphotransferase (hyg) gene was excised from pGL345hyg 
plasmid using SpeI and BamHI restriction endonucleases; and nourseothricin 
acetyltransferase (sat) gene was excised from pGL158sat plasmid using SpeI 
and BamHI restriction endonucleases. The DNA fragments were purified 
using the QIAquick gel extraction kit (QIAGEN) and used to generate probes 
with the Gene Images AlkPhos direct labeling kit (GE Healthcare).  The 
denatured probe was added to the hybridization buffer and left to bind 
overnight at 60°C. The labeled membrane was washed three times for 10 
minutes with primary buffer (2 M urea, 0.1 (w/v) sodium dodecyl sulphate, 
50 mM sodium phosphate pH 7, 150 mM NaCl, 1 mM MgCl2 and 0.2% blocking 
reagent) at 60°C and then washed two times for 10 minutes with secondary 
buffer (1 M tris base, 2 M NaCl and 2 mM MgCl2) at room temperature. The 
membrane was covered with CDP-Star detection reagent (GE Healthcare) for 
1 minute. The excess of reagent was discarded and membrane was sealed 
into a plastic bag. The membrane was exposed to Hyperfilm autoradiography 
film (GE Healthcare) for 1.5 h and subsequently developed using a Konica 
Minolta SRX-101A film developer. To further analyze the DNA, the 
membrane was striped using 0.5% SDS at 60°C for 2 hours before being pre-
hybridize and probed again as described above.  
   
2.4.7 Synthesis of cDNA 
RNA extracted from L. donovani lines was used to synthesize cDNA for 
subsequent comparative expression level analyses of a number of genes. 
Reactions were set up using the RETROscript® Kit (Ambion). Each reaction 
contained 1.5 µg total RNA, 2.5 µM of random decamers, reverse 
transcriptase buffer containing 30 mM MgCl2, 500 µM dNTPs, 100 units of 
MMLV-reverse transcriptase, and 10 units of RNase inhibitor. A control 
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reaction contained 500 ng of the provided control template RNA (mouse 
liver RNA) instead of the RNA isolated from L. donovani. The presence of 
cDNA was checked by PCR reaction using the AAT20 primer set that targets 
the amino acid transporter 20 gene of L. donovani. The successful reverse 
transcription of the control template RNA was verified using the provided 
primer set. PCR products were analyzed by agarose gel electrophoresis.  
 
2.4.8 Polymerase chain reaction 
2.4.8.1 AccuPrimeTM Pfx DNA SuperMix 
AccuPrimeTM Pfx DNA SuperMix was used to amplify genes from plasmids or 
L. donovani gDNA to be later used in transfection. The SuperMix includes 
22U/mL of AccuPrimeTM Pfx DNA polymerase, 1.1 mM MgSO4 and 330 µM 
deoxyribonucleotide triphosphate (dNTPs). The PCR was set up with 
AccuPrimeTM Pfx DNA polymerase according to manufactures instructions, 
200 ng of primers, and 4 ng of gDNA, to 25 µL of final volume. The PCR 
thermoprofile was as follows: 
 
Initiation 98°C for 3 minutes 
30 cycles of  
Denaturation 98°C for 30 seconds 
Annealing 55°C for 30 seconds 
Elongation 72°C for 45 seconds 
Final elongation 72°C for 10 seconds 
 
PCR products were analyzed by agarose gel electrophoresis. When necessary 
DNA was quantified using the Nanodrop spectrophotometer. Fragments with 
the expected size were cloned into pSC-B-amp/kan Strataclone PCR cloning 
vector or pGEM-T easy intermediate vector. 
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2.4.8.2 ReddyMix PCR Master Mix  
ReddyMix PCR Master Mix was used for PCR analysis of genomic/plasmid 
DNA. The mastermix includes 0.625 units of ThermoPrime Taq DNA 
polymerase, 1.5 mM MgCl2 and 0.2 mM dNTPs. The PCR reaction was set up 
with ReddyMix according to manufactures instructions, 200 nM primers and 
bacterial colony/up to 100 ng of gDNA. The final PCR reaction volume was 
10 µL and the thermoprofile was the following: 
 
Initiation 98°C for 3 minutes 
30 cycles of  
Denaturation 98°C for 30 seconds 
Annealing 55°C for 30 seconds 
Elongation 72°C for 45 seconds 
Final elongation 72°C for 10 seconds 
 
PCR products were analyzed by agarose gel electrophoresis.  
 
2.4.8.3 Taq DNA polymerase 
Taq DNA polymerase was used for PCR analysis of cDNA. The PCR reaction 
was set up with 0.625 units of Taq DNA polymerase, ThermoPol reaction 
buffer containing 2 mM MgSO4, 200 µM dNTPs (Invitrogen), 200 nM primers 
and up to 100 ng of cDNA. The final PCR reaction volume was 25 µL and the 
thermoprofile was the following:   
 
Initiation 95°C for 3 minutes 
30 cycles of  
Denaturation 95°C for 30 seconds 
Annealing 65°C for 30 seconds 
Elongation 68°C for 45 seconds 
Final elongation 68°C for 10 seconds 
PCR products were analyzed by agarose gel electrophoresis. 
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2.4.9 Quantitative real-time PCR 
The reactions were set up in a 96-well plate in triplicate containing 100 ng 
cDNA template, 400 nM primers, and Power Sybr® Green PCR Master Mix 
according to manufactures instructions, in a total volume of 25 µL. GPI8 
gene was used as an endogenous control. The PCR reactions were run in a 
7500 real time PCR system with the following thermoprofile: 
 
1 cycle 50°C for 2 minutes 
1 cycle 95°C for 10 seconds 
40 cycles 95°C for 15 seconds 
1 cycle 60°C for 1 minute 
 
PCR results were gathered from the 7500 real time PCR system software 
(Applied Biosystems) and analysed using the 2-ΔΔCT method (Livak and 
Schmittgen, 2001). 
 
2.4.10 Subcloning into intermediate vectors 
2.4.10.1 StrataClone Blunt PCR Cloning Kit 
The L. donovani cysteine synthase (cs) gene was amplified from gDNA and 
ligated into the pSC-B-amp/kan intermediate vector (Figure 2.1) to 
facilitate the cloning into the final vector. This kit was chosen because the 
PCR products generated by AccuPrimeTM Pfx polymerase have blunt ends 
that allow the ligation into the blunt ended vector provided by this cloning 
kit. The ligation reaction was set up according to manufacturer‟s 
instructions, and contained 5 ng of the PCR product, StrataClone Blunt 
Cloning Buffer (Stratagene), and StrataClone Blunt Vector Mix amp/kan 
(Stratagene). 1 µL of ligation was transformed into StrataClone SoloPack 
competent cells provided by the kit and plated in agar plates containing 100 
µg/mL ampicillin/kanomycin, 50 mg/mL X-gal and 0.1 M of isopropyl β-D-1-
thiogalactopyranoside (IPTG). Positive bacterial colonies were selected by 
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blue/white selection and were used to inoculate 5 mL of LB-medium 
containing 100 µg/mL ampicillin/kanomycin and incubated at 37ºC for 18 
hours at 225 rounds per minute (rpm). Plasmid DNA was extracted from the 
bacterial cultures by alkaline lysis using the Qiagen MiniPrep method (see 
section 2.1.5) and subsequently digested with EcoRI as specified on section 
2.2.3 to confirm the presence of an insert of the correct size (1,014 bp in 
the case of cs).   
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 – The pSC-B-amp/kan_Ldoncs construct. 
Vector map of the pSC-B-amp/kan intermediate vector ligated with the 
Ldoncs gene. The pSC-B-amp/kan vector is equipped with a kanomycin 
(KanR) and ampicillin (AmpR) resistance sequence, a lac promotor (LacP) 
and a β-galactosidase α-fragment coding sequence (LacZ’) to allow the 
blue/white bacterial colony screening, a f1 origin for single stranded DNA 
replication (f1 ori), a loxP recombinase recognition sequence (<loxP>) to 
allow the Cre-mediated recombination creating a circular DNA molecule, 
and a pUC origin of double stranded DNA replication (pUC ori). 
 
2.4.10.2 pGEM-T easy 
The L. major cysteine synthase (Lmjcs) gene was amplified from pET21a+ 
construct using Lmj1 and Lmj2 primers and the PCR product was analyzed by 
agarose gel electrophoresis (see section 2.2.4). Lmjcs (1,014 bp) was 
isolated from the agarose gel using QIAquick gel extraction kit. Lmjcs was 
subcloned into pGEM-T easy as per manufacturer‟s instructions. Figure 2.2 
illustrates the vector map where pGEM-T vector is ligated to Lmjcs gene. 
pSC-B-amp/kan Ldoncs
5286 bp
f1 ori
lacP
pUC ori
lacZ' end
AmpR
KanR
LdonCS PCR product
<loxP>
PCR insertion sitelacZ' start
EcoRI (1022)
EcoRI (5276)
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Figure 2.2 – The pGEM-T_Lmjcs construct. 
Vector map of the pGEM-T intermediate vector ligated with the Lmjcs 
gene. The pGEM-T vector is equipped with an ampicillin (AmpR) 
resistance sequence, a lacZ start codon (LacZ’) to allow the blue/white 
bacterial colony screening, and a pUC origin of double stranded DNA 
replication (pUC ori). 
 
 
2.4.11 Cloning into transformation/ transfection vectors 
2.4.11.1 Generation of pET15b_Lmjcs construct 
 
Lmjcs insert was excised from pGEM-T easy using BamHI and NdeI. The 
pET15b vector was linearized with the same restriction endonucleases. The 
ligation reaction was set up using a molar ratio of 1:3 vector to insert, T4 
DNA ligase, and T4 DNA ligation reaction buffer, as per manufacturer‟s 
instructions.  3 µL of ligation was transformed into DH5α competent bacteria 
(see section 2.1.4) and plated onto LB-agar plates containing 100 µg/mL of 
ampicillin, and incubated for 18 hours at 37ºC. Bacterial colonies were used 
to inoculate 5 mL LB-medium and incubated for 18 hours at 37ºC at 225 rpm. 
Plasmid DNA was extracted using QIAprep spin Miniprep kit (QIAGEN) and 
digested with BamHI and NdeI to assess the presence of an insert with the 
correct size before choosing at least two clones that were analysed by 
sequencing (Source Bioscience). Figure 2.3 depicts the vector map of the 
construct pET15b ligated to Lmjcs gene. 
p-GEM-T-Easy Lmjcs
4030 bp
AmpR
pUC ori
lacZ'
Lmj CS
T7 Transcription start
lacZ'
BamHI (1073)
NdeI (69)
NdeI (1113)
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Figure 2.3 – The pET15b_Lmjcs construct. 
Vector map of the pET15b expression vector ligated with the Lmjcs gene. 
The pET15b expression vector is equipped with an ampicillin (AmpR) 
resistance sequence, a T7 lac promoter, a lac repressor (lacI), a T7 lac 
terminator, and a pBR322 origin that confers stability to the plasmid. The 
TEV cleavage site allows the removal of the His-tag after the protein is 
expressed. 
 
2.4.11.2 Generation of pGL102cs construct 
Plasmid DNA was isolated from the positive bacterial clones (selected by 
blue/white screening) using QIAprep spin Miniprep kit (QIAGEN) and digested 
with EcoRV (generating a blunt end) and BamHI (generating the 5‟ overhang 
GATCC). DNA fragments were purified as described above. The destination 
plasmid (pGL102) was linearized using SmaI (blunt end) and BamHI (5‟ 
overhang GATCC), purified and used in the ligation. Colonies were tested for 
the presence of the insert by colony PCR. Once identified, plasmid miniprep 
was performed and the DNA of at least two positive clones was analyzed by 
DNA sequencing. Figure 2.4 shows the vector map of the final construct 
pGL102_Ldoncs. 
 
 
 
 
 
pET15b Lmjcs
6719 bp
Amp
lacl
pBR322 ori
T7 lac promoter
His-Tag
T7 terminator
Lmj CS
TEV cleav age site
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Figure 2.4 – The pGL102_Ldoncs construct. 
Vector map of the pGL102 expression vector ligated with the Ldoncs 
gene. The pET15b expression vector is equipped with an ampicillin 
(AmpR) resistance sequence and a neomycin phosphotransferase (neo) 
resistance sequence, a Leishmania splice acceptor (5’DST) and a 13 kb 
RNA (3’13K). 
 
2.4.12 Preparation of chemically competent E. coli 
Competent bacteria used throughout this work were generated using either 
of the two methods described below. 
 
2.4.12.1 Calcium chloride method 
5 mL of LB-medium (containing the appropriate antibiotic) were inoculated 
with the desired bacterial strain and were incubated overnight at 37°C with 
at 225 rpm. From this culture, 1 mL was used to inoculate 50 mL LB-medium 
(containing the appropriate antibiotic) and incubated at 37°C with at 225 
rpm, until OD600 = 0.6. The culture was transferred to a sterile 
microcentrifuge tube, incubated at 4°C for 10 minutes, and pelleted for 10 
minutes at 4,000 rpm at 4°C. The pellet was resuspended in 50 mM CaCl2 
(ice cold) and incubated at 4°C for 40 minutes; and pelleted again for 10 
minutes at 4,000 rpm at 4°C (AccuSpin MicroR, rotor 13-100-515). The pellet 
was resuspended in 1 mL of ice-cold 50 mM CaCl2. Glycerol at 20% in PBS was 
pGL102 Ldoncs
7796 bp
LdonCS
AmpR
NEO
3'13K
5'DST
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added to aliquots of competent cells prior to being transferred to -80°C for 
storage. 
 
2.4.12.2 Rubidium chloride method 
The initial steps of this method are essentially the same as described above. 
After pelleting the bacteria, they were resuspended in TFBI buffer (100 mM 
RbCl, 50 mM MnCl2-4H2O, 30 mM NaH2AsO4, 10 mM CaCl2-2H2O and 15% 
glycerol) and incubated at 4°C for 15 minutes. The pellet was collected by 
centrifugation for 5 minutes at 4,000 rpm at 4°C (AccuSpin MicroR, rotor 13-
100-515), and resuspended in 300 µL of ice-cold TFBII buffer (0.2 M MOPS, 10 
mM RbCl, 75 mM CaCl2-2H2O and 15% glycerol). Aliquots of competent cells 
were frozen in dry ice before being transferred to -80°C for storage. 
 
2.4.13 Transformation of competent bacteria 
Transformations of competent bacteria were set up using a 100 L aliquot of 
cells and adding up to 10 µL of ligation reaction or 1 µL of plasmid DNA. The 
transformation reaction was incubated on ice for 30 min; heat shocked at 
42°C for 45 seconds; incubated on ice for 2 min before 250 µL of LB-medium 
was added to the reaction. The transformation reaction was then incubated 
at 37°C at 225 rpm for 1 h. 100 µL of the transformation reaction was plated 
onto LB-agar plates containing the appropriate antibiotic.  
 
2.4.13.1 Isolation of plasmid DNA from transformed bacteria 
The isolation of plasmid DNA was performed in order to further screen for 
positive inserts in a plasmid. 5 mL of LB-medium supplemented with the 
appropriate antibiotic was inoculated with a single bacterial colony and 
incubated overnight at 37°C. The bacterial culture was pelleted, a single 
colony was picked and plasmid DNA isolation was carried using the QIAprep 
spin Miniprep kit according to manufacturer‟s recommendations.  
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2.5 Biochemical methods 
2.5.1 Protein quantification methods 
2.5.1.1 Bradford assay  
A range of known concentrations (0.1 to 0.5 mg/mL) of bovine serum 
albumin (BSA) was used as standard for determination of the extracted 
protein concentration. 10 µL of either standard or sample were mixed as per 
manufacturer‟s instructions with 250 µL of filtered Bradford (Bradford, 1976) 
protein assay reagent (BioRad) prediluted in 1:5 in ddH2O. The absorbance 
(A595 nm) was read. 
  
2.5.1.2 BCA assay 
The BCA (Smith et al., 1985) kit provides a 2 mg/mL albumin standard from 
which standard concentrations (0.025 to 2 mg/mL) are prepared. The 
working reagent was prepared by mixing BCA reagent 1 with BCA reagent 2 
in a 50:1 ratio as per manufacturer‟s instructions. 10 µL of either standard 
or sample were mixed with 200 µL of working reagent in a 96-well plate. 
The plate was incubated at 37°C for 30 min and the absorbance at 562 nm 
was read.  
 
2.5.2 Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) 
Proteins were analysed by separation in a non-gradient 10% SDS-PAGE 
(Laemmli, 1970). Gels were prepared by first pouring 7 mL of resolving 
solution on a gel cassette. This solution contained 1.5 mL of resolving buffer 
(1.5 M Tris-HCl pH 8.9, 0.4% SDS), 2.5 mL of water, 2 mL of 30% acrylamide, 
and supplemented with polymerisation reagents: 20 µL of 20% ammonium 
persulphate (APS) and 6 µL of tetramethylethylenediamine (TEMED). The gel 
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was allowed to set and then 3 mL of stacking solution was added, containing 
1.75 mL of water, 750 µL of stacking buffer (0.5 M Tris-HCl pH 6.7, 0.4% 
SDS), 0.5 mL of 30% acrylamide, and supplemented with 10 µL of 20% 
ammonium persulphate (APS) and 3 µL of tetramathylethylenediamine 
(TEMED). A comb was placed on top of the stacking solution according to the 
necessary number of wells. Once the gel was set, 5 to 10 µg of protein were 
mixed with 6 x SDS-PAGE loading buffer and boiled for 3 min. A protein 
ladder (Precision Plus ProteinTM Dual Color Standards, Bio-Rad) was loaded 
onto the gel along with the samples to allow relative size determination. Gel 
cassettes were mounted in a gel tank (Bio-Rad) and run in PRB electrode 
buffer (25 mM Tris base, 1.92 mM glycine, pH 8.3 containing 1.3 mM SDS) at 
20-60 mA.  
SDS-PAGE gels were stained with GelCodeTM Blue Safe Protein Stain (Thermo 
Scientific) or with Coomassie blue stain (40% (v/v) methanol, 10% (v/v) 
acetic acid, 0.1% (w/v) Coomassie brilliant blue R-250) for 1 hour and 
subsequently destained with water or 20% methanol, 10% acetic acid. 
 
2.5.3 Western-blot analyses 
After separation of proteins by SDS-PAGE they were transferred to 
nitrocellulose membrane using a TransBlot SD Semi-dry transfer cell (Bio-
Rad). The protein containing-SDS-PAGE gel was placed on top of the 
nitrocellulose membrane, and both were placed between eight layers of 
filter papers, four on top and four at the bottom. The membrane, gel and 
filter papers were soaked in towbin buffer (25 mM Tris base, 1.92 mM 
glycine, 1.3 mM SDS and 20% methanol). The transfer occurred at 20 V, 5 mA 
for 1 hour. Ponceau-S (Sigma) solution was used to visualize protein on the 
nitrocellulose to confirm the transfer of protein. The protein-containing 
membrane was blocked in PBS with 5% Marvel milk powder for 1 h at room 
temperature or overnight at 4°C, with shaking. Primary antibodies raised 
against Leishmania recombinant proteins were diluted to the appropriate 
concentration (see section 2.1.6) in PBS with 1% (w/v) Marvel milk powder. 
The membrane was incubated at room temperature for 1 h with the diluted 
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antibodies and then washed three times for ten minutes with shaking in PBS 
with 0.1% (v/v) Tween 20. Horse radish peroxidase (HRP)-conjugated 
secondary antibodies were diluted to appropriate concentration (see section 
2.1.6) in PBS with 1% (w/v) Marvel milk powder. Membranes were incubated 
for 1 h at room temperate in diluted secondary antibodies and then washed 
as previously explained. The detection of the secondary antibody was 
carried out by adding to the membrane ImmobilonTM Western 
chemiluminescent HRP substrate (Millipore) for 5-10 seconds at room 
temperature. The resulting chemioluminescence was detected by Kodac 
Medical X-ray film (Kodac) and revealed in a Konica Minolta tabletop 
processor model SRX-101A (Konica). 
 
2.5.4 Expression of recombinant C- and N-terminally 6 x His-
tagged LmjCS 
Three types of recombinant L. major cysteine synthase (CS) were expressed: 
LmjCS with a C-terminal His-tag and CS with an N-terminal His-tag. The 
plasmids used were pET15bcs (N-terminal His-tag, see section 2.1.2.1) and 
pET21a+cs1 (C-terminal His-tag). Both plasmids were used to transform 
BL21/DE3 competent bacteria. 6 mL of LB-medium were inoculated with the 
resultant colonies from the transformation reaction (see section 2.1.4) and 
incubated overnight at 37°C. 1 mL of overnight culture was used to 
inoculate 250 mL of LB media and incubated at 37°C at 225 rpm. 1 or 2 mM 
IPTG was added when O.D.600 reached 0.6. The cultures induced with 1 mM 
IPTG were transferred to 15°C and left to express the LmjCS overnight 
whilst the ones induced with 2 mM IPTG were transferred to 37°C. 
 
 
 
                                                     
1
 Kindly provided by Dr Gareth Westrop from University of Strathclyde. 
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2.5.5 Purification of recombinant C- and N-terminally 6 x His-
tagged LmjCS 
Bacteria expressing LmjCS were harvested by centrifugation (Sigma 6K15, 
rotor 11150) and the pellet was resuspended in lysis buffer (50 mM 
phosphate buffer pH8, 300 mM NaCl and 10 mM imidazole). A cell disruptor 
(Constant cell disruption systems) was used to mechanically lyse the cells. 
The cell suspension was centrifuged for 1 h at 20,000 rpm (Beckman Coulter 
AvantiTM J-26XP, rotor JA-25.50). The fraction that contains CS protein was 
identified by running both soluble and insoluble fractions in SDS-PAGE (see 
section 2.2.2) and staining with Coomassie (section 2.2.3). The fraction 
containing the protein was transferred to a Ni+-agarose column. The column 
was then washed with wash buffer (50 mM sodium phosphate buffer pH8, 
300 mM NaCl and 20 mM imidazole) to remove non-specific bound proteins. 
His-tagged LmjCS was eluted from the column using elution buffer (50 mM 
sodium phosphate buffer pH8, 300 mM NaCl and 250 mM imidazole). Aliquots 
of all fractions were analyzed by SDS-PAGE to assess purification efficiency 
and purity of the recombinant protein. The concentration of LmjCS was 
determined using the Bradford protein quantification method.  
 
2.5.6 Removal of N-terminal His-tag 
The non-tagged rLmjCS was generated from the N-terminally tagged protein. 
The N-terminally His-tagged LmjCS was used to remove the His-tag using 
TEV protease. After His-tag purification, N-rLmjCS was passed through a 
ZebaTM desalt spin column to exchange the buffer that the protein was 
eluted in to a imidazole free buffer (50 mM sodium phosphate buffer pH8 
and 300 mM NaCl) to allow a post-cleavage purification of the then non-
tagged recombinant protein. The optimal conditions were assed using 
TEV:CS ratios 1:1, 1:50, 1:100, and 1:200 for 1 h at 30°C. The efficiency of 
TEV cleavage was assessed by SDS-PAGE. With the optimal cleavage 
conditions established, non-tagged LmjCS was separated from His-tagged 
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LmjCS by passing the reaction mixtures through the Ni+-agarose column as 
described above.    
 
2.5.7 Kinetic characterization of N-rLmjCS, C-rLmjCS and 
LmjCS  
1 mL reaction mix contained 0.4 mM sodium phosphate buffer pH 7.8, 20 mM 
EDTA, 10 mg/mL gelatine, 2 mM pyridoxal 5‟-phosphate, 0.5-15 mM O-acetyl 
serine, and cysteine synthase (250 ng/mL N-rLmjCS, 250 ng/mL C-rLmjCS, 
and 500 ng/mL rLmjCS). The reaction was initiated with when sodium 
sulphide (3 mM) was added. The reaction was stopped at time 2, 4 and 6 
minutes. 10 μL of reaction mix were mixed with 50 μL nitrous acid (1 part 
sodium nitrite 0.1 M and 99 parts of sulphuric acid 0.4 M). Here the thiol of 
the cysteine formed is treated with an excess of nitrous acid originating a 
stable S-nitrosothiol derivative. The excess of nitrous acid is removed with 
20 μL ammonium sulfamate 0.5%. Then a mixture of 1% mercuric chloride, 
3.44% sulphanilamide and 0.1% N-1-naphthylethylenediamine (NEDA) is 
added. The mercuric ion decomposes the S-nitrosothiol, giving nitrous acid. 
The sulphanilamide diazotes the nitrous acid, which will then couple with 
the NEDA to give a stable azo dye (A540 nm). 
 
2.5.8 Inhibition of N-rLmjCS, C-rLmjCS and LmjCS  
Thus experiment was set up as mentioned on section 2.2.8 except that the 
inhibitors were added to the reaction mix before the reaction was started 
with sodium sulphide. In addition, the inhibitor was pre-incubated for 15, 30 
and 60 min at 0.1 mM with the non-tagged LmjCS protein before both were 
added to the reaction mix. The pre-incubation times tested were 0, 15 and 
30 minutes. A control with no inhibitor was setup in parallel to ensure the 
potential difference seen was due to the inhibitor and not because of the 
pre-incubation. The pre-incubation was done at room temperature and the 
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cysteine synthesis reaction was carried as explained on section 2.5.7 at 
room temperature. 
 
2.5.9 Development of a fluorescent CS assay using 7-
diethylamino-3-(4’maleimidylphenyl)-4-methylcoumarin 
The standard assay conditions are similar to the assay described on section 
2.5.7 (Kredich and Tomkins, 1966), only that 7-diethylamino-3-
(4‟maleimidylphenyl)-4-methylcoumarin (CPM) is used to detect cysteine 
synthesis (Chung et al., 2008). High levels of background were detected 
using CPM and therefore a series of experiments had to be carried in order 
to identify the source and minimize it. The pH, sodium sulphide (Na2S), 
protein stabilizer (BSA and gelatine), CPM storage and concentrations, were 
assessed as possible causes of background formation. 
 
2.5.9.1 Assessing the effect of sodium sulphide on the 
fluorescence background at varying pH 
A series of 100 µL reactions were set up containing assay buffer (0.1 mM 
sodium potassium phosphate pH variable, 1 mM EDTA, 10 mg/mL bovine 
serum albumin (BSA), and 1 mM O-acetyl serine (OAS) substrate. 40 µM 
cysteine (Cys) and 0.5 mM Na2S substrate were tested alone or 
simultaneously.  In a 96-well plate, 100 µL of each reaction were taken and 
mixed with 100 µL of 7-diethylamino-3-(4‟-maleimidylphenyl)-4-
methylcoumarin (CPM) in 50% DMSO. CPM reacts with the free thiol groups 
generating a fluorescent compound that can be measured (λexcitation = 340 
nm, λemission = 465 nm). All reactions were made in triplicate for statistical 
analysis.  
 
 
 
Chapter 2 – Materials and methods                                                                      60 
 
 
2.5.9.2 Assessing the effect of BSA and gelatine in the 
fluorescence background 
0.1 and 1 mg/mL of gelatine and BSA were tested in order to determine 
their influence in the background. Five reactions were set containing assay 
buffer pH 7.8 only (see section 2.5.9.1) where the variable was the protein 
stabilizer. The first reaction contained no protein stabilizer, the second 
contained 1 mg/mL BSA, the thirst one contained 0.1 mg/mL BSA, the fourth 
one contained 1 mg/mL gelatine, and the fifth one contained 0.1 mg/mL 
gelatine. In a 96-well plate, 100 µL were mixed with 100 µL CPM in 50% 
DMSO and the fluorescence was measured (λexcitation = 340 nm, λemission 
= 465 nm). All reactions were made in triplicate for statistical analysis. 
 
2.5.9.3 Assessment of the influence of CPM storage length in 
the fluorescence detection   
To ensure the good quality of CPM stock storage length, three CPM stocks 
(50 µg/mL) were prepared. CPM preparations were tested on day 0, 3 and 9. 
Two reactions were set up per day, one containing assay buffer (see section 
2.5.9.1) to be used as blank and another containing assay buffer and 40 µM 
cysteine. Here 100 L of reaction were mixed with 100 L CPM (50 µg/mL) in 
50 % DMSO in a 96-well plate and the fluorescence was measured (λ 
excitation = 340 nm, λemission = 465 nm). All reactions were made in 
triplicate for statistical analysis. 
 
 
2.5.9.4 Analysis of increasing CPM concentrations and its 
influence in the assay linearity 
To determine the ideal CPM concentration, four reactions were set up 
containing assay buffer (see section 2.5.9.1), 40 µM cysteine and/or 0.5 mm 
Na2S. The CPM concentrations tested were 25, 50 and 100 µg/mL. In a 96-
well plate, 100μL of each reaction were mixed with 100μL CPM in 50% DMSO 
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and the fluorescence was measured (λexcitation = 340 nm, λemission = 465 
nm). All reactions were performed and statistically analyzed (section 2.7.3). 
 
2.5.9.5 Determination of the fluorescence generated by 
known cysteine concentrations using the CPM detection 
method 
To determine the correlation between fluorescent read and cysteine 
concentration present in reaction, concentrations of cysteine (0, 20, 40, 60, 
80 and 100 M) were mixed with assay buffer (see section 2.5.9.1), 
0.1mg/mL gelatine and 0.5 mM Na2S. 100 L of reaction were mixed with 
100 L CPM (100 g/mL) in 50% DMSO in a 96-well plate and the 
fluorescence was measured (λexcitation = 340 nm, λemission = 465 nm). All 
reactions were made in triplicate for statistical analysis. The results were 
used to plot a standard curve. 
 
2.5.9.6 Quantification of cysteine generated in an enzymatic 
reaction by extrapolation from a standard curve 
The ideal N-rLmjCS concentration was determined by setting up reactions 
containing increasing concentrations of N-rLmjCS. 1 mL reaction contained 
assay buffer pH 7.8 (see section 2.2.10.1), 0.1mg/mL of gelatine, 1 mM of 
OAS substrate and N-rLmjCS (25, 50 or 75 ng/mL). The reaction was 
incubated for 10 minutes at room temperature and then initiated with the 
addition of 0.5 mM Na2S substrate. A reaction with no enzyme was set up as 
used to measure the background. The synthesis of cysteine was monitored 
every 2 minutes over a period of 10 minutes. 100 L of reaction were mixed 
with 100 L CPM (100 g/mL) in 50% DMSO in a 96-well plate and the 
fluorescence was measured (λexcitation = 340 nm, λemission = 465 nm).  All 
reactions were performed and statistically analyzed (section 2.7.3) 
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2.5.9.7 Inhibition of N-rLmjCS with DYVI peptide and 
determination of its IC50 using the CPM detection method 
DYVI was tested as potential LmjCS inhibitor. 1 mL reaction was set with 
assay buffer, 0.1 mg/mL of gelatine, 1 mM of OAS substrate, 50 ng/mL N-
rLmjCS and 0.1 mM DYVI. The reaction was incubated for 10 minutes at 
room temperature and was then started with the addition of 0.5 mM Na2S 
substrate. The synthesis of cysteine was monitored every 2 minutes over a 
period of 10 minutes. 100 L of reaction were mixed with 100 L CPM (100 
g/mL) in 50% DMSO in a 96-well plate and the fluorescence was measured 
(λexcitation = 340 nm, λemission = 465 nm). All reactions were performed 
and statistically analyzed (section 2.7.3) 
To determine DYVI IC50 using the CPM detection method, several reaction 
were set up using increasing concentrations of this inhibitor. The assay 
buffer was mixed with 50 ng/mL of N-rLmjCS, 0.1 mg/mL of gelatine, 1 mM 
of OAS substrate and DYVI (0.5, 1, 1.5, 2.5, 5, 10, 20, 50, 100 and 200 µM). 
The reactions were initiated with Na2S substrate at 0.5 mM of final 
concentration. The fluorescence (λexcitation = 340 nm, λemission = 465 nm) 
was determined at minute 6 by mixing an aliquot of the reaction with CPM 
(100 µg/mL) in 50% DMSO in a 96-well plate. 
 
2.5.10 HPLC methods 
2.5.10.1 Detection and quantification of thiols 
2.5.10.1.1 Sample preparation 
Parasites were harvested as explained on section 2.6.5 and derivatized on 
the same day. Standard curves of the thiols of interest were set up in order 
to facilitate the determination of thiol concentration on parasite extracts 
and to determine the retention time in the HPLC column.  The 
concentrations of the standards ranged from 50 to 250 pmol, and the thiols 
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derivatized were cysteine, glutathione, trypanothione and glutathione. Both 
sample and standard were suspended in 50 µL of HPLC buffer (40 mM N-[2-
hydroxyethyl]-piperazine-N‟[3-propanesulphonic acid] (EPPS), 4 mM of 
diethylenetriamine pentaacetic acid (DTPA), and pH 8 adjusted with 1 M 
lithium hydroxide) with 0.7 mM of tris(2-carboxyethyl)phosphine (TCEP) and 
incubated on ice for 45 minutes. The samples/standards were derivatized by 
adding 50 µL of 2 mM monobromobimane in absolute ethanol were added to 
each sample/ standard and heated to 70°C for 3 minutes. Then the samples/ 
standards were deproteinized with 100 µL of 4 M methanosulphonic acid pH 
1.6 (pH adjusted with lithium hydroxide powder) and then incubated on ice 
for 30 minutes. Tubes were centrifuged at 13,000 rpm at 4°C for 45 minutes 
and the supernatant was transferred to a HPLC tube for further analysis. The 
samples/ standards were analyzed on the same day of preparation or stored 
at -20°C for no more than a week.  
 
2.5.10.1.2 System operation 
Thiol molecules were detected and quantified using reverse phase HPLC. 
The column used was a Gemini 5 µm C18 250 x 4.6 mm silica column 
(Phenomenex, UK). In order to protect the main column, the system was 
fitted with a pre-column (security guard column KJ0-4282, Phenomenex, UK) 
that would be changed when the system pressure would reach 1500 PSI. If 
not in use, the column was stored in 100% methanol. The instrument used 
was a Dionex Ultimate 3000 HPLC equipped with an auto-sampler (Ultimate 
3000 autosampler), a UV detector (Dionex Ultimate 3000 Variable 
Wavelength Detector) and a fluorescence detector (Dionex RF 2000 
Fluorescence Detector) as well as with the ChromeleonTM (Dionex) software 
to control the system. 
The mobile phase consists of solvent A: 0.25% acetic acid; and solvent B: 
100% acetonitrile.  
All solvents were filtered and degassed before being applied in the HPLC 
system to avoid cluttering of the system tubes and column damage. The 
filtration and degasification process consisted in a bottle with a magnetic 
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stir with a filtration unit attached. A tube connects the filter unit to an 
electric pump. The solvents would pass through the filter (0.20 m of pore 
size) to the bottle. The magnetic stir inside the bottle aids the release of 
the gas, which is lead out by the vacuum generated by the pump.  
Before being used, the column was washed with filtered and degassed ddH2O 
to remove the methanol before 50% solvent A/ 50% solvent B were applied 
to the column. 100% of acetonitrile would then be run over a period of 20 
min to avoid the generation of high pressure. The samples/standards were 
placed into the autosampler and 10 or 20 L were injected for analysis. The 
samples were separated using the solvent gradient shown in Table 2.1 at a 
flow rate of 0.55 mL/min.  
 
Minutes 0 10 40 100 110 111 121 
Solvent A (%) 100 100 92 85 50 100 100 
Solvent B (%) 0 0 8 15 50 0 0 
 
Table 2.1 - Gradient used to separate thiol-monobromobimane 
derivatives.  
 
2.5.10.2 Method validation of detection and quantification of 
polyamines 
2.5.10.2.1 Determination of the ideal solvent/ gradient 
System operation was the same as explained on section 2.5.10.1.2. There 
were two solvent combinations tested: 100% methanol/water, and 75% 
Octane-1-sulfonate (20mM) + 25% acetonitrile/20% Octane-1-sulfonate 
(20mM) + 80% acetonitrile (Table 2.2) (Das Gupta et al., 2005; Müller et al., 
1988; Wittich et al., 1987). There were three modified gradients based on 
Wittich et al. (1987) (Table 2.2). The flow rates tested were 0.55 to 1 
ml/mL and adjusted to the machine pressure. 
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Gradient A: 
Time (minutes) 0 25 37.5 46.25 50 52.5 62.5 
Solvent A (%) 42.5 32.5 17.5 0 0 42.5 42.5 
Solvent B (%) 57.5 67.5 82.5 100 100 57.5 57.5 
Flow rate = 0.55 mL/ min 
Solvent A – Methanol 
Solvent B – ddH2O 
 
Gradient B: 
Time (minutes) 0 13 18 29 32 51 56 62.5 
Solvent A (%) 75 70 35 25 0 0 75 75 
Solvent B (%) 25 30 65 75 100 100 25 25 
Flow rate = 1 mL/ min 
Solvent A – 75% Octane-1-sulfonate (20mM) and 25% acetonitrile 
Solvent B – 20% Octane-1-sulfonate (20mM) and 80% acetonitrile 
 
Gradient C: 
Time (minutes) 0 15 45 62.5 
Solvent A (%) 70 0 0 70 
Solvent B (%) 30 100 100 30 
Flow rate = 1 mL/ min 
Solvent A – 75% Octane-1-sulfonate (20mM) and 25% acetonitrile 
Solvent B – 20% Octane-1-sulfonate (20mM) and 80% acetonitrile 
 
Table 2.2 – Gradients tested for the separation of polyamines. 
The tables show the gradients used in the separation of polyamines in 
order to quantify them. Gradients are identified as A, B and C. The 
solvent combination and flow rate applied is referred bellow each table. 
 
To test gradient A, 20 pmol of 1,6-diaminohexane were run in the HPLC; to 
test gradient B, 20 pmol of 1,6-diaminohexane was tested; and to test 
gradient C, 1 nmol of putrescine was used.  The referred amount of 
polyamines were mixed with 10% trichloroacetic acid (TCA), and perchloric 
acid to a final concentration of 0.2 mM. This solution was saturated with 
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sodium carbonate in order to bring the pH up. 2 mg/mL of dansyl chloride 
were added and the solution was incubated overnight at room temperature 
in the dark. After incubation, 25% proline was added to one of the solutions. 
800 µL of solution were transferred to a 15 mL tube and 4 mL of ether were 
added. The tubes were gently shaken for 1 hour in order to extract the 
dansyl chloride derivatives. 3.5 mL of ether were transferred to a clean 15 
mL tube and the tubes were placed in a heat plate at 70°C with lids 
removed to evaporate the ether to dryness. Dansyl chloride derivatives were 
resuspended in 200 µL 5% acetic acid in methanol and 150 µL were 
transferred to a clean HPLC tube. The sample tubes were immediately 
loaded in the HPLC machine otherwise they were kept at – 20°C. The above-
mentioned gradients were used for each correspondent sample and the 
fluorescence was measured (λexcitation = 365; λemission = 485 nm). 
Injected volume varied from 10 to 20 µL. 
 
2.5.10.2.2 Polyamine separation using 10 mg/mL of dansyl 
chloride with and without proline 
When increasing the concentration of dansylchloride one has to ensure that 
the background will not interfere with the reading of the chromatogram. In 
an attempt to lower the background caused by excess of dansylchloride, 1 
nmol/ 20 µL of putrescine were derivatized in the presence/ absence of 
proline. One solution was made without putrescine and another without 
proline to use as negative controls. 50 nmol of putrecine were mixed with 
10% TCA, and perchloric acid to a final concentration of 0.2 mM. This 
solution was saturated with sodium carbonate in order to bring the pH up. 
10 mg/mL of dansylchloride were added and the solution was incubated 
overnight at room temperature in the dark. After incubation, 25% proline 
was added to one of the solutions. 800 µL of solution were transferred to a 
15 mL tube and 4 mL of ether were added. The tubes were gently shaken for 
1 hour in order to extract the dansylchloride derivatives. 3.5 mL of ether 
were transferred to a clean 15 mL tube and the tubes were placed in a heat 
plate at 70°C with lids removed to evaporate the ether to dryness. 
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Dansylchloride derivatives were resuspended in 250 µL 5% acetic acid in 
methanol and 200 µL were transferred to a clean HPLC tube. The sample 
tubes were immediately loaded in the HPLC machine otherwise they were 
kept at –20°C. The gradient C (see section 2.5.10.2.1) was used and the 
fluorescence was measured (λexcitation = 365; λemission = 485 nm). 
Injected volume varied from 10 to 20 µL. 
 
2.5.10.2.3 Polyamine detection and quantification in cell 
extracts 
To quantify polyamines in cell extracts, standard curves were set up of the 
polyamines of interest. Putrescine standard curve was set up between 125 
pmol and 500 pmol; spermidine standard curve was set up between 125 
pmol and 800 pmol; and spermidine standard curve was set up between 250 
pmol and 800 pmol. 1,6-diaminohexane was added to each standard at 500 
pmol and used as an internal standard. Polyamines were prepared in a mix. 
100 µL of polyamine mix were treated with 10% TCA, and perchloric acid to 
a final concentration of 0.2 mM. 500 pmol of 1,6-diaminohexane were added 
at this stage. The solution was saturated with sodium carbonate in order to 
bring the pH up. 10 mg/mL of dansylchloride were added and the solution 
was incubated overnight at room temperature in the dark. After incubation, 
25% proline was added to one of the solutions. 800 µL of solution were 
transferred to a 15 mL tube and 4 mL of ether were added. The tubes were 
gently shaken for 1 hour in order to extract the dansylchloride derivatives. 
3.5 mL of ether were transferred to a clean 15 mL tube and the tubes were 
placed in a heat plate at 70°C with lids removed to evaporate the ether to 
dryness. Dansylchloride derivatives were resuspended in 250 µL 5% acetic 
acid in methanol and 200 µL were transferred to a clean HPLC tube. The 
sample tubes were immediately loaded in the HPLC machine otherwise they 
were kept at –20°C. The gradient C (see section 2.5.10.2.1) was used and 
the fluorescence was measured (λexcitation = 365; λemission = 485 nm). 
Injected volume varied from 10 to 20 µL. 
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2.6 Culturing of Leishmania 
2.6.1 L. donovani promastigote culture 
L. donovani were cultured in HOMEM containing 10% fetal calf serum (FCS) 
and 1% penicillin/streptomycin with the appropriate antibiotics to select for 
the presence of selectable markers and sub-passaged weekly to a density of 
5x105 parasites/mL. Parasites recovered from the hamster spleen by limiting 
dilution assay (see section 2.6.4) or from a frozen stock (see section 2.6.2), 
were first cultured in the medium referred to above but containing 20% FCS. 
Antibiotics were added as follows when required: G418 at 50 µg/mL, 
hygromycin at 50 µg/mL and neurseothricin at 50 µg/mL. Cultures were 
incubated at 25°C.  
 
2.6.2 Freezing/ thawing of parasites 
Parasites were cryopreserved in 50% HOMEM, 20% FCS, 1% 
penicillin/streptomycin and 10% DMSO and transferred to -80°C for 24 hours 
before being transferred into liquid nitrogen. 
To recover the parasites, the stabilates were quickly thawed and placed in 
HOMEM, 20% FCS and 1% penicillin/ streptomycin. Flasks were incubated at 
25°C. 
  
2.6.3 Analysis of L. donovani growth 
Parasite density was determined daily by transferring an aliquot of culture 
to 2% formaldehyde in PBS. Parasites were counted using a Newbauer 
haemocytometer and observed on an inverted light microscope (Zeiss 
Wetzlar) using a 40x magnification. Cell growth was analyzed over a period 
of 6 days until the parasites reached stationary phase, and they were then 
sub-passaged to 5x105 parasites/mL as described above. 
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2.6.4 Isolation of L. donovani from hamsters 
Golden hamsters were culled six months after having being infected with L. 
donovani parasites (strain BPK 206 clone 10). Dr Elmarie Myburgh, carried 
out the infection. Three groups of 6 hamsters had been previously infected 
with L. donovani BPK 206 clone 10 (wild-type, WT), L. donovani BPK 206 
clone 10 lacking the cs alleles (Δcs), and L. donovani BPK 206 clone 10 
lacking the cs alleles with an episomal re-expression plasmid (RE). The 
hamsters were dissected, and spleens and livers were removed, weighed and 
measured. A small portion of each organ was placed into HOMEM containing 
20% FCS with 1% penicillin/streptomycin. The remainder of the organ was 
ground in PSGEMKA medium and used in a limiting dilution assay by liver and 
spleen homogenates into the first well of 96 well plates in a 1:2 dilution. 
From this well sequential 1:2 dilutions were made until the end of the plate.  
  
2.6.5 Harvest of L. donovani from a culture 
Cultures were transferred to a 15 mL Falcon tube and centrifuged at 4°C, 
1,600g for 10 minutes. The supernatant was discarded and the parasites 
were washed twice with PBS with centrifuge steps in between where 
supernatant is discarded. Finally cells are resuspended in the intended 
buffer depending on the purpose.  
  
2.6.6 Isolation of DNA 
Parasites were harvested as explained on section 2.6.5. The isolation of 
gDNA from L. donovani parasites was performed using the QIAamp DNA mini 
kit (Qiagen) as per manufacturer‟s instructions. gDNA was stored at 4°C for 
further analysis. 
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2.6.7 Isolation of RNA 
Parasites were harvested as explained on section 2.6.5. The isolation of 
genomic DNA from L. donovani parasites was performed using the RNeasy 
Mini kit (Qiagen) as per manufacturer‟s instructions. RNA was stored at -
80°C for further analysis. 
 
2.6.8 Isolation of protein 
L. donovani promastigote parasites were pelleted and lysed using the lysis 
buffer (0.25 M sucrose, 0.25% Triton X-100, 10 mM EDTA, 20 M E-64, 4 M 
1,10-phenanthroline, 8 M pepstatin A, 2 mM phenylmethylsulfonylfluoride). 
The suspension was incubated on ice for 10 min and the soluble fraction, 
containing the total protein extract, and centrifuged at 13,000 rpm for 30 
minutes at 4°C (Sigma 1-15, rotor 12124). The protein concentration of the 
supernatant was determined using the BCA protein quantification method.  
 
2.6.9 Transfection of L. donovani 
L. donovani ∆cs promastigotes parasites were briefly counted and 5x107 
parasites were pelleted at 1,000g for 10 minutes at 4°C (Beckman Coulter 
AllegraTM X-12R, rotor SX4750). 100 µL of Human T Nucleofector solution 
(Lonza) were added to the pellet and gently mixed. pGL102cs construct was 
ethanol precipitated (see section 2.2.2) and 10 µg were added to the pellet 
in a cuvette supplied by the Nucleofector® kit. Amaxa® Nucleofector® 
Device (Lonza). The program used was U-033 to electroporate the parasites. 
Electroporated parasites were transferred into 10 mL HOMEM containing 20% 
FCS and 1% penicillin/streptomycin. The appropriate selective drug was 
added to the cultures the following day. 
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2.6.10 Cloning by limiting dilution 
Clones were isolated by a limiting dilution assay. The transfected parasites 
were diluted in HOMEM with 20% FCS and 1% penicillin/streptomycin. The 
dilutions were made as follows: 
 
Dilution 1 4 mL of culture + 20 mL medium 
Dilution 2 2 mL of dilution 1 + 22 mL medium 
Dilution 3 4 mL of dilution 2 + 20 mL medium 
Dilution 4 4 mL of dilution 3 + 20 mL medium 
 
After 2 weeks incubation, clones were subpassaged into 3 mL HOMEM with 
10% FCS, 1% penicillin/streptomycin, and 50 g/mL of G-418. When the 
parasites reached the appropriate density, gDNA (see section 2.6.6), RNA 
(see section 2.6.7) and protein was extracted (see section 2.6.8).   
 
2.6.11 Determination of IC50 values 
The determination of L. donovani promastigote susceptibility to compounds 
was performed using resazurin dye/ Alamar Blue® (7-hydroxy-3H-
phenoxazin-3-one 10-oxide) assay (Kulshrestha et al., 2013; Mikus and 
Steverding, 2000). On a 96-well plate, 100 L of a late-log parasite culture 
containing 2x106 parasites/mL were transferred into each well; 100 L of 
compound would be sequentially diluted in the wells rendering a final 
density of 1x106 parasites/mL. The inhibitors tested were propargylglycine 
(0.3 M to 20 mM) and α-difluoromethylornithine (0.001 M to 20 mM); the 
pro-oxidants tested were hydrogen peroxide (0.02 to 30 mM), cumene 
hydroperoxide (1 M to 1 mM), and tert-butyl hydroperoxide (1 M to 1 mM); 
the metals tested were cadmium chloride (0.003 to 40 mM), and potassium 
arsenate (0.003 to 20 mM). The plates were incubated for 72 h before 
resazurin was added to each well at 125 μg/mL final concentration. The 
plates were incubated further for 48 h and the fluorescence using an 
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λemission = 620 nm and λexcitation = 544 nm. Since the assay had strong 
background fluorescence which varied from experiment to experiment, the 
values obtained from this “dead cell control” was used to assess 100% cell 
death. 200 M of pentamidine was used as positive control, since the 
determined IC50 for WT was 5.6 µM, for ∆cs was 2.3 µM, and for RE was 3.4 
µM. The percentage of viability was calculated in relation to this value.   
 
 
2.7 Bioinformatic methods 
2.7.1 Sequence identification 
All L. donovani and L. major gene sequences identified were retrieved from 
the NCBI website (http://www.ncbi.nlm.nih.gov/protein/).    
 
2.7.2 Sequence alignment 
Gene sequence alignments were performed in AlignX from Vector NTI 
Advanced® (version 11.5.1, Invitrogen).  
 
2.7.3 Statistical analysis 
All the statistical analyses were carried using Graphpad Prism 5 software 
(Graphpad). Grouped data were analyzed with one-way ANOVA with 
Dunnett‟s post-test using a control sample or Tuckey‟s post-test. The 
Dunnett‟s post-test test allows the comparison of a mean with the mean of a 
control group, which has been defined for each situation, without comparing 
the groups between themselves. The Tuckey‟s test allows the comparison of 
the means between groups without defining a control group. All the groups 
are compared with each other. The data was classified according with the P-
value (Table 2.3). Unless otherwise stated, all graphs were generated using 
the GraphPad Prism 5 software package. 
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P-value Summary 
> 0.05 n.s. 
0.01 to 0.05 * 
0.001 to 0.01 ** 
< 0.001 *** 
  
Table 2.3 – P-value classification. 
The table shows the P-value classification according to the significance. 
(n.s.) not significant. 
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3 Characterization of a recombinant L. 
major cysteine synthase 
3.1 Introduction 
This chapter focuses on the analysis of the recombinant cysteine synthase 
(CS) from L. major (LmjCS). Previously, it was shown that Leishmania 
possess two pathways that generate cysteine, the sulphydrylation pathway 
and the reverse trans-sulphuration (RTS) pathway (Williams et al., 2009). CS 
catalyses the formation of cysteine from O-acetyl serine (OAS) and hydrogen 
sulphide (H2S). OAS is generated from serine and acetyl-CoA by serine 
acetyl-transferase (SAT). It was previously shown that SAT and CS forms a 
complex that is important to the regulation of CS activity in Arabidopsis 
thaliana (Bonner et al., 2005; Francois et al., 2006; Heeg et al., 2008; 
Kumaran and Jez, 2007). This work showed that the C-terminus of SAT 
interacts with the active site of CS thereby inhibiting CS activity and 
promoting SAT activity. These observations initiated a screening of peptides 
and resulted in the finding that pentapeptides with C-terminal isoleucine 
are sufficient to inhibit CS activity of the Haemophilus influenzae enzyme 
(Salsi et al., 2009). William et al. (2009) showed that Leishmania CS and SAT 
also form a complex. Based on these observations it was postulated that 
LmjCS should also be susceptible to inhibition by small peptides and this 
hypothesis was tested in this chapter. In addition, this chapter focussed on 
establishing a new CS enzyme assay based on the detection of cysteine using 
a fluorescent dye, 7-diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin 
(CPM) (Chung et al., 2008). 
 
3.2 Generation of the pET15bcs construct 
To characterize LmjCS, kinetically and structurally, the open reading frame 
of Lmjcs was cloned into pET15b, generating an expression construct that 
lead to expression of an N-terminally His-tagged LmjCS protein (see section 
Chapter 3 – Characterization of a recombinante L. major cysteine synthase        76 
 
2.4.11.1). LmjCS was amplified by PCR (Figure 3.1, Lane 1) and subcloned 
into pGEM-T easy (Figure 3.1, Lane 2) before being excised using QIAquick 
gel extraction kit (QIAGEN, UK) and cloned into the destination plasmid 
pET15b (Figure 3.1, Lane 3). The sequence of the expression construct was 
verified before it was used to generate the recombinantly N-teminally His-
tagged LmjCS. After attempts to crystallize a C-terminally His-tagged LmjCS 
protein by William Hunter at University of Dundee (personal 
communication), it was speculated that this was probably due to the 
presence of the His-tag. The pET15b vector, which adds an N-terminal His-
tag allows the removal of the recombinant His-tag via tabacco etch virus 
(TEV) protease digest. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 - Generation of pET15bLmjcs 
(1) PCR amplification of Lmjcs from pET21a+Lmjcs. (2) EcoRI restriction 
endonuclease digest of the intermediate construct pGEM-TLmjcs. (3) 
BamHI and NdeI restriction endonuclease digest of pET15bLmjcs.   
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3.3 Expression and purification of N-LmjCS 
The expression of the N-rLmjCS protein was carried by induction of the 
lacUV5 promoter with IPTG, which controls the expression of the T7 RNA 
polymerase gene in the E. coli BL21/DE3 cells. pET15b is a T7lac promoter 
containing vector and contains an N-terminal His-tag cleavable with TEV 
protease. Two expression conditions were tested.  Bacterial cells were 
incubated at 37°C until optical density at 600 nm (OD600) was 0.6, and then 
divided into two flasks. One flask was induced with 1 mM IPTG and 
incubated overnight at 15°C, and the other flask was induced with 2 mM 
IPTG and incubated for 4 h (see section 2.5.4). The bacterial pellets were 
lysed and the soluble and insoluble fractions were analyzed by SDS-PAGE. A 
prominent protein band of the expected size (37.8 kDa) of LmjCS can be 
seen both in the soluble and the insoluble fractions (Figure 3.2). The empty 
pET15b vector was also transformed into E. coli BL21/DE3 and used as a 
negative control and the 37.8 kDa protein was absent in these bacterial 
lysates. The absence of the 37.8 kDa protein strongly suggests that the band 
observed in the pET15b-rLmjCS transformation corresponds to N-rLmjCS. At 
37°C more protein is present in the insoluble fraction. At 15°C, 
approximately 50% of the expressed protein is found in the soluble fraction, 
while this proportion was lower when expression was done at 37°C.  
The recombinant N-rLmjCS was purified using the Ni+-agarose column 
affinity batch method (see section 2.5.5). Figure 3.3A illustrates the 
purification of N-rLmjCS after an expression at 37°C for 4 h with 2 mM IPTG. 
The yield was 6 mg/L. Figure 3.3B depicts the purification of N-rLmjCS 
expressed at 15°C, overnight with 1 mM IPTG. The yield was 110 mg/L. 
Thus, it was decided to prepare a larger scale expression of N-rLmjCS at 
15°C induction of expression with 1 mM IPTG overnight. 
In both purifications N-rLmjCS was yellow, which is consistent with the 
presence of pyridoxal 5‟-phosphate (PLP) in the active site. As seen in Figure 
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3.3A and B, an unidentified protein of a bigger size was co-purified with N-
rLmjCS. 
 
 
 
 
Figure 3.2 – Expression trials N-rLmjCS. 
Coomassie stained SDS-PAGE (10%) showing the expression trial of N-
rLmjCS carried at 15°C and 37°C. Soluble and insoluble fractions were 
screened for the presence of N-rLmjCS. The bacterial lysates transformed 
with the empty vector was used as a negative control. (V) BL21/DE3 
bacteria transformed with empty pET15b; (CS) BL21/DE3 bacteria 
transformed with pET15b-rLmjCS construct.  
 
 
 
 
 
 
 
 
 
Chapter 3 – Characterization of a recombinante L. major cysteine synthase        79 
 
 
 
 
 
Figure 3.3 – Purification of N-rLmjCS. 
Panel A – Coomassie stained SDS-PAGE (10%) showing the protein 
purification of N-rLmjCS expressed at 37°C and induced with 2 mM IPTG. 
Panel B - Coomassie stained SDS-PAGE (10%) showing the protein 
purification of N-rLmjCS expressed at 15°C and induced with 1 mM IPTG. 
N-rLmjCS expected size is 37.8 kDa. (Ts) Total protein from the soluble 
fraction; (Ft) flow-through; (W) wash with 20 mM imidazole; (E) elution 
with 250 mM imidazole. (*) Co-purifiyed unidentified protein. 
 
 
 
A 
B 
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3.4 Purification of the recombinant C-terminally His-
tagged L. major cysteine synthase in E. coli 
A C-terminally His-tagged recombinant LmjCS protein was expressed as 
previously described by Williams et al. (2009). The expression pET21a+-Lmjcs 
construct was provided by Dr Westrop, Strathclyde University. The C-rLmjCS 
(37.8 kDa) was purified with 250 mM imidizale. The C-rLmjCS yield was ~140 
mg/L.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 – Purification of C-rLmjCS. 
Coomassie stained SDS-PAGE showing the purification of C-rLmjCS. The 
expected size of C-rLmjCS is 37.8 kDa. (Ft) flow-through; (W) wash with 
20 mM imidazole; (E) elution with 250 mM imidazole. 
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3.5 Generation of native rLmjCS 
The non-tagged rLmjCS was generated by cleaving of the His-tag from N-
rLmjCS with TEV protease (see section 2.5.6). To determine the optimal 
cleavage conditions, ratios and incubation times were determined (see 
section 2.2.7). The optimal TEV:CS ratio was found to be 1 µg:0.8 µg which 
resulted in a good cleavage of the His-tag. The times tested were 2 h, 4 h, 
and overnight incubation at 37°C (Figure 3.5A). Having established the 
conditions, N-rLmjCS (37.8 kDa) was successfully cleaved, and purified using 
Ni+-agarose column (Figure 3.5B). 
 A reaction containing N-rLmjCS (37.8 kDa) alone was used to distinguish the 
size of the non-cleaved N-rLmjCS (Figure 3.5B, lane –TEV; 37.8 kDa) and 
cleaved rLmjCS (Figure 3.5B, lane +TEV; 35.5 kDa). TEV protein size is 52 
kDa and can be seen on Figure 3.5B (lane +TEV) where the digest of N-
rLmjCS (37.8 kDa) is depicted showing the cleaved rLmjCS which is 35.5 kDa. 
The digest was further purified using a Ni+-agarose column (Figure 3.5B, 
Pure) after imidazole was removed from the solution. 
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Figure 3.5 – Generation and purification of rLmjCS. 
Panel A – Coomassie stained SDS-PAGE showing the determination of the 
optimal TEV digest (+TEV). A digest without TEV (-TEV) was used as 
negative control. Panel B – Coomassie stained SDS-PAGE showing the 
purification of rLmjCS after digest with TEV protease. A digest without 
TEV was used as negative control. N-rLmjCS expected size is 37.8 kDa; 
rLmjCS expected size is 35.5 kDa; TEV expected size is 52 kDa.  
 
 
 
A 
B 
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3.6 Kinetic characterization of N-rLmjCS, C-rLmjCS and 
LmjCS  
3.6.1 Quantification of cysteine synthesis 
The kinetic characterization of the various forms of rLmjCS was performed 
using an enzyme assay for the detection of aliphatic thiols described by 
Kredich and Tomkins, (1966). Briefly, the thiol of the cysteine formed reacts 
with an excess of nitrous acid originating a stable S-nitrosothiol derivative. 
The excess of nitrous acid is quenched by ammonium sulfamate. The S-
nitrosothiol derivative is decomposed in the presence of mercuric ion giving 
nitrous acid. The nitrous acid diazotes the sulphanilamide, and the latter 
reacts with the naphthylethylenediamine, forming a stable azo dye 
(chromophore) which can be detected by spectrophotometry at 540 nm 
(A540nm).  
 
3.6.2 Kinetic characterization of recombinant LmjCS enzymes 
In order to quantify the cysteine formed in an assay, a standard curve was 
generated using increasing cysteine concentrations (1 to 20 nmol), 0.1 M 
potassium phosphate buffer pH 7.8, 1 mM EDTA, 0.5 mM Na2S, and 1 mg/mL 
gelatine (Figure 3.6) (see section 2.5.7). A regression curve was plotted with 
the results and the resultant equation of the curve (A540nm = 0.082
 x cysteine 
(nmol)) was used to quantify cysteine synthesis in the forthcoming assays. 
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Figure 3.6 – Cysteine standard curve for the mercury chloride assay. 
Graph showing the absorbance (540 nm) generated by increasing 
concentrations of cysteine. The linear regression curve was plotted and 
the absorbance was used to quantify cysteine synthesis in enzyme 
reactions. Values depicted represent means with S.E.M. from five 
experiments performed in different days.  
 
The three forms of rLmjCS were compared kinetically by their ability to 
synthesise cysteine. Different enzyme concentrations were tested as 
depicted in Figure 3.7. Each reaction contained the enzyme, 0.1 M 
potassium phosphate buffer pH 7.8, 1 mM EDTA, 0.5 mM Na2S, 10 mM OAS, 
and 1 mg/mL gelatine. The optimal enzyme concentration should result in 
proportionally increasing product (Cys) formation over time without 
saturating the detection system. Figure 3.7 shows the resultant regression 
curves. 250 ng/mL of C-rLmjCS was used in future assays because it gives 
more flexibility to do a substrate saturation assay. The same concentration 
was chosen for N-rLmjCS. For rLmjCS, 500 ng/mL were chosen instead. The 
rates of reaction (Table 3.1) for these concentrations were 2 nmol/min for 
C-rLmjCS; 3.4 nmol/min for N-rLmjCS; and 1.3 nmol/min for rLmjCS. 
Although a higher concentration of rLmjCS was used compared with two 
forms of LmjCS, the rate was about half. 
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Figure 3.7 – Enzyme concentrations test. 
The graphs illustrate cysteine generated by the different rLmjCS 
enzymes at different enzyme concentrations as indicated. The OAS 
concentration was 10 mM. The experience was performed once. Panel A – 
C-rLmjCS enzyme; Panel B – N-rLmjCS enzyme; Panel C – rLmjCS enzyme.   
 
A B 
C 
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Enzyme 
[Enzyme] 
ng/mL 
Rate 
(nmol/min) 
C-rLmjCS 
250 2.0 
800 4.0 
N-rLmjCS 
250 3.4 
500 5.6 
rLmjCS 
250 0.8 
500 1.3 
1000 2.3 
 
 
Table 3.1 – Enzyme activity. 
Table showing the reaction rate (nmol/min) for each tested enzyme 
concentration.  
 
To determine the kinetic parameters, a substrate saturation curved was 
plotted. Increasing concentrations of OAS (0.5 to 5 mM) were tested with 
the previously chosen enzyme concentrations mixed with 0.1 M potassium 
phosphate buffer pH 7.8, 1 mM EDTA, 0.5 mM Na2S, and 1 mg/mL gelatine. 
The cysteine levels were measured every two minutes, up to six minutes 
(Figure 3.8A, B and C). The rates of reaction increase with the increase of 
OAS concentration (Table 3.2). The rates along with the enzyme 
concentration were used to calculate the specific activity (µmol/min/mg) 
for each OAS concentration (Table 3.3). All the experiments were performed 
in triplicate.  
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 [N-rLmjCS] [C-rLmjCS] [rLmjCS] 
 250 ng/mL 250 ng/mL 500 ng/mL 
OAS (mM) Rate (pmol/min ± S.E.M.) in 10 µL of reaction, n=3 
0.5 284 ± 25  225 ± 37  387 ± 114  
1 558 ± 22  358 ± 8  624 ± 96  
2 1011 ± 4  603 ± 13  1006 ± 130  
3 1284 ± 26  752 ± 28  1372 ± 180  
5 1539 ± 84  983 ± 29  1883 ± 182  
8 1995 ± 31  1246 ± 41  2160 ± 207  
15 2318 ± 48  1335 ± 43  2431 ± 170  
 
Table 3.2 – Rates of cysteine synthesis for each enzyme. 
The average rate (pmol/min) of cysteine synthesis was measured with 
increasing concentrations of OAS substrate (0.5-15 mM). The absorbance 
(540 nm) was determined in 10 L of reaction at 2, 4 and 6 minutes. The 
experiment was performed in triplicate and the concentration of each 
enzyme is shown (please refer to the table).  
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Figure 3.8 – Substrate saturation curves. 
Graphs showing cysteine synthesis generated when increasing 
concentrations are used. Panel A – C-rLmjCS enzyme (250 ng/mL); Panel 
B – N-rLmjCS enzyme (250 ng/mL); Panel C – rLmjCS enzyme (500 ng/mL). 
The numbers are means and S.E.M. of three independent experiments 
performed in triplicate. 
 
 
 
 
 
 B 
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Table 3.3 – Specific activity. 
Table displaying the specific activities calculated from the rates 
(pmol/min) of the reactions with increasing OAS concentrations. The data 
are means ± S.E.M. of three independent experiments. 
 
 
 
Two plots were used to analyse enzyme kinetic parameters: the Michaelis-
Menten plot (Figure 3.9A); and the Lineweaver-Burk plot (Figure 3.9B). 
Kinetic parameters are summarised in Table 3.4. 
The Km value (or Michaelis-Menten constant) is the concentration of the 
substrate, here OAS, that leads to half of the maximum velocity (Vmax) of the 
enzyme (Cornish-Bowden, 2004; Segel, 1993). This constant is independent 
of the enzyme concentration. The Km values of all three recombinant 
enzymes were the same for N-rLmjCS, C-rLmjCS, and rLmjCS, 4 mM (Figure 
3.9A and B and Table 3.4).  
Vmax is specific to the enzyme concentration and is the limiting velocity for 
high substrate concentrations, meaning the velocity will not increase even if 
the substrate concentration increases (Cornish-Bowden, 2004; Segel, 1993). 
The Vmax for C-rLmjCS and rLmjCS (696 and 630 µmol/min/mg, respectively) 
were lower than for N-rLmjCS (1192 µmol/min/mg) (Figure 3.9A and B and 
Table 3.4).  
kcat, or turnover number, is the number of substrate molecules that are 
converted into product per active site of an enzyme, per unit of time, when 
 
Specific activity 
(µmol/min/mg ± S.E.M.), n=3 
OAS (mM) N-rLmjCS C-rLmjCS rLmjCS 
0.5 114 ± 10 90 ± 15 77 ± 23 
1 223 ± 9 143 ± 3 125 ± 19 
2 404 ± 2 241 ± 5 201 ± 26 
3 514 ± 10 301 ± 11 274 ± 36 
5 615 ± 34 393 ± 12 377 ± 36 
8 798 ± 12 498 ± 17 432 ± 41 
15 927 ± 19 534 ± 17 486 ± 34 
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the enzyme is completely saturated (Cornish-Bowden, 2004; Segel, 1993). 
kcat is expressed in sec
-1 and the results can be seen on Table 3.4. The kcat 
values (Table 3.4) for the C-rLmjCS and rLmjCS (438 sec-1 and 373 sec-1, 
respectively) are lower than for the N-rLmjCS (751 sec-1 for rLmjCS). 
And finally, kcat/Km is the measure of the enzymes catalytic efficiency and it 
can be calculated by dividing kcat by Km. The kcat /Km is expressed in M
-1/sec-1 
(Cornish-Bowden, 2004; Segel, 1993). The efficiency of the N-rLmjCS (Table 
3.4) is the nearly double (1.9x105 M-1/sec-1) than the C-rLmjCS (1.1x105 M-
1/sec-1). The kcat /Km  of rLmjCS (9.3x10
4 M-1/sec-1) is the lowest of the three 
enzymes but closer to the C-rLmjCS kcat /Km. 
The N-rLmjCS enzyme is more efficient then the C-rLmjCS and rLmjCS 
enzymes. The kcat/Km magnitude of these enzymes (~10
5 M-1/sec-1) is the half 
of the kcat/Km of other known super-efficient enzyme such as superoxide 
dismutase (1010 M-1/sec-1) (Folcarelli et al., 1999).  The tag can influence the 
activity of an enzyme if it is located close to the substrate binding site 
(Ledent et al., 1997). In this case the His-tag does not cause a loss in the 
enzyme efficiency. Conversely, the N-rLmjCS enzyme is two times more 
efficient than the non-tagged enzyme but still in the same order of 
magnitude (105 M-1/sec-1). 
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Figure 3.9 – Comparative kinetic analysis. 
The specific activities are illustrated in a Michaelis-Menten (Panel A) and 
Linweaver-Burk (Panel B) plots for comparative kinetic analysis between 
the three forms of rLmjCS (Software used - GraFit5). 
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Cysteine 
synthase 
Km (mM) 
Vmax 
(μmol/min/mg) 
kcat (sec
-1) kcat/Km (M
-1/sec-1) 
N-rLmjCS 4 ± 0.3 1192 ± 58 751 1.9x105 
C-rLmjCS 4 ± 0.2 696 ± 24 438 1.1x105 
rLmjCS 4 ± 0.3 630 ± 28 373 9.3x104 
 
 
Table 3.4 – Analysis of kinetic parameters. 
Table showing the kinetic parameters calculated or extrapolated from 
the Michaelis-Menten and Linweaver-Burk plots. 
 
 
3.7 Inhibition of N-rLmjCS, C-rLmjCS and rLmjCS  
Peptide analogues of the LmjSAT and AtSAT C-terminus were tested as 
putative inhibitors of the three forms of rLmjCS enzyme (see section 2.5.8). 
DYVI (0.1 mM), an AtSAT C-terminal peptide analogue, inhibits ~90% of all 
three forms of LmjCS activity. EGDGSGI (0.1 mM), an LmjSAT C-terminal 
peptide analogue, inhibits ~30% of N-rLmjCS and rLmjCS activity and inhibits 
50% of C-rLmjCS activity. Enantiomeric forms of polyglutamate (0.1 mM and 
0.5 mM of D-γEγEγEγE, and 0.1 Mm of L-γEγEγEγE) and also the non-chiral 
form EEEE (0.1 mM) were also tested as potential inhibitors. These 
compounds were added to the enzyme and the cysteine levels were 
measured every two minutes. Figure 3.10 illustrates the synthesis of 
cysteine over time when the reactions are performed in the presence of 
these compounds. Table 3.5 summarises the percentages of inhibition data. 
D-γEγEγEγE (0.1 mM), a polyglutamate enantiomer found bound to the 
active site of the crystallised LmjCS (Fyfe et al., 2012), inhibited 20% of C-
rLmjCS. When added to the reaction at a concentration five times greater 
(0.5 mM), D-γEγEγEγE, was not able to inhibit C-rLmjCS to the same extent. 
No inhibition was detected for N-rLmjCS and rLmjCS enzyme forms. The 
levorotary enantiomer (L-γEγEγEγE) and the non-chiral polyglutamate 
(EEEE) were not able to inhibit rLmjCS. 
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 % Inhibition 
 N-rLmjCS C-rLmjCS rLmjCS 
Control 0 0 0 
0.1 mM DYVI 94 ± 6 91 ± 0 94 ± 3 
0.1 mM EGDGSGI 36 ± 6 49 ± 4 33 ± 7 
0.1 mM D-γEγEγEγE n.d. 20 ± 4 0 
0.5 mM D-γEγEγEγE n.d. 20 ± 11 0 
0.1 mM L-γEγEγEγE - - 0 
0.1 mM EEEE - - 0 
 
 
Table 3.5 – Inhibition of rLmjCS. 
Percentage of inhibition of all three forms of LmjCS enzymes using 
peptides: 0.1 mM DYVI; 0.1 mM EGDGSGI; 0.1 mM D-γEγEγEγE; 0.5 mM D-
γEγEγEγE; 0.1 mM L-γEγEγEγE; and 0.1 mM EEEE. The experiments were 
carried out on two separate occasions and the values are presented as 
means of percentage of inhibition ± standard deviation (S.D.); (-) not 
determined. 
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Figure 3.10 – Inhibition of rLmjCS. 
The graphs illustrate the inhibition of the various forms of rLmjCS 
enzymes, using peptides: 0.1 mM DYVI; 0.1 mM EGDGSGI; 0.1 mM D-
γEγEγEγE; 0.5 mM D-γEγEγEγE; 0.1 mM L-γEγEγEγE; and 0.1 mM EEEE. 
Panel A – C-rLmjCS enzyme; Panel B – N-rLmjCS enzyme; Panel C – rLmjCS 
enzyme. The experiments were carried on two separate occasions and 
the values are presented as means of percentage of inhibition with 
standard deviation (S.D.). 
 
 
C 
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3.8 Validation of a novel cysteine detection method 
3.8.1 Assay validation 
7-Diethylamino-3-(4‟-maleimidylphenyl)-4-methylcoumarin (CPM) (Chung et 
al., 2008) is a coumarin derivative that contains a thiol-reactive maleimide. 
CPM may aid to determine cysteine concentration because it forms a 
complex between the thiol-reactive maleimide and the sulfhydryl (-SH) 
group of cysteine. Once the complex is formed, the CPM fluorescence 
increases at a λexcitation of 340 nm and λemission of 465 nm. Being a less 
laborious and toxic detection method than the mercury chloride assay 
system (Kredich and Tomkins, 1966), the CPM detection method may be 
adaptable for high-throughput screening of for instance inhibition by peptide 
libraries or other inhibitor libraries against LmjCS.  
Initially, the CPM had high levels of non-specific background fluorescence 
(data not shown) only leaving a small window that would allow the 
quantification of cysteine (see section 2.5.9). Therefore, experiments were 
performed to optimise the assay system to maximise the signal to noise 
ratio. The influence of Na2S, pH, BSA, CPM storage length, and CPM 
concentration were tested.  
Figure 3.11 shows the result of testing the influence of pH(s) 6.5, 7.0, and 
7.8 in the formation of background (see section 2.5.9.1). In this assay four 
reactions were set up: assay buffer (0.1 M sodium potassium phosphate pH 
6.5, 7.0 or 7.8, and 1 mM EDTA) (Figure 3.11A); assay buffer with 40 µM 
cysteine (Figure 3.11B); assay buffer with 0.5 mM Na2S (Figure 3.11C); and 
assay buffer with 40 µM cysteine and 0.5 mM Na2S (Figure 3.11D).  
The buffer with a pH of 7.8 generates a significantly (***, P<0.001) higher 
background than buffer with a pH of 7.0 and 6.5. The background 
fluorescence is however 2 orders of magnitude lower than the background 
determined when 0.5 mM Na2S was added to the reaction. In fact, the buffer 
pH had no effect on background fluorescence when 0.5 mM Na2S was present 
in the reaction mixture. Presumably the Na2S in solution is converted into 
NaS- (Figure 3.12), which can react with CPM generating fluorescence.  
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The addition 40 µM cysteine resulted in an increase of fluorescence as 
expected but the signal was only marginally larger (1.5 times) than the 
background signal determined with 0.5 mM Na2S (3x10
4 vs. 2x104 RFU). 
When 0.5 mM Na2S and 40 µM Cys were added to the different buffers, the 
signal increased further to 5x104 RFU in line with the observed fluorescence 
of the individual reaction mixtures. 
So, overall it appeared that the fluorescence of the buffer itself was 
negligible and that pH did not affect interaction of CPM with sulphur 
containing molecules. 
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Figure 3.11 – Influence of pH in the fluorescence detection. 
The graphs illustrate the fluorescence measured (λexcitation = 340 nm; 
λemission = 465 nm) when 40 µM of cysteine and 0.5 mM of Na2S were 
added to the assay buffer, alone (Panel B and C) or together (Panel D). 
The assay buffer alone (Panel A) was used to determine the fluorescence 
background. The experiment was performed in triplicate. The results are 
presented in means of relative fluorescent units (RFU) ± S.E.M and were 
analyzed using 1-way ANOVA with Tuckey post-test. The statistical 
results are represented as: ***, P<0.001. 
 
 
 
C D 
A B Assay buffer 
Assay buffer + 40 M Cys 
Assay buffer + 0.5 mM Na2S 
Assay buffer + 40 M Cys + 
0.5 mM Na2S 
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Figure 3.12 – Dissolution of sodium sulphide. 
In the presence of water, sodium sulphide is ionised in NaS-, OH- and 
2Na+. CPM reacts with the sulphide group, NaS-, forming a complex and 
thus fluorescence. This fluorescence contributes to the background 
interfering with the detection of cysteine synthesis. 
 
 
BSA is a component of the CPM assay system. However, BSA is a protein rich 
in cysteine residues that can react with CPM and generate background. BSA 
is added to the CPM reaction to prevent the adhesion of protein to the walls 
of the reaction tube. Gelatine, a cysteine-free molecule with a similar 
feature as BSA was tested as a potential replacement for BSA in order to 
decrease the background of the reaction. Five reactions were set up with 
0.1 M potassium phosphate pH 7.8, since it helps to stabilise the LmjCS 
enzyme, and BSA or gelatine at 1 or 0.1 mg/mL (see section 2.5.9.2). 
Freshly prepared CPM at 50 µg/mL was added and the fluorescence was 
measured. Figure 3.13 summarises the data obtained. The background 
fluorescence of the reaction mix when 1 mg/mL BSA was added increased 
from 2.2x103 to 3.1x104 RFU (***, P<0.001) while addition of 1 mg/mL 
gelatine only increased the background fluorescence from 2.2x103 to 3.1x103 
RFU. Decreasing BSA to 0.1 mg/mL reduced the background fluorescence 
dramatically from 3.1x104 to 6.5x103 RFU (***, P<0.001), a 5 fold reduction 
compared to the fluorescence determined when 1 mg/mL BSA was used in 
the reaction mixture. 
A similar reduction was not observed when gelatine was lowered to 0.1 
mg/mL; this only reduced the RFU from 3.1x103 to 2.7x103 relative to the 
assay mix containing 1 mg/mL. 
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Figure 3.13 – Influence of BSA vs. gelatine on the fluorescence 
background. 
The graphs illustrate the fluorescence measured (λexcitation = 340 nm; 
λemission = 465 nm) when the assay buffer contains gelatine or BSA 
under 1 or 0.1 mg/mL of concentration. The experiment was performed 
in triplicate. The results are presented in means ± S.E.M. 
 
The data generated showed that the use of gelatine at 1 mg/mL was more 
suitable to the assay because it dramatically reduced the fluorescent 
background of the assay system. 
The next component that needed to be assessed for its effect or background 
fluorescence was CPM itself. Reactions containing assay buffer only; 0.5 mM 
Na2S; 40 M cysteine; 40 M cysteine and 0.5 mM Na2S were set up and their 
fluorescence determined after addition of 25, 50 or 100 mg/mL CPM (Figure 
3.14) (see section 2.5.9.4). 
The buffer alone had little (7.9x102 to 1.3x103 RFU) fluorescence while 
increased to 2.3x104 - 3.3x104 RFU when Na2S was added to the reaction 
mixture. 
Adding Cys alone resulted in an elevated fluorescence presumably due to 
complex formation between CPM and Cys further increased when both Na2S 
3.1x104 
6.5x103 
3.1x103 2.7x103 2.2x103 
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and Cys were present in the reaction mix (similar to earlier observations). 
The data show that the signal to noise is not significantly affected by the 
CPM concentration presumably because CPM at concentration of 25 g/mL 
already saturates the assay system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14 – Determination of the optimal CPM concentration. 
The graph shows the variability of fluorescence generated by the assay 
buffer alone or in the presence of when 40 µM of cysteine, 0.5 mM of 
Na2S or both, when incubated with different concentrations of CPM. 
 
CPM is a light sensitive fluorochrome therefore it is important to assess the 
effect of storage in its stability. A reaction containing phosphate buffer pH 
7.8 and 40 µM of cysteine was mixed with 100 µg/mL of CPM used on the 
same day of preparation or previously stored for 3 or 9 days at -20ºC (see 
section 2.5.9.3). Figure 3.15 shows that the fluorescence significantly (***, 
P<0.001) varies between storage periods. The fluorescence increases with 
storage length and therefore CPM should be prepared fresh. 
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Figure 3.15 – Effect of storage on CPM fluorescence. 
The stability of the CPM solution upon storage up to 9 days was assessed 
by mixing assay buffer, 40 µM of cysteine and 100 µg/mL of CPM. The 
relative fluorescence (λexcitation = 340 nm; λemission = 465 nm) was 
determined. The experiment was performed in triplicate and the results 
were analyzed using 1-way ANOVA with Tuckey post-test. The statistical 
results are represented as: ***, P<0.001. 
 
 
3.8.2 Detection and quantification of cysteine synthesis  
Having established the conditions for the CPM detection method, a standard 
curve was set up with increasing concentrations of cysteine (2-10 nmol) 
(Figure 3.16). Cysteine standards were prepared with 0.1 M potassium 
phosphate buffer pH 7.8, 1 mM EDTA, 0.5 mM Na2S, 1 mg/mL gelatine, and 1 
mM OAS (see section 2.5.9.5). An aliquot of each reaction was further mixed 
with 100 g/mL CPM and the florescence was measured. The CPM assay 
showed a linear increase of RFU for a range of 0 to 10 nmol of cysteine 
(Figure 3.15). Variation of RFU increased with increasing cysteine 
concentrations. A regression curve was plotted and the resultant equation of 
the curve (RFU = 9171 x cysteine (nmol)) was used to determine cysteine 
synthesis in subsequent enzyme assays. 
Chapter 3 – Characterization of a recombinante L. major cysteine synthase        102 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16 – Cysteine standard curve. 
Cysteine (2 to 10 nmol) was mixed with assay buffer, 0.1 mg/mL gelatine 
and 100 µg/mL CPM and the fluorescence was measured (λexcitation = 
340 nm; λemission = 465 nm). The experiment was performed six times 
(n=6) on different occasions and means ± S.E.M. are presented. 
 
Three concentrations of N-rLmjCS enzyme (25, 50 and 75 ng/mL) were 
tested (Figure 3.17) (see section 2.5.9.6). Cysteine synthesis was monitored 
every two minutes for a total of six minutes. All three concentrations 
resulted in cysteine being synthesised (Figure 3.17 and Table 3.6). The 
calculated rate (Table 3.7) shows that 50 ng/mL of N-rLmjCS synthesed 
cysteine at the highest rate (0.7 nmol/min) in comparison with 25 ng/mL 
(0.1 nmol/min) and 75 ng/mL (0.5 nmol/min).  
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Figure 3.17 – Cysteine synthesis. 
The graph illustrates the cysteine synthesis when different 
concentrations of N-rLmjCS are tested. Three N-rLmjCS enzyme 
concentrations were tested using 100 µg/mL of CPM and the fluorescence 
was measured (λexcitation = 340 nm; λemission = 465 nm). 
 
 
 
 
Time (min) 25 ng/mL 50 ng/mL 75 ng/mL 
2 1.9 2.8 4.2 
4 1.8 4.2 5.4 
6 2.1 5.3 5.9 
 
 
Table 3.6 – Analysis of cysteine synthesis. 
The table depicts the cysteine (nmol) values after the subtraction of the 
background (reaction with no N-rLmjCS). 
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[N-rLmjCS] Rate (nmol/min) 
25 ng/mL 0.1 
50 ng/mL 0.7 
75 ng/mL 0.5 
 
 
Table 3.7 – Reaction rate. 
Table showing the cysteine (nmol) synthetized per minute for each 
tested N-rLmjCS concentration (25, 50 or 75 ng/mL). 
 
 
3.8.2 Inhibition of N-rLmjCS  
The reaction described previously where 50 ng/mL of N-rLmjCS were used to 
synthesise cysteine, was repeated this time in the presence of 50 M DYVI 
(see section 2.5.9.7). As shown using the mercury chloride assay, DYVI is a 
potent inhibitor of LmjCS; 0.1 mM DYVI inhibited 94% of N-rLmjCS activity. 
The concentration CPM used was 50 µg/mL, and the DYVI concentration (50 
M) was reduced here. Cysteine synthesis was monitored every two minutes 
for a period of 6 minutes. Figure 3.18 shows that in the absence and 
presence of 50 M DYVI, the results show that in the presence of 50 M DYVI 
the CS activity was reduced by 86%; similar to the data presented in the 
previous section. This validated that the CPM assay has potential for further 
development. 
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Figure 3.18 – Inhibition of N-rLmjCS with 50 µM DYVI. 
The graph illustrates the inhibition of N-rLmjCS with 50 µM DYVI. 
 
 
 
 
 Rate (nmol/min) 
50 ng/mL N-rLmjCS 0.6 
50 M DYVI 0.08 
 
 
Table 3.8 – Rate of cysteine synthesis in the presence of 50 µM DYVI 
peptide. 
The table shows the rates calculated for each reaction and the presence 
and absence of DYVI. The values are presented in cysteine (nmol) 
synthesised per minute. 
 
The CPM assay was then also used to determine the IC50 of DYVI. The 
substrate (OAS) concentration was kept constant and increasing 
concentrations of DYVI were assayed. N-rLmjCS activity was determined and 
the IC50 curve represented in Figure 3.18. The DYVI IC50 was determined to 
be 2 µM.  
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Figure 3.19 – Determination of DYVI IC50. 
The graph illustrates a sigmoidal dose-response curve from where DYVI 
IC50 value is extrapolated, 2 µM.    
 
 
3.9 Results acquired from collaborators 
The crystal structure of LmjCS has been resolved by Dr Paul Fyfe from 
Professor William Hunter‟s research group at the University of Dundee. The 
generated construct pET15b-rLmjCS (section 3.2) was sent and the rLmjCS 
purified and crystallised at the referred facility. As illustrated on Figure 
3.20, the LmjCS is an asymmetric dimer. Each subunit contains two domains. 
The purified protein was yellow in colour consistent with the presence of 
PLP (previously observed on section 3.3), albeit crystals being colourless 
(Fyfe et al., 2012). Further observations have revealed the presence of a 
polyglutamate (PGA) fragment attached to the same region on both 
subunits, and no PLP (Figure 3.21). The absence of PLP seems to be related 
to the presence of the PGA (Fyfe et al., 2012).  Additionally, LmjCS has 
been found to have 47% structure conservation when compared with the A. 
thaliana cysteine synthase (AtCS) (Fyfe et al., 2012).   
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Figure 3.20 – Crystal structure of LmjCS (Taken from (Fyfe et al., 2012)). 
Ribbon diagram of rLmjCS enzyme as an asymmetric dimer. On subunit A 
helices are coloured green and strands are coloured brown; On subunit B 
helices are coloured cyan and strands are coloured blue; The PGA 
molecules are depicted in yellow (C atoms), red (O atoms) and blue (N 
atoms); the domains, and N- and C-terminals are illustrated. 
Printed with permission from the Acta Crystallographica Section F. 
 
 
 
 
 
 
 
 
 
 
Figure 3.21 – Polyglutamate in the active site. 
Stereo-view of PGA fragment bound to subunit A of LmjCS enzyme. The 
LmjCS in illustrated in green; N and O atoms from specific side chains are 
illustrated in blue and red, respectively; hydrogen bonds are depicted in 
yellow dots; water molecules are depicted in cyan (Fyfe et al., 2012). 
Printed with permission from the Acta Crystallographica Section F. 
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3.10 Summary 
 
 C-rLmjCS and N-rLmjCS were successfully expressed and purified. 
rLmjCS was generated by TEV protease digest from N-rLmjCS. 
 
 Kinetic analysis of the three forms of rLmjCS show that the Vmax of N-
LmjCS is higher than C-rLmjCS and rLmjCS; the N-rLmjCS turnover (kcat) 
is higher than the other two forms and this is reflected on the enzyme 
efficiency (lower kcat/Km), rendering a 2 times more efficient enzyme.  
 
 The inhibition reaction testing peptides mimicking the C-terminal of SAT 
revealed that DYVI inhibits ~90 % of the enzymes activity of the three 
LmjCS forms at a concentration of 0.1 mM. EGDGSGI inhibit 30-50% the 
enzyme‟s activity. 
 
 The PGA found to be bound to the LmjCS crystal structure tested as a 
putative inhibitor showed that only the enantiomer D-γEγEγEγE (0.1 
mM) had a moderate inhibitor effect on C-rLmjCS activity (20%). At 0.5 
mM, D-γEγEγEγE did not showed higher inhibition of the C-rLmjCS 
activity. 
 
 The CPM detection method validation revealed that Na2S and BSA highly 
contribute to the background fluorescence. While the pH of the buffer 
only marginally affected fluorescence, replacing the BSA with gelatine 
dramatically reduced the fluorescence background and increased the 
signal:noise ratio. 
 
 CS activity was successfully detected using the CPM assay and it was 
shown to be suitable for the study of inhibition of enzyme activity. This 
provided some evidence that the CPM assay may be suitable for future 
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development into a HTS assay to test future inhibitors of CS from 
Leishmania or other organisms.  
 
 The results acquired by collaborators showed that LmjCS is an 
asymmetric dimer. Each dimer has two domains. PLP was absent in the 
crystal structure. The presence of PGA is believed to be the cause of its 
absence. 
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4 Characterization of a cysteine synthase 
knockout 
4.1 Introduction 
Williams et al. 2009 have provided evidence for the existence of two 
cysteine biosynthetic pathways operating in L. major. Cysteine (Cys) is a 
building block of glutathione (GSH), which is itself a crucial component of 
trypanothione (TSH). TSH, as outlined in the introduction, is involved in the 
defence against oxidative stress and detoxification of drugs used against 
leishmaniasis (Ariyanayagam and Fairlamb, 2001; Oza et al., 2005; Wyllie et 
al., 2004). Thus, dissecting the cysteine biosynthetic mechanisms may 
reveal potential new targets exploitable for further anti-leishmanial drug 
discovery and development. Both cysteine synthase knockout (∆cs) and 
cysteine synthase re-expressor (RE) cell lines have been previously 
generated in L. donovani (Dr Lesley McCaig PhD‟s thesis). These lines along 
with the wild-type (WT) line were used to infect hamsters before this work 
was commenced and at its outset these animals were available for me for 
assessment.  
 
4.2 Results 
4.2.1 Assessment of the ability of L. donovani WT, cs and RE 
to infect hamsters  
18 golden hamsters (Mesocricetus auratus) were infected by Dr Elmarie 
Myburgh with L. donovani wild type (WT), cysteine synthase knockout (cs) 
and cysteine synthase re-expressor (RE). Six months after infection the 
hamsters were culled and their spleens and livers (target organs of L. 
donovani) were analyzed for signs of infection. The hamsters infected with 
L. donovani WT and with L. donovani ∆cs had parasites in both liver and 
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spleen. The organs of all animals were excised, measured and weighed 
(Tables 4.1 and 4.2) (see section 2.6.4).  
The spleen of the infected animals had a higher parasitic burden than the 
liver as it was also observed by (Moreira et al., 2012; Ott et al., 1967) and 
more recently by Moreira et al., 2012 (Table 4.1). Interestingly the parasitic 
burden was higher in animals infected with the cs line than the WT line 
(Table 4.2). It is possible that there is a compensation mechanism that has 
been activated in those infected with the cs line that allows the survival of 
these mutant parasites and therefore the maintenance of parasitic virulence 
in the absence of cysteine synthase. Surprisingly, none of the 6 hamsters 
infected with the RE line showed sign of parasitic infection. It was later 
found out (section 4.2.2) that the plasmid used to generate the RE line prior 
to hamster infection did not actually express the full-length CS which 
possibly rendered the recombinant protein inactive. Therefore it is possible 
that the expression of a truncated version of the CS had an adverse effect 
on the parasitic virulence. The spleen of the hamsters infected with the RE 
line was on average smaller than the ones infected with the other two lines 
(Table 4.2). This is consistent with the lack of parasites found in these 
hamsters. Conversely, the liver of the hamsters infected with the RE line 
was shown to be larger than the ones from the hamsters infected by the 
other two parasitic lines but this result could possibly be a negligible 
variation between hamsters (Table 4.2). The weight of the organs appeared 
to be unaffected regardless of the presence/absence of infection and 
parasite line used to infect them (Table 4.2). 
Overall WT parasites were recovered in 4 out of 6 hamsters; cs were 
infective to 2 out of 6 animals and RE did not infect hamsters at all. 
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Table 4.1 – L. donovani found in the liver and spleens of 6 hamsters 
infected. 
The table shows the hamster group (WT/∆cs/RE) and number (1-6) where 
the parasites were recovered. The number of parasites per gram of organ 
was determined by limiting dilution and the organ from where they were 
found is stated.  
 
 
 
Weight  
(g ± S.E.M.) 
Size  
(cm ± S.E.M.) 
Group Spleen Liver Spleen Liver 
WT 0.2  0.0 3.5 ± 0.3 3.4 ± 0.2 2.7 ± 0.2 
Δcs 0.1 ± 0.0 3.6 ± 0.4 3.4 ± 0.1 2.7 ± 0.1 
RE 0.1 ± 0.0 3.8 ± 0.2 2.5 ± 0.1 3.5 ± 0.1 
 
 
Table 4.2 – Measurements of the infected organs recovered from the 
hamsters. 
The table shows the size (cm ± S.E.M.) and weight (g ± S.E.M.) of the 
infected organs from where the three L. donovani lines were recovered. 
 
 
 
 
 
 
Hamster Organ 
Number of  
parasites/g of organ 
WT3 Spleen 18 
WT3 Liver 2 
WT4 Spleen 3 
WT6 Spleen 12 
Δcs4 Spleen 306 
Δcs6 Spleen 31 
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4.2.2 Phenotypic and genotypic characterization of L. 
donovani  
Two knockout cassettes were generated previously to replace both alleles of 
the cs coding region with two antibiotic resistant genes, hygromycin (hyg) 
and nourseothricin acetyltransferase (sat) (Figure 4.1A). A cs re-expressor 
plasmid (pGL102Ldcs, Figure 4.1B) was previously generated and transfected 
into the cs knockout line. The protein and gDNA of the parasitic lines were 
extracted and compared to the wild-type line (WT) (see sections 2.4.6 and 
2.5.3). Figure 4.1C shows a western-blot probed with anti-CS and anti-EF-1 
antibodies. The anti-CS antibody detected a band with 35.5 kDa in the WT 
lane while the protein detected in the RE lane appears smaller. No protein 
of this size was detected in the cs lane confirming the absence of CS 
protein in the cs L. donovani. The 49 kDa bands correspond to the EF-1 
protein and it is used to ensure protein load. Figure 4.1C shows a southern-
blot of restricted gDNA isolated from WT and cs L. donovani. The 
membrane was probed with the cs ORF, hyg ORF and sat ORF. The blots 
revealed the 4.7 kb and 0.6 kb bands diagnostic to the presence of the CS 
gene in the WT lane while these bands are no longer present in the cs lane 
where the two selectable marker bands are detected confirming the 
replacement of both CS alleles with sat and hyg. The RE lane confirms the 
presence of the episomal pGL102Ldcs in the CS genomic background.  
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Figure 4.1 – Phenotypic and genotypic analysis of L. donovani WT, cs 
and RE parasitic lines. 
(A) A schematic diagram showing the cs knockout cassette used 
previously to replace both alleles of the cs coding region (orange) with 
two antibiotic resistance genes, hygromycin phosphotransferase (hyg, 
purple) and nourseothricin acetyltransferase (sat, green), by homologous 
recombination. XhoI restriction enzymes are shown along with the 
expected sizes of resultant DNA fragments. (B) A schematic diagram of 
the pGL102Ldcs RE construct previously generated. The arrows indicates 
the XhoI restriction enzyme sites (0.7 kb and 3.7 kb) and the predicted 
sizes of resultant DNA fragments; (3’13K) 13 kb RNA; (5’DST) Leishmania 
splice acceptor; (FR) flanking region. (C) The previously generated Δcs 
B 
D 
A C 
Probes:  
anti-CS antibody (1:5,000) 
anti-EF-1 antibody(1:10,000) 
Probes:  
cs, hyg, and sat coding regions. 
 
pGL102cs
7796 bp
neo
amp
LdonCS
3'13K
5'DST
XhoI (4102)
XhoI (7116)
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and RE lines were analyzed by western blotting. 10 µg of total protein 
extract was separated by SDS-PAGE (10%) blotted onto nitrocellulose and 
probed with anti-CS antibody at 1:5,000 and anti-EF-1α antibody at 
1:10,000 (loading control), and exposed for 5 seconds. (D) Southern blot 
analyses after diagnostic digestion with XhoI. 2 µg of genomic DNA was 
loaded in each lane and were probed against cs, hyg and sat.  
 
4.2.3. Generation of a new pGL102Ldcs construct 
The CS protein synthesised in the RE line appeared smaller than the protein 
detected in the WT line (Figure 4.1C). This finding prompted an 
investigation into the CS sequence used to generate the RE line. The 
previous plasmid was re-sequenced and revealed a 27 bp shorter CS gene. 
Upon re-analysis of the L. donovani CS sequence available on GeneDB 
(LdBPK_363750.1), a new now full-length CS construct was generated in 
pGL102. The cs gene (1,014 bp), amplified from L. donovani WT gDNA, was 
ligated to pSC-B-amp/kan intermediate vector (Stratagene). The cs gene 
was digested out and ligated to the digested pGL102 transfection vector, 
generating a new pGL102Ldcs transfecting plasmid (Figure 4.2).    
 
 
 
 
 
 
Figure 4.2 – Generation of the new pGL102Ldcs plasmid for transfection. 
NcoI restriction enzyme digest of pGL102Ldcs construct originates 2.1 kb 
and 5.7 kb fragments. 
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4.2.4. Phenotyping of WT, cs and RE L. donovani. 
The loss of CS activity clearly could impact on a variety of pathways 
operating in L. donovani. Therefore a number of phenotypic features of the 
three parasite lines available were performed.  
4.2.4.1. Analysis of parasite growth 
The growth of the WT, cs and the new RE lines was monitored until the 
parasites reached the stationary phase (see section 2.6.3). The initial cell 
density was 5x105 parasites/mL.  The growth curves (Figure 4.3A) present 
four phases: the lag phase (days 1 and 2); the log phase (days 3 and 4); the 
late log phase (day 5); and the stationary phase (day 6). The experiment was 
performed in triplicate on several occasions. The results were statistically 
analyzed using one-way ANOVA with Dunnett‟s post-test using the WT line as 
a control. The cell densities (Figure 4.3B) reveal that the growth of the cs 
line is significantly slower (***, P<0.001) from the WT line. This growth 
defect is not seen in the RE line which shows that the growth defect is a 
consequence of the absence of the cs gene.  
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Day WT Δcs RE 
1 5.0x105 ± 0  
(n=6) 
5.0x105 ± 0  
(n=18) 
5.0x105 ± 0  
(n=3) 
2 8.6x105 ± 1.1x105 
(n=6) 
5.0x105 ± 0  
(n=12)** 
1.1x106 ± 2.1x105  
(n=3) 
3 6.9x106 ± 2.4x106 
(n=8) 
1.9x106 ± 5.4x105 
(n=14)*** 
2.6x106 ± 2.1x105 
(n=5) 
4 1.4x107 ± 1.4x106 
(n=11) 
5.0x106 ± 1.1x106 
(n=14)*** 
1.1x107 ± 6.6x105 
(n=8) 
5 2.0x107 ± 2.5x106 
(n=6) 
6.8x106 ± 4.8x105 
(n=6)*** 
2.4x107 ± 1.6x106 
(n=6)* 
6 3.2x107 ± 7.0x106 
(n=6) 
7.9x106 ± 8.1x105 
(n=3)*** 
3.2x107 ± 3.0x106 
(n=6) 
 
Figure 4.3 – Growth curves of the L. donovani lines.  
The graph and the table show the growth analysis of the L. donovani WT, 
Δcs and RE lines. All the cultures were diluted to 5x105 parasites/mL. 
Parasite density was recorded every 24 hours. The experiments were 
carried out in triplicate on multiple occasions (n, number of replicates) 
and the data is displayed as mean ± S.E.M. The data was analyzed with 
one-way ANOVA and Dunnett’s post-test for multiple comparisons 
relative to WT control (please refer to the table).  
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4.2.4.2. Analysis of mRNA synthesis 
To assess if this was the result of transcriptional or post-transcriptional 
events, the mRNA levels of expression of the cs and cbs genes were 
measured by QRT-PCR (see sections 2.4.1, 2.4.7 and 2.4.9). The results were 
analyzed using the        method (Livak and Schmittgen, 2001). Figure 4.4A 
shows the cs expression in the cs and RE lines in comparison with the WT 
line. The results were statistically analyzed using one-way ANOVA with 
Dunnett‟s post-test using the WT line as a control. As expected, cs line did 
not have a CS mRNA in accordance with the absence of the gene.  In the RE 
line the cs expression was 27 times higher than in the WT line (***, P<0.001). 
Regarding the cbs gene, the expression was 22 times higher in the cs line 
than in the WT line (*, 0.01<P<0.05), and it was reduced to near WT levels in 
the RE line. This suggests that cbs is over-expressed in the cs line in 
response to the loss of CS.  
 
 
Figure 4.4 – Expression of cs and cbs genes. 
The expression of cs and cbs mRNA was determined by qRT-PCR relative 
to the expression of these genes in WT parasites. The data displayed are 
means ± S.E.M. of three independent determinations performed in 
triplicate (n, number of replicates); one-way ANOVA and Dunnett’s test 
for multiple comparisons relative to WT control. Panel A: Relative 
Gene WT Δcs RE 
cs 1 ± 0.0 (n=3) 0 ± 0.0 (n=3) 27 ± 4.0 (n=3)*** 
cbs 1 ± 0.0 (n=3) 22 ± 9.0 (n=3)* 2 ± 0.9 (n=3) 
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expression of cs gene. Panel B: Relative expression of cbs gene. (***) 
P<0.001; (*) 0.01<P<0.05.  
 
4.2.4.3. Analysis of protein content 
Figure 4.4 assessed weather the reverse transsulphuration pathway could 
potentially compensate for the loss of CS. A western blot of the 3 parasitic 
lines was done and probed with anti-CS and anti-CBS antibodies (Figure 
4.5A) (see section 2.5.3). Anti-oligopeptidase B (OPB) was used as loading 
control. The western-blot confirms the absence of CS protein from the cs 
line and the re-expression of the protein with the correct size in the new RE 
line. The RE line over-expressed CS presumably because it is expressed from 
an episome rather than a copy of the gene integrated into it, for instance in 
the rRNA locus of the parasites genome. 
CBS shows a slight overexpression in both the cs and RE lines suggesting a 
marginal up-regulation of the reverse-transsulphuration pathway on the 
protein level. However, enzyme activity determinations would be required 
to fully assess whether reverse transsulphuration is indeed upregulated in 
the cs and RE lines.  
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Figure 4.5 – Western blot of the WT and cs recovered from the hamster 
samples and the newly generated RE line that did not went through 
hamster. 
(A) Western blot analysis of the newly generated RE line in comparison 
with WT and Δcs lines recovered from the hamster samples. 5 µg of total 
protein extracts were loaded in each lane and probed with anti-CS 
antibody at 1:5,000, anti-CBS antibody at 1:10,000 and lastly anti-OPB 
antibody at 1:10,000 to assess equal loading. (B) Band sizes relative to 
WT anti-OPB control, for each protein analyzed in the western blot. The 
means were determined with the image processing and analysis software 
package LabImage1D.  
 
4.2.5. Susceptibility to oxidative stress and metal stress 
Cysteine synthase is a key enzyme in the sulphydrylation pathway that leads 
to the formation of cysteine from O-acetyl serine (Williams et al., 2009). 
Cysteine is the building block of glutathione (GSH) and trypanothione (TSH) 
(Figure 4.6). TSH is a low molecular thiol responsible for protecting 
Leishmania and other trypanosomatids against oxidative stress (Oza et al., 
2005). Thus a CS knockout line should be in theory more susceptible to 
oxidative stress if indeed the sulphydrylation pathway is the main supplier of 
cysteine for GSH and TSH biosynthetic pathways.  
 
 WT cs RE 
CBS 1 2.3 1.5 
CS 1 - 3.4 
A B 
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4.2.5.1 Susceptibility to pro-oxidants 
The susceptibility of L. donovani lines to hydrogen peroxide, cumene 
hydroperoxide, and tert-butyl hydroperoxide was assayed (Figure 4.7) (see 
section 2.6.11).  These are known to induce lipid peroxidase in cells (Cao et 
al., 2013; Jovanovic and Jovanovic, 2013; Zavodnik et al., 2013).  
Half of the L. donovani WT were killed with 265 M hydrogen peroxide. Both 
the cs and RE lines did not significantly differ (324 M and 300 M, 
respectively) from the control WT line, albeit cs being slightly more 
resistant.   
All three lines were more sensitive to cumene hydroperoxide. 21 M was 
enough to kill half of the WT parasites; for the cs line, 16 M were needed; 
for the RE line, 14 M. Again, the absence of cs did not result in a 
significantly greater sensitivity to this pro-oxidant. 
When testing the effect of tert-butyl hydroperoxide, the cs line (44 M) 
showed no significant difference compared with the WT line (51 M) and the 
RE line (41 M). 
In other organisms glutathione peroxidase is responsible for the 
detoxification of hydroperoxides. This enzyme is however absent from 
trypanosomatids (Fairlamb and Cerami, 1992). In trypanosomatids, TSH is 
involved in the detoxification of peroxides via tryparodixyn (TXN)-mediated 
reactions (Flore and Milunsky, 2012). TXN is kept in a reduced state by TSH 
(Fairlamb and Cerami, 1992). 
The absence of cs did not make the cs line more sensitive for oxidative 
stress. On the contrary the line presented the same sensitivity as the WT 
line. As mentioned previously, cysteine is part of the backbone of TSH, thus 
it is possible that the reverse trans-sulphuration pathway is compensating 
for the absence of cs by supplying cysteine molecules to the GSH/TSH 
biosynthetic pathways (Figure 4.6).  
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Figure 4.6 – Cysteine, glutathione and trypanothione biosynthetic 
pathways. 
Cysteine (dark blue) can be synthesized by the sulphydrylation pathway 
or by the reverse trans-sulphuration pathway (RTS). Cysteine is used to 
synthesize glutathione (green) in the glutathione biosynthetic pathway. 
Glutathione along with spermidine, from the polyamine pathway, come 
together to generate trypanothione in the trypanothione pathway. 
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Figure 4.7 – Susceptibility to oxidative stress. 
Determination of L. donovani promastigotes IC50 for hydrogen peroxide 
(A), cumene hydroperoxide (B), and tert-butyl hydroperoxide (C). The 
table shows the IC50 value with S.E.M. determined by GraFit5 software. 
The experiments were performed on different days and the number of 
repeats (n) is indicated in the table. The concentrations ranged from 
0.02 to 30 mM for hydrogen peroxide; from 1 µM to 1 mM for cumone 
hydroperoxide; and 1 µM to 1 mM for tert-butyl hydroperoxide. 
 
IC50 (μM) WT Δcs RE 
Hydrogen peroxide 265 ± 11  (n=7) 324 ± 44 (n=16) 300 ± 11 (n=8) 
Cumene hydroperoxide  21 ± 1 (n=6) 16 ± 2 (n=6) 14 ± 0.3 (n=5) 
tert-Butyl 
hydroperoxide  
51 ± 6 (n=6) 44 ± 4 (n=8) 41 ± 8 (n=6) 
A  B 
D 
C 
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4.2.5.2 Susceptibility to metal stress 
Metal-containing drugs (e.g. pentavalent antimonial drugs) are used 
frequently in the treatment of visceral leishmaniasis. Trypanothione forms 
metal-TSH complexes that are extruded from the cells leading to reduction 
of the thiol buffering capacity of Leishmania (Decuypere et al., 2012; 
Fairlamb and Cerami, 1992; Mittal et al., 2007; Rai et al., 2013). P-
glycoprotein A (P-gpA), an ABC transporter of metal-thiol conjugates into 
the vacuole, is believed to be involved in this efflux (Rai et al., 2013; Singh 
et al., 2007).  Elevated thiol levels have been used as markers of antimony 
and arsenite-resistance (Mukhopadhyay et al., 1996; Rai et al., 2013). This is 
accompanied by high levels of TSH and over-expression of its biosynthetic 
pathway enzymes (Ashutosh et al., 2007; Mandal et al., 2007; Mukhopadhyay 
et al., 1996). Thus, it is expected that a putative thiol deficient Leishmania 
line would be more sensitive to metal stress.  
Figure 4.8 shows a sensitivity study to metal stress in the three lines of L. 
donovani (see section 2.6.11). Surprisingly, the cs line was significantly 
more resistant to potassium arsenate (255 M; *, 0.01<P<0.05) than the WT 
line (148 M). The sensitivity was recovered in the RE line (190 M). Again 
the non-sensitivity of the cs line to the stress points towards the existence 
of another mechanism of cysteine supply.  
Regarding cadmium chloride there was a significant difference (*, 
0.01<P<0.05) between the cs (115 M) and the WT line (241 M). The RE 
line is significantly more resistant (547 M; ***, P<0.001) to cadmium 
chloride than the WT line. So far there is no clear evidence that the high 
levels of CS results in resistance to pro-oxidants or high levels of stress 
generated by metals.  
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IC50 (μM) WT Δcs RE 
Potassium arsenate  148 ± 9 (N=13) 255 ± 42* (N=14)  190 ± 27 (N=8) 
Cadmium chloride  241 ± 21 (N=17) 115 ± 17* (N=17) 547 ± 120 (N=8)*** 
 
Figure 4.8 – Susceptibility to metal stress. 
Determination of L. donovani promastigotes IC50 of potassium arsente 
(A), and cadmium chloride (B). The table shows the IC50 value with S.E.M. 
determined by GraFit5 software. The experiments were performed on 
different days and the number of repeats (n) are indicated in the table. 
The concentrations ranged from 0.003 to 20 mM for potassium arsenate, 
and from 0.003 to 40 mM for cadmium chloride. (*) 0.01<P<0.05; (***) 
P<0.001. 
 
 
 
 
 
 
 
 
A B 
C 
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4.2.6 Determination of thiol levels and the role of the trans-
sulphuration pathway 
Thiols are the major protectors against xenobiotic toxicity and oxidative 
damage (Decuypere et al., 2012; Fairlamb and Cerami, 1992; Mittal et al., 
2007; Rai et al., 2013). Previous data suggested that there could be a 
compensation mechanism being activated in the cs line as a result of the 
lack of cs. This sub-chapter aims to address this question and to test this 
hypothesis by analysing the thiol content of the three cell lines.  
4.2.6.1 Effect of cysteine synthase knockout on the thiol 
levels  
Figure 4.9 shows a typical chromatogram of L. donovani WT harvested on 
day four after inoculation with a cell number of 2.7x108 cells extracted (see 
section 2.5.10.1). In the first instance the HPLC system was calibrated using 
cysteine (Cys), homocysteine (HCys), trypanothione (TSH) and glutathione 
(GSH) (Figure 4.9A). The system allowed separation of these four thiols with 
retention times for Cys of 44 ± 0.3 min; HCys of 52 ± 0.2 min; TSH of 56 ± 
0.3 min; GSH of 72 ± 0.5 min. The detection range for the detection of all 
the four thiols was between 50 and 500 pmol.  
 
The next step was then to assess the parasitic cell number required to 
detect the thiols. It was found out that a minimum of 2.5x107 cells were 
required to obtain reproducible peaks with peak areas within the detection 
range. 
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Figure 4.9 – Schematic diagram showing the correlation of the 
chromatograms of the standards (A) with the WT line (B) on day 4. 
Chromatogram A shows the peaks of cysteine (Cys, blue), homocysteine 
(HCys, yellow), trypanothione (TSH, red), glutathione (GSH, green), and 
solvent (S, black). The lines connect the standard peaks with the 
homologue peak in the WT chromatogram. Only one peak was not 
identified and it was thus labelled as X. 
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Figure 4.10, 4.11 and Table 4.4 show the thiol levels of the three L. 
donovani lines measured by reverse-phase HPLC over a period of four days 
(day 3 to day 6 of growth). The data was statistically analyzed using the 
one-way ANOVA with Dunnett‟s post-test relative to WT control (Graphpad 
Prism5 software). The three major thiols present and detectable in 
Leishmania are Cys, GSH and TSH, while the levels of HCys were negligible. 
In agreement with previous reports, the concentration of TSH (4-5 nmol/108 
cells) does not vary during log phase (days 3 and 4) and decreases in 
stationary phase (days 5 and 6) (Ariyanayagam and Fairlamb, 2001; Weldrick 
et al., 1999). The same behaviour is observed for Cys and GSH. TSH is the 
major thiol accounting for 67% of the total thiols on day 4; followed by GSH 
present at 21%; and Cys with 12% (day 4). 
The WT thiol levels were compared with the cs and RE lines from day 3 to 
day 6. On day 3, the absence of CS in the cs line does not affect the total 
level of the thiols present. On day 3 the level of Cys is 0.8 nmol/108 cells in 
the cs and WT lines; the level of TSH is 4.2 nmol/108 cells (WT line) and 
4.8 nmol/108 cells (cs line); and the level of GSH is 1.4 nmol/108 cells (WT 
line) and 2.3 nmol/108 cells (cs line). The RE line behaves like an over-
expressor with a significant higher level of total thiols (12.5 nmol/108 cells; 
***, P<0.001) compared with the WT line (6.5 nmol/108 cells). This is 
reflected on a significantly higher level (*, 0.01<P<0.05) of Cys (1.8 
nmol/108 cells) and TSH (8.2 nmol/108 cells), but not GSH (2.3 nmol/108 
cells), suggesting GSH is promptly used in the biosynthesis of TSH.  
On day 4 the thiol levels in the cs line decrease dramatically. Cys (0.2 
nmol/108 cells), TSH (1.0 nmol/108 cells) and GSH (0.3 nmol/108 cells) are 
significantly (***, P<0.001) lower than WT line (Cys - 0.9 nmol/108 cells; TSH 
– 5.2 nmol/108 cells; GSH – 1.7 nmol/108 cells). This is obviously reflected in 
the total thiol level where the cs line (1.5 nmol/108 cells) has significantly 
lower level of total thiols (***, P<0.001) than the WT line (7.8 nmol/108 
cells). The total levels of thiol of the RE line decreases which is reflected in 
a reduction of TSH and GSH levels. 
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In late-log (day 5) and stationary phases (day 6) there is no significant 
difference between total and individual levels of thiols between the three L. 
donovani lines. 
On day 5 (late-log phase) there is a drop in all thiol levels of WT. Cys droped 
from 0.9 nmol/108 cells (day 4) to 0.5 nmol/108 cells (day 5). Cys level 
decreases further on day 6 to 0.3 nmol/108 cells. TSH decreases from 5.2 
nmol/108 cells (day 4) to 1.8 nmol/108 cells (day 5). TSH level increases to 3 
nmol/108 cells on day 6. GSH levels reduce the same manner as seen in Cys. 
From day 4 to day 5, GSH levels lower from 1.7 nmol/108 cells to 1.0 
nmol/108 cells, and continues to lower from day 5 to day 6 (0.7 nmol/108 
cells).  
In the cs line the lower level of thiols determined on day 4 are increasing 
on day 5. Cys increases from 0.2 nmol/108 cells (day 4) to 0.8 nmol/108 cells 
(day 5). TSH increase from 1.0 nmol/108 cells (day 4) to 3.9 nmol/108 cells 
(day 5). And GSH increase from 0.3 nmol/108 cells (day 4) to 1.3 nmol/108 
cells (day 5). On day 6 (stationary phase) the level of Cys (0.5 nmol/108 
cells), TSH (3.5 nmol/108 cells), and GSH (1.0 nmol/108 cells) are similar to 
day 5. 
The RE line has similar level of Cys (0.6 nmol/108 cells) on day5 to day 4 (0.8 
nmol/108 cells). TSH levels are also similar between both days 4 (3.4 
nmol/108 cells) and day 5 (3.6 nmol/108 cells). The level of GSH drop to 
nearly half betwen day 4 (2.1 nmol/108 cells) and day 5 (1.5 nmol/108 cells). 
Between day 5 and day 6 the thiol levels almost half for Cys (0.3 nmol/108 
cells), TSH (1.5 nmol/108 cells), and GSH 1.0 nmol/108 cells).  
Overall, this data suggests that CS (and thus the sulphydrylation pathway) 
has an important role in maintaining thiol levels specially during the log 
phase of parasitic growth (i.e. day 4). The absence of CS resulted in reduced 
levels of Cys, TSH and GSH, suggesting that cysteine uptake or biosynthesis 
via the trans-sulphuration pathway were not suficient to supply enough 
cysteine for the GSH and TSH biosynthetic pathways. Correlating this effect 
of thiol level reduction with growth, suggests that the delayed growth of L. 
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donovani lacking CS activity is caused by a reduced ability to generate 
thiols. Nonetheless, higher levels of TSH and GSH were observed on day 5. 
This suggests that perhaps while on day 4 the available cysteine suppliers 
were not able to cope with the high cell division, where thiol synthesis is at 
its peak (according with data from the WT line). Whereas on day 5, where 
the cell division slows down to reach stationary phase on day 6, the 
alternative mechanisms available for cysteine synthesis are able to supply 
suffient amount to the GSH and TSH biosynthetic pathways.   
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Figure 4.10 – Quantification of total thiols. 
The level of cysteine (Cys, blue), trypanothione (TSH, red), glutathione 
(GSH, green), and homocysteine (HCys, yellow) were quantified by 
reverse-phase HPLC. Cultures were simultaneously diluted to 5x105 
cells/mL and at least 2.5x107 cells/mL were harvested. Thiols were 
derivatized from day 3 to 6 for thiol analysis. The data is displayed in 
mean ± S.E.M. (please refer to Table 4.4).  
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Table 4.4 – Analysis of the thiol quantification. 
The table summarises the levels of cysteine (Cys), trypanothione (TSH) 
glutathione (GSH) and homocysteine (HCys) for the L. donovani WT, cs, 
and RE lines. Levels were determined by reverse-phase HPLC from day 3 
to day 6. Each thiol was analyzed separately and compared between the 
three lines using one-way ANOVA and Dunnett’s post-test for multiple 
comparisons relative to WT control (n, number of replicates). (*) 
0.01<P<0.05; (**) 0.001<P<0.01; (***) P<0.001; (n.d.) not detectable. 
  
 
 
 
 Thiol levels per day (nmol/108 cells ± S.E.M.) 
 3 4 5 6 
WT 
Cys 
0.8 ± 0.1 
(n=7) 
0.9 ± 0.1 
(n=10) 
0.5 ± 0.1 
(n=5) 
0.3 ± 0.0 
(n=5) 
TSH 
4.2 ± 0.7 
(n=7) 
5.2 ± 0.4 
(n=10) 
1.8 ± 0.9 
(n=5) 
3.0 ± 0.4 
(n=5) 
GSH 
1.4 ± 0.2 
(n=7) 
1.7 ± 0.2 
(n=10) 
1.0 ± 2.2 
(n=5) 
0.7 ± 0.1 
(n=5) 
HCys 
0.1 ± 0.0 
(n=7) 
n.d.  
(n=10) 
n.d. 
(n=5) 
n.d. 
(n=5) 
Total thiols 6.5 7.8 3.3 4 
Δcs 
Cys 
1.1 ± 0.5 
(n=5) 
0.2 ± 0.0 
(n=10)*** 
0.8 ± 0.1 
(n=6) 
0.5 ± 0.1 
(n=7) 
TSH 
4.8 ± 1.7 
(n=5) 
1.0 ± 0.1 
(n=10)*** 
3.9 ± 0.2 
(n=6) 
3.5 ± 0.3 
(n=7) 
GSH 
2.3 ± 0.2 
(n=5) 
0.3 ± 0.0 
(n=10)*** 
1.3 ± 0.1 
(n=6) 
1.0 ± 0.2 
(n=7) 
HCys 
n.d.  
(n=5) 
n.d.  
(n=10)* 
n.d.  
(n=6) 
n.d.  
(n=7) 
Total thiols 8.2 1.5*** 6 5 
RE 
Cys 
1.8 ± 0.1 
(n=6)* 
0.8 ± 0.2 
(n=11) 
0.6 ± 0.1 
(n=9) 
0.3 ± 0.1 
(n=5) 
TSH 
8.2 ± 0.4 
(n=6)* 
3.4 ± 0.6 
(n=11)* 
3.6 ± 0.6 
(n=9) 
1.5 ± 0.2 
(n=5) 
GSH 
2.3 ± 0.1 
(n=6) 
2.1 ± 0.3 
(n=11)* 
1.5 ± 0.3 
(n=9) 
0.7 ± 0.1 
(n=5) 
HCys 
0.2 ± 0.1 
(n=6)* 
0.1 ± 0.0 
(n=11) 
n.d.  
(n=9) 
n.d.  
(n=5) 
Total thiols 12.5** 6.4 5.7 2.5 
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Figure 4.11– Analysis of individual thiol variation with the growth of L. 
donovani.  
The thiol levels of the WT, cs, and RE lines were plotted against the 
growth curve (black dashed line): TSH (red), GSH (green), and Cys (blue). 
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4.2.7 Effect of propargylglycine on the thiol balance  
Propargylglycine (PAG) is an inhibitor of pyridoxal 5‟-phosphate (PLP)-
dependent enzymes. The pathways involved and linked to cysteine 
biosynthesis (Figure 4.6) have several PLP-dependent enzymes that can be 
targetted by this inhibitor. The enzymes are CS from the sulphydrylation 
pathway; and cystathionine -lyase (CGL), cystathionine -synthase (CBS), 
cystathionine -synthase (CGS), and cystathionine -liase (CBL) from the 
reverse trans-suphuration pathway; in addition to this, ornithine 
decarboxylase (ODC) from the polyamine pathway is also a PLP-dependent 
enzyme.  
The sensitivity to PAG was analyzed by determination of PAG IC50 in the 
three L. donovani lines (Figure 4.12) (see section 2.6.11). Surprisingly, not 
only is the cs line (215 M) is more resistant to PAG than the WT line (102 
M), this difference is highly significant (P<0.001). The RE line is less 
resistant (195 M) than the cs line but still significantly (**, 0.001<P<0.01) 
more resistant than the WT line. 
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IC50 (μM) WT Δcs RE 
Propargylglycine 
(PAG) 
102 ± 6 (n=10) 
215 ± 17 
(n=18)*** 
195 ± 23 (n=6)** 
 
Figure 4.12 – IC50 determination of Propargylglycine. 
Determination of propargylglycine (PAG) IC50 of L. donovani 
promastigotes. The table shows the  IC50 value with S.E.M. determined by 
GraFit5 software (Erythacus). The experiments were performed on 
different days and the number of repeats (n) is indicated in the table. 
The concentrations ranged from 1 µM to 1 mM of PAG. (**) 0.001<P<0.01; 
(***) P<0.001. 
 
To further analyze the contribution of the RTS pathway to the synthesis of 
Cys and thus other thiols, the three L. donovani lines were incubated for 24h 
with 0, 50 and 250 M PAG during log phase (Figure 4.13 and Table 4.5).  
The no drug control values include all the measurements performed on a 
non-treated line, hence being the same as the day 4 data presented in Table 
4.4. A general overview shows that total thiol levels were most affected by 
250 M of PAG. Incubating with this concentration of PAG, resulted in a 
reduction of total thiols in the WT line to 2.8 nmol/108 cells in contrast with 
7.8 nmol/108 cells (no drug) (***, P<0.001); the cs line has a third of total 
thiol levels (0.5 nmol/108 cells) of the no drug control (1.5 nmol/108 cells) 
(**, 0.001<P<0.01); and in the RE line thiols were reduced by half (2.9 
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nmol/108 cells) compared to the no drug control (6.4 nmol/108 cells) (*, 
0.01<P<0.05) (Table 4.5). 
Looking at each individual thiol, at 5 M PAG, the WT line presents similar 
levels of Cys (1.2 nmol/108 cells) and TSH (4.6 nmol/108 cells) to the no drug 
control (Cys 0.9 nmol/108 cells; TSH 5.2 nmol/108 cells). However the levels 
of GSH (2.6 nmol/108 cells) are significantly higher (*, 0.01<P<0.05) than the 
control (1.7 nmol/108 cells), possibly suggesting an accumulation of GSH 
that is not used for TSH synthesis. The same pattern is seen in the cs line 
for the same PAG concentration. In the RE line the level of each thiol was 
unaffected by 5 M PAG.  
At 50 M the level of GSH in the WT line is still significantly higher (2.7 
nmol/108 cells, **, 0.01<P<0.05) than the control (1.7 nmol/108 cells). The 
levels of Cys and TSH are similar to the control. In the cs line, the levels of 
Cys, TSH and GSH are similar to the control. 50 M of PAG does not show 
significant effects in the thiol levels on this line. In the RE line the levels of 
Cys significantly decrease (0.4 nmol/108 cells, *, 0.01<P<0.05) in the 
presence of 50 M PAG. TSH and GSH are not affected by this concentration.  
As mentioned previously, 250 M PAG has the most marked effect on the 
total thiol levels, particularly on TSH and GSH. On the WT line the TSH level 
significantly (P<0.001) drop from 5.2 nmol/108 cells (WT control) to 0.6 
nmol/108 cells. Cys and GSH are not significantly affected. In the cs line, 
both TSH (0.3 nmol/108 cells, **, 0.001<P<0.01) and GSH (0.2 nmol/108 cells, 
*, 0.01<P<0.05) are significantly lower that the cs control (TSH 1.0 
nmol/108 cells; GSH 0.3 nmol/108 cells). TSH (0.8 nmol/108 cells, ***, 
P<0.001) and GSH (1.4 nmol/108 cells, *, 0.01<P<0.05) are also significantly 
lower in the RE control line (TSH 3.4 nmol/108 cells; GSH 2.1 nmol/108 
cells). 
The fact that TSH and, to a lesser extent, GSH were significantly more 
affected by PAG, indicates that not only the enzymes from the cysteine 
biosynthetic pathways are being inhibited but also ODC from the polyamine 
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pathway may be limited to PAG. In fact PAG seemed to show negligible 
effects on the biosynthesis of cysteine - there was no significant loss of Cys 
in the presence of the drug for the treated parasites. The data implis that 
PAG may have inhibited ODC activity resulting in this remarkable reduction 
of TSH observed in all three parasite lines at 250 M PAG.  
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Figure 4.13 – Thiol quantification on day 4 in the presence of 
propargylglcyine. 
The thiols quantified were cysteine (blue, Cys), trypanothione (red, 
TSH), glutathione (green, GSH) and Homocysteine (yellow, HCys). 
Cultures were simultaneously diluted to 5x105 cells/mL. Propargylglycine 
(PAG) was added to the cultures at different concentrations on day 3. No-
drug cultures were used as controls. Thiols were derivatized with 
monobromobimane, which forms a fluorescent compound with the thiol-
containing proteins (λemission = 480 nm; λexcitation = 365 nm). The 
thiol derivatives were separated by reverse-phase HPLC and data was 
collected in form of a chromatogram. The experiment was carried out in 
duplicates on several occasions.  
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Thiol levels (nmol/108 cells ± S.E.M.) 
Propargylglycine 
(µM) 
0 µM 5 µM 50 µM 250 µM 
WT 
 
Cys 
0.9 ± 0.1 
(n=10) 
1.2 ± 0.0 
(n=3) 
1.1 ± 0.1 
(n=4) 
0.9 ± 0.1 
(n=5) 
TSH 
5.2 ± 0.4 
(n=10) 
4.6 ± 2.3 
(n=3) 
4.7 ± 0.6 
(n=4) 
0.6 ± 0.1 
(n=5)*** 
GSH 
1.7 ± 0.2 
(n=10) 
2.6 ± 0.1 
(n=3)* 
2.7 ± 0.3 
(n=4)** 
1.3 ± 0.1 
(n=5) 
HCys 
n.d. 
(n=10) 
n.d. 
(n=3) 
0.3 ± 0.1 
(n=4) 
n.d. 
(n=5) 
Total 7.8 8.4 8.8 2.8*** 
Δcs 
 
Cys 
0.2 ± 0.0 
(n=10) 
0.2 ± 0.0 
(n=3) 
0.2 ± 0.0 
(n=4) 
0.1 ± 0.0 
(n=6) 
TSH 
1.0 ± 0.1 
(n=10) 
1.2 ± 0.0 
(n=3) 
0.5 ± 0.1 
(n=4) 
0.3 ± 0.0 
(n=6)** 
GSH 
0.3 ± 0.0 
(n=10) 
0.5 ± 0.1 
(n=3)* 
0.2 ± 0.1 
(n=4) 
0.2 ± 0.0 
(n=6)* 
HCys n.d. (n=10) 
n.d. 
(n=3) 
n.d. 
(n=4) 
n.d. 
(n=6) 
Total 1.5 1.9 0.9 0.5** 
RE 
Cys 
0.8 ± 0.2 
(n=11) 
0.9 ± 0.2 
(n=5) 
0.4 ± 0.1 
(n=4)* 
0.6 ± 0.1 
(n=6) 
TSH 
3.4 ± 0.6 
(n=11) 
3.6 ± 0.7 
(n=5) 
2.0 ± 0.7 
(n=4) 
0.8 ± 0.1 
(n=6)*** 
GSH 
2.1 ± 0.3 
(n=11) 
2.3 ± 0.5 
(n=5) 
1.8 ± 0.5 
(n=4) 
1.4 ± 0.2 
(n=6)* 
HCys 
0.1 ± 0.0 
(n=11) 
0.1 ± 0.0 
(n=5) 
0.1 ± 0.1 
(n=4) 
0.1 ± 0.0 
(n=6) 
Total 6.4 6.9 4.3 2.9* 
 
Table 4.5 – Analysis of the thiol levels measured on day 4 in the presence 
of propargylglycine. 
The table depicts the numeric data from the comparative study on thiol 
levels in the presence of propargylglycine (PAG). The data are displayed 
in mean ± S.E.M. (n, number of replicates). Each thiol was analyzed 
separately and compared with the no-drug control using one-way ANOVA 
and Dunnett’s test for multiple comparisons relative to WT control. (*) 
0.01<P<0.05; (**) 0.001<P<0.01; (***) P<0.001; (n.d.) not detectable. 
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4.2.8 Characterization of the polyamine pathway 
PAG had a pronounced effect on the levels of TSH while GSH and cysteine 
were only marginally or not affected at all by the inhibitor.  
This suggests that the enzymes responsible for the synthesis of Cys may 
either not be inhibited or that an inhibitor of the Cys sulphydrylation or RTS 
pathways have no effect on Cys levels. Therefore it was surprising to see 
this significant reduction of TSH in all treated parasitic lines but particularly 
in the WT parasites (5.2 nmol/108 cells to 0.6 nmol/108 cells). One possible 
reason for this strong reduction could be that the synthesis of TSH may be 
affected by PAG. In fact, ODC, the rate-limiting enzyme of polyamine 
biosynthesis is also a PLP-dependant enzyme and may well be affected by 
PAG. Since TSH biosynthesis requires both GSH and the polyamine 
spermidine, it can be suggested that the strong reduction of TSH levels may 
be due to inhibition of its synthesis possibly due to ODC inhibition. Since the 
degree of TSH reduction was more pronounced in WT parasites than in the 
cs line, the expression levels of ODC in the parasites was assessed by RT-
PCR (see sections 2.4.1, 2.4.7 and 2.4.9). The results were analyzed using 
the        method using the WT levels as a reference (Livak and Schmittgen, 
2001). The experiment was carried in triplicate on three separate occasions. 
The results were statistically analyzed using one-way ANOVA with Dunnett‟s 
post-test using the WT line as control.  
Figure 4.14 shows that the level of odc expression in the cs line is 7 times 
higher than in the WT line (P<0.001) (Figure 4.14) and the levels of odc 
expression in the RE line were 2 times higher than in the WT line. These 
results indicate that higher levels of odc expression observed in the cs 
result from the absence of the cs gene. When the cs gene is episomally 
expressed in the RE line, the level of odc expression is lower, closer to the 
level seen on the WT line. 
To assess how this affects the amount of ODC protein in these parasites 
western blots were performed (Figure 4.15) (see section 2.5.3). The 
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experiment was repeated on several occasions (Figure 4.17). 5 g of protein 
extracted from the WT, cs and RE lines was loaded onto a membrane. Four 
antibodies where sequentially tested to avoid superimposition of protein 
bands. The anti-ODC and anti-CS antibodies were applied first to the 
membrane (Figure 4.15A) and proteins with sizes matching that of ODC (77.2 
kDa) and CS (35.5 kDa) proteins were detected in the WT and RE lanes. As 
expected, the CS (35.5 kDa) band was absent from the cs line. Surprisingly, 
the ODC (77.2 kDa) band was nearly absent in cs as well, which is opposed 
to the expectation given the increased mRNA levels detected by QRT-PCR 
(Figure 4.14). The membrane was subsequently stripped and then probed 
with anti-CBS antibody first and then anti-OPB as loading control (Figure 
4.15B). OPB (82.9 kDa) and CBS (39 kDa) protein bands appeared in all three 
lanes, confirming equal loading in all three lanes of the western blot. As 
previously observed, the CBS (39 kDa) band was more intense in the cs line 
than the other two lines.   
These results suggest that the ∆cs line appears not to rely on polyamine 
biosynthesis since ODC levels appear to be low.  
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Figure 4.14 – Relative expression of odc. 
The relative expression of odc was determined by quantitative real time 
PCR relative to WT. Data displayed as mean ± S.E.M. of three 
independent determinations (n, number of replicates); one-way ANOVA 
and Dunnett’s post-test for multiple comparisons relative to WT control. 
(***) P<0.001. 
 
 
Figure 4.15 – Western blot analyses of the ODC protein expression. 
Analyses of ODC expression by western blot. 5 µg of total protein extracts 
were loaded in each lane and probed with anti-ODC antibody at 1:5,000 
and anti-CS antibody at 1:5,000 (panel A). The membrane was then 
stripped and probed with anti-CBS antibody at 1:10,000 and anti-OPB 
antibody at 1:10,000 for equal loading control (panel B). Anti-CS and 
anti-CBS antibodies are, in this case, also used as controls. ODC 
expression in the Δcs line is reduced compared with the WT line. The 
ODC expression is recovered in the RE line. The 35.5 kDa band seen on 
lane RE corresponds to residual anti-CS antibody still bound to the CS 
protein. 
Gene WT Δcs RE 
odc 1 ± 0.0 (n=3) 7 ± 0.4 (n=3)*** 2 ± 0.3 (n=3) 
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ODC was further characterized by determining the IC50 of DFMO, a specific 
suicide inhibitor of the enzyme, for the three lines (Boitz et al., 2009; 
Olenyik et al., 2011).  
The parasites were diluted to 1x106 cells/mL and incubated for 72 h with 
increasing concentrations of DFMO (0.001 M to 20 mM) (see section 2.6.11). 
To determine the cell viability, resazurin was added and the parasites were 
further incubated for 48 h and the fluorescence was measured (λemission = 
549 nm; λexcitation = 590 nm). The experiment was carried out in duplicate 
or triplicate and performed on different occasions.  
Figure 4.19 shows the sigmoidal dose-response curves for each line. The 
determined IC50 value for WT was 103 M; for cs it was not possible to 
determine the IC50 value even when in DFMO concentration of more than 10 
mM were applied; the RE IC50 value was 77 M for DFMO and thus in the 
same range as the determined for the WT parasites. This data suggests that 
the lack of cs results in a severe down-regulation of ODC activity. The 
reasons for this are yet to be fully understood. 
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Figure 4.16 – IC50 determination of DFMO. 
IC50 determination of L. donovani promastigotes exposed α-
difluoromethylornithine (DFMO). Cultures were diluted to 1x106 cells/mL 
and incubated with varying dilutions of DFMO, in a limiting dilution 
manner. The concentrations ranged from 0.001 µM to 20 mM. Metabolic 
activity was determined by the addition of resazurin sodium salt after 72 
hours, and fluorescence (λemission = 549 nm; λexcitation = 590 nm) was 
measured after 48 hours. Graph – Sigmoidal dose-response curve showing 
the percentage of cell viability with the log of the molar concentration of 
DFMO. Table – Means of the IC50 values for each line with S.E.M. (n, 
number of replicates). 
 
4.2.9 Validation of detection and quantification of polyamines 
To better understand and characterise the effect of the cs on ODC and 
presumably downstream metabolic processes, attemptes were made to 
determine the polyamine levels in L. donovani WT, cs and RE lines by HPLC 
(see section 2.5.10.2). A number of different analysis techniques using HPLC 
are available in the literature and it was decided that suitability to the HPLC 
system available had to be assessed (Das Gupta et al., 2005; Jiang et al., 
1999; Kabra et al., 1986; Shim and Fairlamb, 1988; Wittich et al., 1987). 
Two methods were tested, one using methanol/H2O as a mobile phase and 
IC50 (μM ± S.E.M.) WT Δcs RE 
α-difluoromethylornithine 
(DFMO) 
48 ± 6 (n=4) >10 mM (n=7) 45 ± 4 (n=8) 
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one using the ion paring compound octane-1-sulfonate and acetonitrile as 
the mobile phase (Tables 4.6) Polyamine standards were derivatized with 
dansyl chloride (Das Gupta et al., 2005; Jiang et al., 1999; Kabra et al., 
1986; Shim and Fairlamb, 1988; Wittich et al., 1987) and the dansylated 
polyamines were extracted from the reaction mixture using ethyl ether.  
In polyamine analyses 1,6-diaminohexane (a diamine not naturally occurring) 
is used as the internal standard to test various derivatisation and separation 
techniques. 
400 pmol of 1,6-diaminohexane was derivatized with dansyl-chloride and 
extracted in 4 mL of diethylether (Wittich et al., 1987). After evaporating at 
70C to dryness, the derivatized diamine was resuspended in 250 L 5% 
acetic acid in methanol, and 10 L (20 pmol) were separated by HPLC using 
solvent gradients A and B and a 250 x 4.6 m silica column. The peaks were 
detected using a Dionex Ultimate 2000 fluorescent detectors at λexcitation 
of 365 nm and λemission of 485 nm. As a control, 10% TCA was also 
derivatized and treated in the same way as 1,6-diamonohexane and 
separated (Jiang et al., 1999). 
Gradient A resulted in a chromatogram with no peaks. The 1,6-
diamonohexane had to be washed off the column with 100% acetonitrile. 
Figure 4.17 shows a chromatogram of a buffer alone (Figure 4.17A) and the 
20 pmol of 1,6-diaminohexane (Figure 4.17B). Comparing the two 
chromatograms suggested 1.6-diaminohexane eluted near a solvent peak at 
34 min.  
To test gradient C, 1 nmol of putrescine was tested instead of 20 pmol of 
1,6-diaminohexane. It was intended that by changing the polyamine one 
would be able to clearly identify its peak from the solvent peaks. Also by 
increasing the injected quantity of polyamine from 20 pmol to 1 nmol would 
again facilitate its identification. Figure 4.18 shows a chromatogram of a 
derivatized buffer alone sample (Figure 4.18A) and 1 nmol putrescine 
(Figure 4.18C). Comparing both chromatograms suggests that putrescine co-
eluted with a solvent peak. The putative putrescine peak is higher than the 
than solvent peak by 10 times. This also suggests that the limit of detection 
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is lower than 1 nmol. Another explanation for the lack of the presence of a 
specific peak could be that putrescine had bound to the column very tightly 
and was not actually eluted from it with the mobile phase used.  
 
Gradient A: 
Time (minutes) 0 25 37.5 46.25 50 52.5 62.5 
% Solvent A  42.5 32.5 17.5 0 0 42.5 42.5 
% Solvent B  57.5 67.5 82.5 100 100 57.5 57.5 
Flow rate = 0.55 mL/ min 
Solvent A – Methanol 
Solvent B – ddH2O 
 
Gradient B: 
Time (minutes) 0 13 18 29 32 51 56 62.5 
% Solvent A  75 70 35 25 0 0 75 75 
% Solvent B 25 30 65 75 100 100 25 25 
Flow rate = 1 mL/ min 
Solvent A – 75 % Octane-1-sulfonate (20mM) and 25 % acetonitrile 
Solvent B – 20 % Octane-1-sulfonate (20mM) and 80 % acetonitrile 
 
Gradient C: 
Time (minutes) 0 15 45 62.5 
% Solvent A 70 0 0 70 
% Solvent B 30 100 100 30 
Flow rate = 1 mL/ min 
Solvent A – 75 % Octane-1-sulfonate (20mM) and 25 % acetonitrile 
Solvent B – 20 % Octane-1-sulfonate (20mM) and 80 % acetonitrile 
 
Tables 4.6 – Gradients and solvents tested for the separation of 
polyamines. 
Tables containing the three gradients tested for the separation of 
polyamines. The gradients are identified as A, B and C. The solvent 
combination and flow rate applied is referred to below each table. 
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Figure 4.17– Chromatograms resultant from gradient B. 
20 pmol of 1,6-diaminohexane were run using the gradient B. Panel A 
shows the chromatogram of a blank with solvent (S) peaks. Panel B shows 
the chromatogram of 1,6-diaminohexane (1,6-DH, red), which is eluted 
close to a solvent peak.  
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Figure 4.18 – Chromatograms resultant from gradient C. 
1 nmol of putrescine was run using the gradient C. Panel A shows the 
chromatogram of a blank. Panel B shows the chromatogram of 
putrescine. (S) solvent peak; (Put) putrescine peak. 
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Having established that gradient C was the most appropriate for polyamine 
separation and identification, the concentration of dansylchloride was 
tested. The concentration of dansylchloride varied between 2 (Das Gupta et 
al., 2005) and 10 mg/mL (Jiang et al., 1999; Rojas-Chaves et al., 1996) 
depending on the publication. Proline, used to quench the excess of 
dansylchloride, was used only when 10 mg/mL of dansylchloride were used. 
Three samples of 1 nmol/20 L of putrescine were derivatized: the first one 
was derivatized with 2 mg/mL without proline (Figure 4.19A); the second 
one was derivatized with 10 mg/mL dansylchloride (Figure 4.19B); and the 
third one was derivatized with 10 mg/mL of dansylchloride following by 
quenching with 25% proline (Figure 4.19C). 
Figure 4.19 shows the identification of the common peak, both from the 
buffer and the putrescine. Increasing the concentration of dansylchloride 
from 2 (Figure 4.19A) to 10 mg/mL (Figure 4.19B) resulted in an increase of 
the background peaks (buffer picks). Also the putative putrescine peak is 
two minutes apart between chromatograms, which might indicate that it 
does not correspond to putrescine. However, given the size of the peak it is 
likely to be putrescine. The background peaks were further reduced when 
25% proline was used to quench the excess of dansyl chloride (Figure 4.19C). 
This also allowed the clear identification of the putrescine peak at 17.56 
min (Figure 4.19C). 
Gradient C and 10 mg/mL of dansylchloride with subsequent quenching with 
25% proline was used to derivatise and separate the other polyamines. The 
standard curve of putrescine (125-500 pmol), spermidine (125-800 pmol), 
and spermine (250-800 pmol) were generated using 500 pmol 1,6-
diaminohexane as an internal standard. An example of a standard 
chromatogram can be seen on Figure 4.20A). This internal standard was 
added to the parasitic extracts. The parasitic extracts (minimum of 5x107 
cells) of the WT and cs lines were derivatized as established previously and 
the resultant chromatogram was compared with the standard 
chromatogram. The parasitic extract chromatograms of both WT and cs 
lines (Figure 4.20B and Figure 4.21B, respectively) presented more peaks 
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than the standard chromatogram (Figure 4.20A and Figure 4.21A, 
respectively).   
The same number of parasites (7.6x107 parasites) was derivatized for both 
lines. This experiment was performed once with only one replicate. The 
parasites were in stationary phase. Polyamines were quantified using the 
standard curves previously generated and the area of the peaks. Table 4.7 
shows the quantification of the detected putrescine and spermidine. As 
expected, the spermine peak was not detected in the parasitic extract 
chromatograms. The level of putrescine in the WT line was 8.3 nmol/108 
cells, whereas in the cs line it was 1.4 nmol/108 cells. The level of 
spermidine in the WT line was 6.1 nmol/108 cells, which is similar to the cs 
line that has 5.9 nmol/108 cells.  
This work could not be finalized due to time constraints. This preliminary 
data do however support the suggestion that ODC activity is reduced in cs 
(a strong reduction of putrescine levels) while spermidine levels appear to 
remain unaffected. This may be explained by the fact the TSH can be 
degraded by TSH synthase/amidase reduction of TSH levels in the cs 
parasite line (Oza et al., 2005).  
Further studies aim to elucidate the link between Cys acquisition pathways 
and polyamine and TSH biosynthetic pathways to fully understand the 
impact on the parasite‟s metabolism of the CS deletion. 
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 nmol/108 cells 
Parasitic line Putrescine Spermidine 
WT 8.3 6.1 
cs 1.4 5.9 
 
Table 4.7 – Quantification of polyamines. 
Polyamine levels of the WT and cs lines when in stationary phase. The 
parasitic extracts were derivatized with 10 mg/mL of dansylchloride and 
subsequently quenched with proline. 1,6-diaminohexane was used as the 
internal standard. The polyamines were separated using gradient C 
conditions. These values are the results from one experiment with one 
replicate.  
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Figure 4.19 - Analysis of dansylchloride derivatisation. 
Panel A – 1 nmol of putrescine derivatized with 2 mg/mL of 
dansylchloride; Panel B – 1 nmol of putrescine derivatized with 10 mg/mL 
of dansylchloride; Panel C – 1 nmol of putrescine derivatized with 10 
mg/mL of dansylchloride with subsequent quenching with proline. (S) 
Solvent peak; (Put) putrescine peak. 
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Figure 4.20 – Analysis of the homologous peaks between the standard and 
the parasitic extract chromatogram. 
Panel A – Standard chromatogram. (Put, orange) 400 pmol putrescine; 
(1,6-HD, red) 500 pmol 1,6-diaminohexane; (Spd, blue) 400 pmol 
spermidine; (Sd, green) 400 pmol spermine; (Bf, black) buffer. Panel B – 
Parasitic extract of the WT line. Putrescine (Put, orange); 1,6-
diaminohexane (1,6-HD, red); spermidine (Spd, blue); spermine (Sd, 
green). 
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Figure 4.21 - Analysis of the homologous peaks between the standard and 
the parasitic extract chromatogram.  
Panel A – Standard chromatogram. (Put) 400 pmol putrescine; (1,6-HD) 
500 pmol 1,6-diaminohexane; (Spd) 400 pmol spermidine; (Sd) 400 pmol 
spermine; (S) solvent. Panel B – Parasitic extract of the cs line. 
Putrescine (Put, orange); 1,6-diaminohexane (1,6-HD, red); spermidine 
(Spd, blue); spermine (Sd, green). 
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4.2.10 Summary 
 Hamsters previously infected with L. donovani WT, cs and RE lines 
were culled and parasites were recovered from the spleens and livers. 
None of the L. donovani RE were found to have infected the 
hamsters, while 2/6 animals infected with cs contained parasites, 
suggesting that CS is not essential. 
 
 Subsequent inspection revealed that the previously generated RE line 
did not re-express the full-length CS. Therefore a new RE line was 
generated in the cs line isolated from hamsters. Thus I had a “full” 
set of WT, cs and RE lines were able to be used for further analyses.  
 
 cs promastigotes had a growth defect. This line did not show 
susceptibility to external stressors. 
 
 Analyses of relative gene expression of cs and cbs revealed that cs 
contained 22 times more cbs mRNA than WT.  
 
 Re-expression of CS did reverse the effect on mRNA/protein levels 
observed in cs. 
 
 Thiol levels in WT, cs and RE lines vary depending on their growth 
phase.  
 
 The cs line generally had reduced leves of thiols compared to WT. 
 
 Inhibition of PLP-dependent enzymes (same as those involved in Cys 
biosynthesis or trans-sulphuration) showed a significant difference in 
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IC50 between WT and cs lines. Surprisingly, cs was less susceptible 
to inhibition by PAG than WT. 
 
 Treatment with 250 M PAG (~IC50) thiols dropped dramatically in WT 
parasites with TSH being reduced by 70-90%. 
 
 The synthesis of TSH requires spermidine. ODC, one of the rate-
limiting steps of polyamine synthesis, is also PLP-dependent. 
Therefore its status was assessed. ODC mRNA levels showed a 7 fold 
increased in cs compared to WT, while protein levels were 
drastically reduced as shown by the western blotting. This suggests 
that ODS mRNA translation is negatively affected in cs. 
 
 The lack of susceptibility (loss of sensitivity) against DFMO supports 
that cs have an altered polyamine metabolism. 
 
 Initial attempts were made to assess this hypothesis further by 
analyzing L. donovani polyamine levels. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
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5 Discussion 
 
Cysteine is the most important building block for the redox active low 
molecular weight thiols like glutathione, which is found almost ubiquitously, 
and trypanothione, which occurs in trypanosomatids (Oza et al., 2005). 
 
Most organisms rely on the supply of cysteine via the reverse 
transsulphuration pathway (see Figure 4.6) or on amino acid uptake (Nozaki 
et al., 2001; Williams et al., 2009). Leishmania have been shown to contain 
not only the reverse and forward transsulphuration pathways (Williams et 
al., 2009) but also possess the cysteine de novo biosynthesis pathway. This 
provides them with at least two pathways to generate this important amino 
acid (Williams et al., 2009). In addition, the parasites can take up cysteine 
from their environment, although the rate of transport determined is much 
lower than that found in another trypanosomatid T. brucei (Duszenko et al., 
1992), another trypanosomatid. These findings are in line with the lack of 
the cysteine de novo biosynthesis pathway in T. brucei (Duszenko et al., 
1992).  
 
Given this unusual metabolic situation in Leishmania, it was postulated that 
in these organisms the de novo biosynthesis of cysteine in these organisms 
might have essential functions. In a number of other prokaryotes and 
eukaryotes such as H. influenza, Mycobacterium tuberculosis, A. thaliana 
and S. cerevisiae, the cysteine de novo biosynthesis pathway has been 
studied and found to offer potential for drug discovery (Huang et al., 2005; 
Poyraz et al., 2013; Schnell et al., 2007; Thomas and Surdin-Kerjan, 1997). 
 
The two key enzymes of the pathway are serine acetyltransferase (SAT) and 
cysteine synthase (CS). SAT and CS are known to form a complex that 
promotes SAT activity and inhibits CS activity (Berkowitz et al., 2002; 
Francois et al., 2006; Salsi et al., 2010; Zhao et al., 2006). Upon O-
acetylserine (OAS) formation the complex dissociates releasing CS, which 
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then converts OAS to cysteine (Berkowitz et al., 2002; Francois et al., 2006; 
Salsi et al., 2010; Zhao et al., 2006). It was previously found that this 
interaction between the two enzymes also occurred between the L. major 
recombinant proteins (Williams et al., 2009), this formed the basis of the 
hypothesis tested in this study that C-terminal peptides derived from the C-
terminal amino acid sequences of a variety of SAT may have inhibitory 
activity on Leishmania CS.  
 
To assess the essentiality of the sulphydrylation pathway and in particular 
CS for the survival of L. donovani, the gene encoding CS was knocked out by 
a previous member of the Müller lab and the parasites were used to 
inoculate hamsters with the aim to assess their virulence. Alongside L. 
donovani cs, the re-expressing line and the wild type L. donovani were 
used to infect the animals. When I joined the lab, the hamsters had been 
infected about 6 months earlier and it was time to analyze their parasite 
load.  
 
Overall, wild type L. donovani had successfully infected four out of six 
hamsters and the cs line was found to have infected two out of six infected 
hamsters. Surprisingly, the re-expressing line had not infected any of the six 
hamsters. As outlined in chapter 4, the RE line was found not to express the 
full-length CS protein which could be one reason for the lack of the 
parasites to establish a successful infection in the animals. Another reason 
however could be that the episomal expression plasmid from which CS was 
expressed in the RE line was lost while in the animal – no selection for 
plasmid was carried out during the 6 months of incubation. However, the 
loss of CS re-expression should not have had a completely deleterious effect 
on parasite infectivity, given that the cs line was able to successfully infect 
the hamsters (albeit at a lower efficiency than the wild type parasites, 
suggesting some reduction in virulence).   
 
The results from the in vivo infectivity assays did not rule out that L. 
donovani CS has some importance in the infectivity and virulence of the 
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parasites in their mammalian host. In order to obtain a better understanding 
of the effect of the CS knockout on the physiology of Leishmania 
promastigotes, a number of assays were performed. First the thiol levels of 
wild type, cs and RE were analyzed throughout their growth phases. The 
major thiol detected in all growth phases of L. donovani WT, cs and RE (lag 
phase, logarithmic phase and stationary phase) was trypanothione followed 
by glutathione and cysteine. Other peaks were detected by the HPLC system 
used but their identity was not followed up. My data compared well with 
those previously published for L. donovani (Jiang et al. 1999), although 
Ariyanayagam and Fairlamb report much higher levels of trypanothione in 
stationary phase of L. donovani that are more similar to those that I 
determined during log phase of parasite growth (Ariyanayagam and 
Fairlamb, 2001). Thiol levels previously determined in other species of 
Leishmania showed some variability between Leishamania species and also 
between trypanosomdatid species (see Table 5.1).  
 
Compared to the WT, the cs line had  a lower level of total thiols. This was 
most obvious during the early log phase of parasite growth. The RE line did 
not show this reduction of thiols during the log phase of growth suggesting 
that the decreased thiol levels in cs is attributable to the loss of CS 
activity.   In late log phase, the thiols in cs appear to recover although they 
are still lower than those detected in WT and RE lines. The recovery of the 
thiol levels may be due to the activation of the reverse-transsulphuration 
pathway compensating for the loss of the sulphydrilation pathway, which 
was tested by analyzing the relative expression of CBS, the rate-limiting 
enzyme of the reverse-transsulphuration pathway. My results show a 
significant increase in cbs mRNA levels which translate to a ~3 fold increase 
in CBS protein levels in the cs line, supporting the suggestion that CBS may 
compensate to some extent for the loss of CS activity. Also Williams et al. 
(2009) showed that LmjCBS has LmjCS activity and thus LdCBS might in this 
case be replacing the activity of LdCS. 
 
 
 
 
 
 
 
 
 
 
 
Table 5.1 – Thiol levels in trypanosomatids. 
The table shows the level of Cys, GSH and TSH in trypanosomatids in different stages of growth. Strain: (1) BPK206, (2) LV9 
(MHOM/ET/67/HU3), (3) LV9 (MHOM/ET/67/HU3), (4) MHOM/IL/80/Fiedlin, (5) MHOM/SA/85/JISH118, (6) TarII WT, (7) 
MNYC/BZ/62/M379, (8) MHOM/ET/72/L100, (9) MHOM/SU/74/K27, (10) HS6, (12) MHOM/BR/78/Silvio, (12) S427 c118.
   Thiol levels (nmol/108 cells) 
Specie Life cycle stage Growth stage Cys GSH TSH Reference 
L. donovani 1 Promastigotes Log 0.8 ± 0.1 1.4 ± 0.2 4.2 ± 0.7 Section 4.2.6.1 
L. donovani 1 Promastigotes Log 0.9 ± 0.1 1.7 ± 0.2 5.2 ± 0.4 Section 4.2.6.1 
L. donovani 1 Promastigotes Late-log 0.5 ± 0.1 1.0 ± 2.2 1.8 ± 0.9 Section 4.2.6.1 
L. donovani 1 Promastigotes Stationary 0.3 ± 0.0 0.7 ± 0.1 3.0 ± 0.4 Section 4.2.6.1 
L. donovani 2 Promastigotes Late-log  2.15 ± 0.37 8.23 ± 1.08 (Jiang et al., 1999) 
L. donovani 3 Promastigotes Stationary  4.8 ± 1.0 6.3 ± 0.5 (Ariyanayagam and Fairlamb, 2001) 
L. major 4 Promastigotes Late-log 1 2 6 (Williams et al., 2009) 
L. major 5 Promastigotes Stationary  0.6 ± 0.1 2.9 ± 0.9 (Ariyanayagam and Fairlamb, 2001) 
L. tarentolae 6 Promastigotes Mid-log 0.13 0.09 0.1 (Mukhopadhyay et al., 1996) 
L. mexicana 7 Promastigotes Stationary  0.9 ± 0.1 3.5 ± 0.7 (Ariyanayagam and Fairlamb, 2001) 
L. aethiopica 8 Promastigotes Stationary  0.7 ± 0.1 1.9 ± 0.2 (Ariyanayagam and Fairlamb, 2001) 
L. tropica 9 Promastigotes Stationary  1.7 ± 0.3 1.5 ± 0.2 (Ariyanayagam and Fairlamb, 2001) 
C. fasciculate 
10 
Choanomastigote 
Stationary 
 4.6 ± 0.5 7.8 ± 1.4 (Ariyanayagam and Fairlamb, 2001) 
T. cruzi 11 Epimastigote Stationary  2.1 ± 0.2 6.4 ± 0.2 (Ariyanayagam and Fairlamb, 2001) 
T. brucei 12 Epimastigote Stationary  2.1 ± 0.2 3.3 ± 0.5 (Ariyanayagam and Fairlamb, 2001) 
C
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This work aimed to assess the essentiality of the cysteine synthase and its 
suitability as a putative drug target. Leishmania cysteine synthase can be 
inhibited and its inhibition should directly affect the synthesis of 
trypanothione, the main defense against xenobiotics and oxidants for these 
parasites.  
 
The fact that the CS knockout had a negative effect on thiol levels in the 
cs parasites, prompted me to test the effect of pro-oxidants and metal 
stressors on the parasite mutants in comparison to wild type L. donovani. 
The defense against oxidative and metal stress depends directly on the level 
of low-molecular thiols in Leishmania (Krauth-Siegel and Leroux, 2012). The 
WT, cs and RE lines‟ susceptibilities to potassium arsenate and cadmium 
chloride were tested to assess the importance of CS in the mechanism of 
defense against these species.  
 
Previous studies have shown that arsenite and antimonial resistance are 
both linked to overexpression of TSH, which results from the overexpression 
of -GCS (rate-limiting enzyme of GSH synthesis) and ODC (rate-limiting 
enzyme of polyamine synthesis). Together this leads to the overexpression 
of TSH, which forms conjugates with these species. As explained before, 
these conjugates are extruded from the parasites via efflux pumps (Haimeur 
et al., 1999; Legare et al., 2001; Mukhopadhyay et al., 1996; Wyllie et al., 
2010). In the absence of CS the cs line was more resistant to potassium 
arsenate. From the literature it would be expected that the cs line would 
be more sensitive to potassium arsenate. The TSH-arsenite conjugate 
extrusion coupled with lower level of all thiols in this line should make this 
line more sensitive (Rai et al., 2013). It is possible that the increased 
expression of the transsulphuration pathway may have compensatory effects 
particularly when stresses are applied to the parasites that explain this 
observation. To assess this, it would be interesting to analyze the level of 
cbs mRNA and CBS protein as well as  the level of thiols in the presence of 
potassium arsenate.  
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Studies in plants have shown that cadmium stress is associated with increase 
of CS activity and expression of the serine acetyltransferase gene family 
(Fediuc et al., 2005; Howarth et al., 2003; Kawashima et al., 2004). In the 
absence of CS the cs line is more sensitive to cadmium chloride and the RE 
line is more resistant than the WT line. This result is in good agreement with 
what was observed in the plants.  
 
The detoxification of peroxides in trypanosomatids depends on 
trypanothione, trypanothione reductase and tryparedoxin. These reduce 2-
Cys-peroxiredoxin-type tryparedoxin peroxidases (Figure 1.10) (Castro et 
al., 2002a; Lin et al., 2005; Wilkinson et al., 2003).  The detoxification of 
hydrogen peroxide, cumene hydroperoxide, and tert-butyl hydroperoxide 
was assessed in the WT, cs and RE lines. The absence of cysteine synthase 
had no significant effect on the resistance towards hydrogen peroxide and 
cumene hydroperoxide.  The cs line was more resistant to tert-butyl 
hydroperoxide. The cases of resistance to this species reported in the 
literature are associated with overexpression of the mitochondrial 2-Cys-
peroxiredoxin-type tryparedoxin peroxidases in L. amazonensis (Castro et 
al., 2002b; Lin et al., 2005). It is not known whether the absence of cysteine 
synthase results in increased levels of these peroxidases. Further studies 
need to be done.  
 
As an inhibitor of PLP-dependent enzymes, it was postulated that 
propagylglycine (PAG) might have a more pronounced effect on cs line than 
WT and RE L. donovani. Surprisingly, my data suggests that the cs line is 
significantly more resistant to PAG than the WT line. This is somewhat 
surprising although (Williams et al., 2009) have shown in his study that the 
L. major recombinant CS protein is not sensitive to inhibition by PAG 
supporting the interpretation that the loss of CS should not necessarily 
affect the susceptibility to the this inhibitor. When incubating WT, cs and 
RE lines with PAG for 24 hours at increasing concentrations and subsequently 
measuring the thiol level of the treated parasites, it was obviously that PAG 
generally led to the reduction of thiols in all three parasite lines. The most 
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severe effect was found in the WT line where trypanothione levels were 
reduced by 89 % when the parasites were treated with 250 µM PAG. Similarly 
the GSH levels were greatly reduced in these parasites. There are a number 
of possible explanations for these findings – (1) the levels of glutathione and 
trypanothione are severely affected because the source of cysteine is 
limiting and (2) the synthesis of trypanothione is affected because the 
source of glutathione may be negatively affected by CS deletion. Another 
possible explanation for the severe reduction of trypanothione levels may 
also be that PAG not only affects the activity of reverse transsulphuration 
and sulphydrylation pathways, but also inhibits ornithine decarboxylase 
(ODC, another PLP-dependent enzyme) therefore disturbing the supply of 
the polyamine spermidine, necessary for trypanothione biosynthesis (see 
Figure 4.6) in the parasites.  
 
ODC is one of the rate-limiting enzymes for polyamine biosynthesis and is 
responsible for the conversion of ornithine into putrescine (Boitz et al., 
2009). ODC is inhibited by difluoromethylornithine (DFMO), an irreversible 
suicide inhibitor of this enzyme (Coons et al., 1990; Kaur et al., 1986; Poulin 
et al., 1992). This drug has proven very effective against T. b. gambiense 
(Fairlamb et al., 1987). This is primarily because the turnover of the ODC 
protein in Trypanosomatids is relatively slow which allows the irreversible 
inhibitor to exert its effects leading to a reduction in polyamines and 
consequently trypanothione levels. These alterations eventually affect the 
ability of the parasites to multiply and they differentiate into forms that no 
longer change their variant surface glycoprotein so that the human immune 
system can remove them. In addition, the parasites are unable to recover 
from the loss of ODC through polyamine uptake and without polyamines the 
level of trypanothione lowers leaving their antioxidant capability seriously 
compromised (Hanson et al., 1992; Hasne and Ullman, 2005).  DFMO in 
Trypanosoma forms a Schiff base with the PLP of one of ODC‟s monomers 
and forms a covalent bond to the Cys of the other monomer. This induces a 
145 rotation of the Cys residue towards the active site (Grishin et al., 
1999). Leishmania has the ability of taking up polyamines from the media 
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and this is believed to be what makes this inhibitor not a suitable drug 
against these parasites. It does however affect cell growth in the absence of 
polyamines in the culture medium (Basselin et al., 2000; Burchmore and 
Barrett, 2001). When assessing whether the levels of ODC are in anyway 
affected in the L. donovani cs lines, I performed RT-PCR and discovered 
that ODC mRNA levels are greatly increased in the mutant parasites. 
However, this does not translate into the over-expression of the protein but 
the western blot analyses of cs shows that the ODC protein is virtually 
absent from these parasites. It is not unusual to see this incongruence in 
trypanosomatids. The mRNA in trypanosomatids is transcribed as 
polycistronic units and it is not regulated at the level of transcription 
initiation. The gene expression is thus regulated post-transcriptionally 
through changes in message stability, protein stability or through 
translational regulation (Martinez-Calvillo et al., 2010; Willert and Phillips, 
2008). Despite this very low level of ODC protein, the mutant parasites must 
contain sufficient ODC to generate spermidine for the synthesis of their 
trypanothione that I detected albeit this synthesis may operate at reduced 
levels.   
 
Protein extraction is usually carried at around day 5 when the cells are at 
the right density. The TSH levels on this day are about 4 nmol/108 cells. 
However on day 4 all the thiols are low (not only TSH) so this should not only 
be a result of low ODC, but also low cysteine synthesis. As outlined above, it 
is intriguing how ∆cs is able to survive on such a low levels of ODC, however 
it is known that this absence can be circumvented by polyamine uptake from 
the media (Jiang et al., 1999). (Jiang et al., 1999) have shown that ∆odc 
mutants are polyamine auxotrophs. The ∆odc mutants were able to take up 
putrescine from the medium and restore the polyamines pools, whereas 
spermidine by itself was not able to restore putrescine lavels. This is an 
indication of the absence of polyamine catabolism pathway in these 
parasites (Jiang et al., 1999). However, the levels of conjugated spermidine 
and TSH were reduced with an accumulation of GSH. Interestingly this is not 
what I observe – the GSH levels are not accumulated in the ∆cs line, which 
Chapter 5 – Discussion                                                                                       167 
 
 
may well be a result of the loss of CS biosynthesis. In this situation L. 
donovani may be challenged as GSH may have roles in maintenance of redox 
homeostasis that do not allow its complete depletion for the cells. In order 
to achieve this it is possible that spermidine biosynthesis is reduced and that 
trypanothione degradation is increased in an effort to maintain redox 
homeostasis and spermidine provision for instance DNA stabilization. These 
are clearly speculations that need to be tested in future studies. To further 
assess my data I performed DFMO inhibiton studies on WT, ∆cs and RE lines. 
The L. donovani DFMO IC50 values vary between 30 and 125 µM (Basselin et 
al., 1997; Coons et al., 1990; Kaur et al., 1986; Mukhopadhyay et al., 1996).  
 
The DFMO IC50 values for the WT and RE determined here are 48 and 45 µM, 
respectively. The cs line appeared entirely resistant to DFMO, even at 
concentrations as high as 10 mM DFMO no inhibition of parasite growth was 
observed. One reason for this observation may be that there is a great 
reduction of ODC activity present in these parasites already - presumably 
they rely heavily on polyamine uptake to allow their survival. This however, 
was not tested in this study and is something to investigate in future work. 
 
To assess whether the absence of ODC is affecting the polyamine levels in 
the ∆cs line, the level of polyamines should be determined. Unfortunately 
due to time constraints it was not possible to complete this part of my 
study. The preliminary data suggests however that the ∆cs line has lower 
polyamine levels than the WT line. The data are in general agreement with 
those previously determined in L. donovani and it would certainly be worth 
following these analyses up in future studies. Low levels of polyamines are 
linked with growth arrest of L. donovani parasites. Should the mutant line 
have lower levels of polyamines, this could certainly explain the growth 
defect observed. 
 
Recombinant L. major cysteine synthase enzymes carrying N-terminal or C-
terminal His-tags were expressed in E. coli and purified via Ni-agarose ion-
affinity chromatography. The C-terminally His-tagged LmjCS was previously 
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studied in detail by (Williams et al., 2009) and it was readily available in the 
lab. A second LmjCS construct with a cleavable N-terminal His-tag was 
generated and recombinantly expressed in order to assess the influence of 
the tag on the kinetic profile of the resulting recombinant protein and to 
utilize the non-tagged protein for crystallization trials.  
 
The three LmjCS enzymes (N-terminally His-tagged, C-terminally His-tagged 
and non-tagged CS) were generated in mg amounts and their kinetic 
parameters were analyzed.  
 
The results show that the Km values for OAS of the three LmjCS enzymes are 
in the same range - 4 mM. The His-tag clearly did not affect the affinity of 
CS to one of its substrates. However, the turnover of the substrate by the 
enzyme is affected by the His-tag and I found that the Vmax of N-terminally 
tagged rLmjCS is double that of untagged rLmjCS and C-terminally tagged 
rLmjCS.  
 
Table 5.2 shows the kinetic parameters of a variety of CS enzymes of other 
species in comparison with the data obtained in this study. If not 
mentioned, the biochemical assay used to determine these parameters was 
the one described by (Kredich and Tomkins, 1966). The enzymes 
characterized T. vaginalis and A. pernix have very high  Km values for OAS 
(39.6 and 28 mM, respectively). This is due to the fact that these organisms 
do not use OAS as a substrate for CS but their preferred substrate OPS which 
has a much more favorable Km value of ~30 mM.   
 
L. donovani (Raj et al., 2012), S. typhimurium (Tai et al., 1993) and L. 
major (Williams et al., 2009) have been reported to have Km values in the 
range of 15-18.2 mM, which is about four times higher than the Km values 
that I determined for the three enzymes tested here. Often these variations 
can be attributed to different  operators and emphasizes that the 
comparison of kinetic parameters showing only small variations may simply 
be within the experiential error rather than being physiologically and 
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biologically meaningful. A good example is the S. typhimurium where the Km 
is five times higher in Becker et al. (1969) than in Tai et al. (1993). The 
calculated Vmax  (3,300 mol/min/mg) based on the data provided in the 
`Williams et al. (2009) work, is three times higher than the highest Vmax 
determined in this work (N-rLmjCS – 1,192 mol/min/mg), and the turnover 
number (2,047 sec-1) is 2.5 times higher than the N-rLmjCS‟s (751 sec-1). The 
efficiency of the enzyme is not however affected as both have the same 
order of magnitude (~105 M-1sec-1). 
 
Low Km shows the specificity of the enzyme towards the substrate. The three 
A. thaliana CS enzymes have relatively low Km values of ~0.5 mM.  
The finding that the His-Tag (whether N- or C-terminal) has little if any 
effect on CS affinity to its substrate but may marginally affect catalytic 
efficiency of the enzyme. This is also in agreement with kinetic analyses 
reported for AtCS enzymes.  
 
Overall this study shows that the His-tag is not affecting the kinetics of the 
LmjCS. Either recombinant His-tagged enzyme can be used in biochemical 
assays to characterize the native non-tagged LmjCS without the need of 
extra His-tag digest and purification steps. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Table 5.2 – Kinetic characterization of the CS enzymes in difference species.  
This table compares the CS enzymes in terms of maximum velocicy (Vmax, mol/min/mg), Michaelis-Menten constant (Km, mM), 
turnover number (Kcat, sec
-1), and catalytic efficiency (Kcat/Km, M
-1sec-1). *Using 5-thio-2-nitrobenzoate (TNB, 412 nm) as an alternative 
substrate to sulphide. 
§
 Calculated. ¶ Reverse-phase HPLC. 
#
 Acid-ninhydrin reagent (546 nm). 
Species His-tag 
Vmax 
(mol/min/mg) 
Km  
(mM) 
Kcat  
(sec-1) 
Kcat/Km  
(M-1sec-1) 
Reference 
L. major 
N-
terminal 
1,192 ± 58 
4 ± 0.3 751 1.9x105 Section 3.6.2 
L. major C-terminal 696 ± 24 4 ± 0.2 438 1.1x105 Section 3.6.2 
L. major - 630 ± 28 4 ± 0.3 373 9.3x104 Section 3.6.2 
L. major C-terminal 3,300
§
 17.5 ± 4.8 2,047 1.2x10
5 (Williams et al., 2009) 
L. donovani* C-terminal  18.2 ± 0.2   (Raj et al., 2012) 
A. thaliana (type A)
¶
 - 906 ± 39 0.7 ± 0.1   (Wirtz et al., 2004) 
A. thaliana (type B)
¶
 - 592 ± 8 0.3 ± 0.02   (Wirtz et al., 2004) 
A. thaliana (type C)
¶
 - 534 ± 9 0.4 ± 0.02   (Wirtz et al., 2004) 
A. thaliana
#
 C-terminal  1.4 ± 0.2 1,780 ± 280 1.3x10
6 (Bonner et al., 2005) 
S. oleacea (type A)
#
 -  1.33   (Warrilow and Hawkesford, 2002) 
S. oleacea (type B)
#
 -  1.16   (Warrilow and Hawkesford, 2002) 
A. pernix
#
   28 202  (Mino and Ishikawa, 2003) 
T. vaginalis C-terminal  39.5 153 ± 44  (Westrop et al., 2006) 
S. typhimyrium  - 
 5 
1.0 ± 0.6 
  
(Becker et al., 1969) 
(Tai et al., 1993) 
S. typhimurium* -  15 ± 3   (Tai et al., 1993) 
E. coli   4.8 2,030  (Mino et al., 2000b) 
Spinach chloroplast   1.3   (Droux et al., 1992) 
Thermus thermophilus    4.8 493  (Mizuno et al., 2002) 
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As mentioned before, CS and SAT form a bimolecular complex where the C-
terminus of SAT interacts directly with the active site of CS and leads to its 
inhibition (Berkowitz et al., 2002; Raj et al., 2012; Wirtz and Hell, 2006; 
Zhao et al., 2006). Detailed analyses of the plant and also bacterial enzymes 
showed that the last 10 amino acids of MtSAT and AtSAT are sufficient to 
lead to CS inhibition and analyses of EcSAT with EcCS showed that the 
carboxyl group of the final Ile of the protein occupies the same position in 
CS as the carboxyl group of the aminoacrylate intermediate that is 
generated during the catalytic cycle of CS. Therefore it can be presumed 
that the C-terminal Ile of SAT blocks the CS active site and hinders PLP from 
binding to active site Lys residue (Francois et al., 2006; Mino et al., 2000a; 
Schnell et al., 2007).  
 
The non-tagged recombinant LmjCS was used for crystallization trials 
resulting in the generation of crystals of the parasite protein. One important 
aspect of the analyses of these crystals was that polyglutamate (PGA) was 
found to have bound to the active site of LmjCS while  PLP was missing from 
the structure (Fyfe et al., 2012). It was hypothesized that perhaps PGA may 
be an inhibitor for the CS activity in a similar way to small peptides. 
Therefore not only C-terminal peptides of SAT but also the PAG enantiomers 
were tested for their inhibitory activity towards LmjCS. The results show 
that D-γEγEγEγE inhibited 20% of C-rLmjCS‟s activity however it was non-
concentration dependent. Five times increase in the inhibitor concentration 
should result in an increased inhibition which was not the case. Therefore 
this inhibition was considered negligible and may be due to variations in the 
assays performed. The PGA also failed to inhibit N-rLmjCS and rLmjCS. 
Overall it was therefore concluded that PGA does not inhibit LmjCS and its 
presence in the active site might result from its high concentration in the 
crystallization buffer. Additionally this impeded co-crystallization studies 
with SAT C-terminal based peptides (Fyfe et al., 2012).   
 
Other peptides that were tested for their inhibitory effect on LmjCS were 
the A. thaliana SAT C-terminal peptide DYVI and the Leishmania SAT C-
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terminal peptide GDGSGI. Surprisingly, DYVI at 0.1 mM inhibited ~90% of 
LmjCS in contract with only ~40% inhibition by EGDGSGI when used at the 
same concentration. The same is observed in E. histolytica where EhSAT 
peptide SPSI inhibits 30% of EhCS in contrast with DFSI peptide (MtSAT C-
terminal) that inhibits 50% of activity of EhCS (Table 5.3) (Kumar et al., 
2011). A whole variety of peptides were tested against various CS proteins 
from different sources (summarised in Table 5.3). Clearly the length and the 
type of amino acid composition of these peptides affected their inhibitory 
efficiency and it becomes clear that cross-species inhibition seems to be a 
common theme (Fyfe et al., 2012; Raj et al., 2012; Wang and Leyh, 2012) 
(Table 5.3). 
 
Salsi et al. (2010) demonstrated through a docking study the importance of 
the terminal Ile and the second and third last amino acids of the peptide. 
Replacing the third last amino acid of MtSAT from phenylalanine to 
tryptophan (DWSI), both with large side chains, increased the inhibitory 
effect of the peptide from 50% to 54%. When phenylalanine was replaced by 
tyrosine (DYSI), also with a large side chain, the inhibitory effect was 
unchanged. On the other hand, when the second and third last amino acids 
were replaced by amino acids with small side chains (DPTI and DTTI), the 
ability to inhibit EhCS decreased significantly (42.17% and 29.96% 
respectively) (Kumar et al., 2011). The same is observed in L. donovani 
where peptides with large side chains (DFSI, DYSI and DWSI) inhibit ~50% of 
LdCS in contrast with peptides with small side chains (DPTI and DTTI) that 
inhibit ~40% (Raj et al., 2012). The authors have also demonstrated that 
larger side chains result in tighter interactions using binding dissociation 
studies. This clearly shows the potential of these peptides as future lead 
compounds to generate inhibitors acting against CS proteins. 
 
Wang et al. (2012) demonstrated that the E. coli CS-SAT complex passes 
through a pre-steady state phase before reaching the final conformation. 
This pre-steady state conformation is similar to the one observed when a 10 
amino acid peptide based on C-terminus of EcSAT is used instead of the full 
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length EcSAT (Wang and Leyh, 2012). This suggests that more than the last 4 
or 5 amino acids of SAT are required to allow the full interaction of SAT with 
the CS active site; suggesting that longer peptides need to be considered 
and that their composition acquired by using peptide scans would be useful 
to dissect the required interactions (Wang and Leyh, 2012). For instance it 
was shown that LmjCS is more sensitive to the 7 amino acids of LmjSAT 
(EDGGSGI) than the last 4 amino acids (GSGI) (Fyfe et al., 2012). The 
inhibition of LdCS by the last 8 amino acids of LdSAT (LERDGSGI), and LmjCS 
by the last 7 amino acids of LmjSAT (EGDGSGI) was comparable (48.8% and 
40% respectively) (Fyfe et al., 2012; Raj et al., 2012). Additionally, Ile 
alone, although having a major role in the binding to the active site and 
impeding the formation of the aminoacrylate intermediate during the 
catalysis of CS, was not able to inhibit LmjCS at a concentration of 4 mM 
(Fyfe et al., 2012). This with the previous information highlights the role of 
all the interactions made by amino acids in preceding positions in the 
inhibition of CS. 
 
The potential of these peptides has been proven to be immense and thus 
there is a need to develop non-toxic high-throughput screening biochemical 
assay that would allow the screening of several peptides in a 96-well plate. 
The present study demonstrates the potential of CPM as a detection method 
that allows high-throughput screening of small peptide inhibitors and also 
potential other chemical libraries against CS. One of the first challenges 
faced when testing this component was the background that is generated by 
the internal fluorescent of CPM and some of the essential components used 
in the enzyme assay. Na2S had the most pronounced effect on fluorescent 
background generation, as did BSA.  The thiol groups of the cysteines 
present in the BSA protein can form complexes with CPM generating high 
background, when BSA was used as protein stabilizer. Replacing  BSA with 
gelatin significantly reduced this background. It was also not surprising that 
Na2S caused background reaction with CPM given that the equilibrium 
between Na2S <-> NaS
- <-> S2- at pH 7-8 promotes complex formation of the 
ionized Na2S with CPM generating fluorescence background. Lowering the pH 
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to 6.5 did not decrease the background (Wirtz et al., 2004). The signal to 
noise ratio did not improve by lowering the CPM concentration from 100 
g/mol to 25 g/mol and variation in the fluorescence was observed when 
CPM was stored. With the assay optimised, cysteine synthesis was 
successfully detected using CPM in a 96-well plate. Further, 94% LmjCS 
activity inhibition was detected by the system. The AtSAT based peptide 
(DYVI) IC50 was determined (2 M), which is 3.5 times lower than the DYVI 
IC50 determine using the mercury-chloride assay (7 M, Table 5.2) (Fyfe et 
al., 2012). 
 
Overall the CPM detection assay is a significantly less toxic assay system 
when compared with the mercury chloride assay. Far fewer steps and 
reagents allow a much swifter assay performance and the fact that it is 
amenable to reduced volumes such as microtitre plate volumes, makes it an 
attractive alternative to the conventional mercury chloride assay system.  
An improved assay system is not only an interesting development for the 
assessment of Leishmania CS activity but also for the testing of CS proteins 
from other sources i.e. plants and other microorganisms where the inhibition 
of this crucial enzyme may have a more pronounced effect than in 
Leishmania.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.3 – Analyses of the C-terminal of SAT as model for putative CS inhibitors. 
This study is based on the cysteine synthase complex formation that results on the inhibition of cysteine synthase 
activity. The table presents the inhibition data collected from studies done in different species using SAT C-terminal as 
a base to design small peptide inhibitor of CS.
CS Specie C-terminal SAT (Specie) IC50 Ki % Inhibition Reference 
L. major DYVI (A. thaliana)   ~90 Section 3.7 
L. major EGDGSGI (L. major)   ~40 Section 3.7 
L. major GSGI (L. major) 1.5 mM   (Fyfe et al., 2012) 
L. major EGDGSGI (L. major) 270 M   (Fyfe et al., 2012) 
L. major DYVI (A. thaliana) 7 M 4 M  (Fyfe et al., 2012) 
L. major I > 4 mM   (Fyfe et al., 2012) 
L. major N-blocked derivatives 250 M   (Fyfe et al., 2012) 
L. donovani DPTI   45.7 ± 3 (Raj et al., 2012) 
L. donovani DTTI   37.3 ± 2 (Raj et al., 2012) 
L. donovani DFSI (large side chains)   48.8 ± 2 (Raj et al., 2012) 
L. donovani DYSI (large side chains)   52.9 ± 2 (Raj et al., 2012) 
L. donovani DWSI (large side chains)   54.6 ± 1 (Raj et al., 2012) 
L. donovani LERDGSGI (L. donovani)   48.8 ± 4 (Raj et al., 2012) 
H. influenza GIDDGMNLNI (E.coli) 130 nM   (Huang et al., 2005) 
M. tuberculosis DFSI (M. tuberculosis)  5 M  (Schnell et al., 2007) 
E. histolytica SPSI  (derived from EhSAT)    30.19 ± 1.6 (Kumar et al., 2011) 
E. histolytica DFSI (M. tuberculosis)   50.41 ± 0.7 (Kumar et al., 2011) 
E. histolytica DPTI   42.17 ± 5.7 (Kumar et al., 2011) 
E. histolytica DTTI   29.96 ± 4.0 (Kumar et al., 2011) 
E. histolytica DYSI (large side chains)   52.17 ± 0.9 (Kumar et al., 2011) 
E. histolytica DWSI (large side chains)   54.64 ± 2.8 (Kumar et al., 2011) 
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6 Conclusion and Future work 
There is certainly a need for finding new drug targets in Leishmania as more 
cases of resistance arise and people are left with drugs that cause serious 
toxic side effects. The present work has highlighted that the parasite‟s thiol 
metabolism in particular the generation of cysteine may be an exploitable 
way of interfering with the parasite‟s viability and virulence. However CS 
itself may not present the ideal drug target as its removal from the parasites 
had only led to the reduction of mammalian infectivity. This clearly means 
that the parasites equipped to compensate the lack of sulphydrylation 
pathway potentially by resorting to the reverse trans-sulphuration pathway. 
This was particularly seen in the exposure to pro-oxidants and metal 
stressors, where the ∆cs line did not show sensitivity to any stressors. 
Another good indication of this is the over-expression of CBS mRNA and 
protein. A double knockout would certainly help to test this hypothesis. 
From the thiol measurements it appears that the reverse trans-sulphuration 
pathway might not be sufficient to maintain the thiol levels throughout the 
growth phases of promastigotes. Perhaps this has an effect on associated 
pathways such as the polyamine biosynthesis pathway as shown by the 
down-regulation of ODC. Low level of GSH resultant from low levels of 
cysteine, would possibly lead to an accumulation of spermidine in the cell. 
Also if no cysteine is converted into methionine by the forward trans-
sulphuration pathway also operating in the parasites, the decarboxylated S-
adenosylmethionine will be possibly lacking for the polyamine biosynthesis. 
Although (Williams et al., 2009) has shown that L. major can uptake 
methionine from the medium and increase the thiol pool by RTS pathway the 
methionine levels may be limiting in the culture conditions and it should be 
tested whether an increase in external methionine (or in fact its withdrawal) 
affects parasite thiol and polyamine pools as well as their survival.  
Because this study was carried in promastigotes it is not known whether the 
two pathways generating cysteine are operating in all parasite stages. It is 
essential that the pathway to be impaired by a putative drug would also 
affect the amastigote stage. Despite the fact that the in vivo experiments 
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suggest that the CS mutants are infective to the vertebrate host it would 
still be informative to assess this infectivity using macrophage infections in 
vitro.  
 
The CS can be inhibited by small molecule peptides. The promising results 
from the CPM assay shows that high-throughput screening of small peptide 
inhibitors is possible with low toxicity. It would be interesting to develop an 
inhibitor of PLP-dependent enzymes that would have affinity for both CS and 
CBS enzymes. This study together with (Williams et al., 2009), shows how 
regulated the cysteine biosynthetic pathway is in these parasites, which is a 
strong indication of its essentiality.  
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